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Over the past few decades, the prevalence of allergic disease has been on the rise in both 
developed and developing countries1. There is strong evidence for differences in the 
prevalence of atopic disorders between urban and rural areas in many parts of the world, 
with higher prevalence of allergic diseases reported in urban areas2-7.
The observed urban-rural differences may be influenced by socio-economic status 
(SES)4. The measurement of a child’s SES can be approximated by consideration of 
household income, parental occupation and education level, living conditions, or habitation 
in geographic locations with a predominantly poor population8,9. These variables have each 
been linked with childhood asthma9,10. However, some studies of SES and asthma have 
reported contradictory results. Some have reported that children in families with low SES 
have an increased asthma risk11-14, while others have found an inverse relation between 
low household income and asthma15 or no relationship between asthma and parental SES 
levels16-18. These conflicting results may stem from the complexity of the meaning of SES, 
which can vary between studies, locations and culture10.
Apart from exposure to allergens, altogether environmental factors that may encompass 
or be related to SES, along with genetics, play a key role in the development of allergic 
diseases. Environmental influences can include exposures to pollution, microbes, parasites 
and lifestyle19,20. Of particular interest have been infections with parasitic helminths that are 
highly prevalent in tropical regions of the developing world. It is estimated that a quarter of 
the world’s population is chronically infected with helminths such as Ascaris lumbricoides 
(roundworm), Trichuris trichiura (whipworm), Necator americanus or Ancylostoma 
duodenale (hookworms), schistosomes and filarial worms21.
Despite the close parallels between immune responses that characterize helminth infections 
and allergic diseases, namely increased levels of immunoglobulin (Ig)-E and eosinophils along 
with T cells that preferentially secrete T helper type 2 (Th2) cytokines, the clinical outcome with 
respect to immediate hypersensitivity and inflammation is not the same22. Moreover, there is 
little geographical overlap worldwide between helminth infections and allergies. In fact, several 
studies have reported a negative association between the presence of helminth infections and 
atopic disorders23. However, the relationship between atopic disorders and helminth infections 
is not always consistent since there are also studies that show that helminth infections have no 
effect or are associated with increased atopic disorders24,25.
HELMINTH INFECTIONS AND ATOPIC DISORDERS
The prevalence of allergic diseases has been increasing mainly in the developed world 
where changes in lifestyle and environment have taken place, characterized by increasing 
sanitation, hygienic measures and urbanization including pollution. In less developed 
countries, the prevalence of atopic disorders is relatively low but the so-called “allergic 




and the environment. Although not as pronounced as in western countries, atopic disorders 
are prevalent in developing countries with the tendency for prevalences in urban centers to 
approach those seen in affluent countries.
In developed countries, the presence of IgE antibodies to allergens increases the risk 
of atopic disorders. These antibodies which bind to high affinity IgE receptors present on 
effector cells of the allergic response, i.e. to mast cells and basophils. These IgE antibodies 
can be cross linked by allergens, an event that leads to effector cell degranulation including 
histamine release. The mast cell degranulation leads to inflammation and if the target 
organ is the airways it can result in symptoms which can be recognized as an asthmatic 
attack. One of the diagnostic methods for allergy is to perform a skin prick test26. This 
is based on applying allergens to the skin, pricking the skin with a lancet and assessing 
whether a reaction develops to the allergen within 15 minutes. A wheal swelling and flare 
(redness) reaction induced by degranulation of skin-resident mast cells is considered as 
proof of sensitization to the allergen extract applied. In developed countries, the skin prick 
test (SPT) is often interchangeable with the measurement of IgE antibodies to allergens 
by in vitro tests27, i.e. both tests usually show quite close correlation, with a positive test 
frequently (but not always!) being associated with clinical allergy. However, the relationship 
between IgE, SPT and symptoms of allergy can be different in different geographical areas. 
For example, the proportion of SPT reactivity in allergic asthma appears to be much smaller 
in some rural areas compared to urban centers in Europe28 or in many developing nations 
compared to developed ones29,30. Helminth infections have some interesting effects on the 
relationship between IgE, SPT and clinical symptoms.
Several epidemiological studies have shown that helminth infections can be negatively 
associated with allergic outcomes23. Some studies have shown that having schistosome or 
filarial infections decreases the risk of SPT positivity31,32. Similarly, studies in Ecuadorian 
and Vietnamese children have demonstrated that having soil transmitted helminth 
infections decreases the risk of SPT positivity33,34. In addition, Cooper et al. found that 
the presence of serological markers of chronic helminth infections (elevated levels of total 
serum IgE or anti-A. lumbricoides IgG4) were independently negatively associated with 
allergen SPT reactivity35. Araujo et al. reported a strong and inverse association between 
skin responses to allergens and infection with Schistosoma mansoni, among persons living 
in an area endemic for this helminth36. Similarly, a study in Gabonese children observed that 
the risk of a positive SPT was reduced by 72% if a child was infected with S. haematobium32. 
Moreover, an investigation conducted among 1385 urban and rural Ghanaian children 
aged 5-16 showed a strong negative association between schistosome infection and SPT 
reactivity to mite but not with reported wheeze or asthma37. However, in regard to clinical 
symptoms of asthma, a case-control study in urban and rural Ethiopians aged 16 to 60 
years, indicated that active hookworm infection reduced the risk of reported wheeze38.
Although the majority of studies have shown a negative association between helminth 
infection and SPT, there are studies that show that helminths may increase the risk of 




factor of atopic disease in populations exposed to mild A. lumbricoides infection24. In line 
with this, a study in China, in an area with a low burden of A. lumbricoides, demonstrated 
a positive association between helminth and allergen skin test reactivity as well as asthma 
risk25. Finally, there are also studies showing no significant association. A study in Brazil 
among patients aged 12 to 30 years with asthma or rhinitis living in an urban area endemic 
for geohelminths showed that individuals infected with a low intensity of A. lumbricoides 
did not differ in the frequency of positive SPT to dust mites from those negative for A. 
lumbricoides living in the same area39. A birth cohort study of children from Ethiopia, 
which investigated the effect of geohelminths on allergic symptoms, at 3 years of age, found 
that there was no association between helminth infections and wheeze nor with eczema40.
Most studies on helminth infections and allergy mentioned above had a cross sectional 
design. Intervention studies using anthelmintic treatment are an important to investigate 
whether helminth infections play a role in atopic disorders. So far, excluding the study in 
this thesis, two randomised placebo-controlled trials with albendazole have been conducted 
but they showed conflicting results. One study conducted in Ecuador, comprising a school-
cluster randomised trial of one year albendazole treatment, reported no change in either 
sensitization to allergens or allergic symptoms41, while another trial in Vietnam showed 
that the prevalence of skin reactivity increased after one year of albendazole treatment 
but, consistent with the Ecuadorean study, clinical allergy did not change significantly42. 
It is difficult to explain these conflicting observations, which may relate to differences in 
treatment regimens (incomplete and/or short-lived helminth eradication), intensity of 
infection, co-infections, reinfections or acute vs chronic infections43,44.
MECHANISMS BEHIND THE ASSOCIATION BETWEEN 
HELMINTHS AND ALLERGIES
Given that most studies seem to show a negative association between chronic helminth 
infections and SPT reactivity, researchers have been looking for the mechanisms that could 
explain this. Although the mechanisms associated with this inverse relationship are not 
fully understood, it has been suggested that strong immune regulatory networks might be 
involved. This means that high levels of suppressory cytokines such as interleukin (IL)-10 
and transforming growth factor-beta (TGF-β) as well as regulatory T and B cells45, which 
seem to expand during chronic infections with helminth parasites, might down regulate 
allergic responses. The question as to where in the allergy cascade they exert their down 
regulatory activity is still unanswered. It is possible that regulatory responses affect Th2 and 
thereby IgE. However, immune regulation could also down-regulate the effector phase of an 
allergic response which involves inflammation induced by mast cell degranulation46. This 
notion is supported by reports showing that IL-10 could inhibit basophil degranulation47 and 
by the negative association between IL-10 and SPT48,49. Regarding antibodies, in the 1970s 
the idea that helminths might induce polyclonal stimulation of IgE-producing plasma cells 




to high affinity IgE receptors on mast cells was first proposed50,51. This competition would 
reduce the chance of an allergen dependent mast cell degranulation and therefore explain 
the absence of strong allergic responses in helminth infected subjects52. However, Mitre et 
al. have shown that the high ratio of polyclonal IgE to allergen specific IgE did not inhibit 
basophil degranulation53. Moreover, it has been shown that increases in IgE result in the 
up-regulation of IgE receptors and that anti-IgE treatment is often accompanied by down-
regulation of IgE receptors which argues against the ability of high total IgE to compete out 
specific IgE54. An alternative hypothesis that helminth infections may be associated with 
increased levels of allergen-specific IgE that are functionally poor and therefore cannot lead 
to basophil or mast cell degranulation55 is gaining support from several recent studies that 
indicate cross-reactive IgE might be associated with poor biological activity56,57.
CROSS-REACTIVITY BETWEEN ALLERGEN  
AND HELMINTH
In general, cross-reactivity reflects the phylogenetic relationship between organisms that 
results in a high degree of homology in the primary structure of proteins58. Cross-reactivity 
occurs when antibodies elicited to one epitope also recognize similar epitopes in other 
homologous molecules59. In allergy, the allergen that is supposed to induce the original 
allergic responses is named the primary sensitizer, and the others are considered cross-
reactive allergens59. Two types of IgE cross-reactivities have been described, one due to 
homologous proteins, and the other due to sugar moieties (complex N-glycans on plant and 
invertebrate glycoproteins) known as cross-reactive carbohydrate determinants (CCDs)58.
Cross-reactive carbohydrate determinants (CCDs) and helminths
The asparagine-linked carbohydrate components of plant and insect glyco-proteins are 
highly cross-reactive and are known as cross-reactive carbohydrate determinants (CCDs)60. 
Two typical non-mammalian substitutions to N-glycans of plant glycoproteins are an 
α(1,3)-linked fucose on the proximal N-acetyl glucosamine and a β(1,2)-linked xylose on 
the core mannose61. Bromelain is a protein from pineapple stem which carries N-glycan 
structure that is often used as a marker for CCDs reactivity.
These CCD epitopes are also found in helminth parasites. The existence of IgE an-
tibodies directed to CCDs was first reported by Aalberse et al. in the early 1980s62. The 
study demonstrated that serum IgE from European pollen or venom allergic patients cross-
reacted with extracts from various allergenic foods. However, treating the extracts with 
periodate, which destroys the carbohydrate structures abolished IgE binding, indicating the 
involvement of carbohydrates in this cross-reactivity62. Another investigation by the same 
group observed elevated levels of IgE against peanut extract among grass pollen-sensitized 
European patients without peanut SPT reactivity or clinical symptoms of peanut allergy63. 




SPT, IgE against CCDs could be detected63. In some of these patients, almost complete 
inhibition of IgE to peanut (as measured by competitive radioallergosorbent test) was 
possible with CCD. In addition, cross-reactive IgE directed against CCDs in this study was 
demonstrated to have poor biologic activity in terms of inducing basophil degranulation63.
The most convincing proof of the complete lack of clinical relevance of CCD-specific 
IgE was reported by Mari et al. in a study where grass pollen allergic patients with high 
titers of CCD-specific IgE were skin tested and subjected to an oral challenge with human 
lactoferrin expressed in rice kernels. This transgenic molecule was substituted with multiple 
IgE-binding glycans, but both SPT and oral challenge were completely negative64. Therefore, 
this study shows that CCDs, although having (poor) biological activity (histamine release 
from basophils) this does not translate into clinical allergy. It has not yet been elucidated 
what the explanation of this lack of clinical relevance is, but the polyvalent conjugation of 
lactoferrin with CCDs demonstrates that it cannot simply be explained by monovalency.
With regard to helminth-induced IgE cross-reactivity, a recent study among schoolchildren 
(aged 5-16 years) in Ghana, West Africa demonstrated how cross-reactivity between helminth 
antigens and allergens can affect IgE sensitization patterns and clinical expression of allergy65. 
In this study the overall prevalence of peanut-IgE sensitization was 17.5% (233 out of 1328). 
However, none of the peanut-IgE sensitized children had either SPT reactivity to peanut or 
reported adverse reactions to peanut. In this study, the presence of S. haematobium infection 
was positively associated with an increased risk of having peanut specific IgE. In a subset 
of this study population, both the CCD marker bromelain and S. haematobium soluble egg 
antigen (SEA) inhibited IgE binding to peanut extract. This study also showed that peanut-
specific IgE was strongly correlated with CCD-specific IgE. These results indicate that much 
of IgE to peanut in Ghanaian children could be directed against CCD which is also present 
in the schistosome SEA. The basophil histamine release assays demonstrated that the IgE 
directed against peanut in this population had low biologic activity65.
This study provides a model which proposes that parasite-induced IgE against CCDs 
that are carried by parasites, might account for high IgE levels to food allergens and the 
finding that this IgE does not lead to reactivity to allergenic extracts either in vitro (in 
basophil release assay) or in vivo (in skin prick testing) further confirms that these IgEs to 
CCDs are clinically irrelevant66.
Peptide cross-reactivity and helminth
Cross reactions between allergens from invertebrates such as for example mite and snail; 
cockroach and Ascaris; mite, shrimp, and cockroach; and mites and schistosomes58 have 
been reported and involve protein cross reactivity. Three of the proteins that are involved in 
these examples are tropomyosin, glutathione S-transferase (GST) and paramyosin58.
Tropomyosins are proteins involved in the contraction of muscle cells along with actin 
and myosin67. Not only are tropomyosins major allergens of seafood, mite and cockroach 




are strong inducers of IgE antibody responses in humans69. Santiago et al. demonstrated 
that there is 72% identity at the amino acid level between the tropomyosin from the filarial 
parasite Onchocerca volvulus (OvTrop) and the house dust mite tropomyosin Der p 1070. 
They showed a strong correlation between specific IgE to Der p 10 and IgE to OvTrop. In 
addition, histamine release from basophils sensitized with the sera of individuals IgE-positive 
to Der p 10 could be triggered by either the OvTrop or Der p 10. It is however important 
to realize that such biological activity is not a proof of clinical allergy. In the study by Mari 
et al. with transgenic lactoferrin, histamine release was reported at relatively high protein 
concentrations, but SPT and oral challenge with the same molecule were negative64. The 
study by Santiago et al. does however confirm that the anti-tropomyosin antibodies induced 
in filarial infection are cross-reactive with those allergenic tropomyosins of invertebrates 
(mite) that may affect sensitization70. As expected, no clinical mite allergy was reported for 
the subjects studied, indicating that these cross-reactive responses are of no clinical relevance. 
In another investigation, Santos et al. showed that the predicted structure of A. lumbricoides 
tropomyosin was similar to that of Periplaneta americana tropomyosin71. The same study 
compared IgE responses to these proteins in Brazilian children aged 3-6 years living in an 
area endemic for helminths to responses in cockroach allergic patients aged 2 to 52 years also 
from Brazil71. A strong correlation was also found for IgE antibodies to tropomyosin from A. 
lumbricoides and from P. americana in sera from both populations. Seventy-six percent (90 
out of 119) of subjects from the parasite endemic area had positive IgE antibodies against 
cockroach tropomyosin without allergy to cockroach71. A study conducted by Acevedo et al. 
has also demonstrated high allergenic cross-reactivity between Blomia tropicalis tropomyosin 
(Blo t 10) and Ascaris tropomyosin in Colombian asthmatic patients72.
The glutathione S-transferases (GSTs) are detoxification enzymes found in most living 
organisms73. The important known sources of GSTs are cockroaches, house dust mites and 
molds, however, those GSTs from invertebrates including helminths are known to be strong 
inducers of IgE74. Moreover, Blattella germanica GST caused positive immediate skin tests in 
cockroach-allergic asthmatic patients, suggesting that GST from cockroach is a clinically relevant 
allergen75. Regarding helminth-induced IgE cross-reactivity, Santiago et al. showed that the GST 
from the filarial worm Wuchereria bancrofti (WbGST) and cockroach GST (Bla g 5) were 30% 
identical at the amino acid with marked similarity in the N-terminal region76. Interestingly, mice 
infected with Heligmosomoides bakeri; a parasite that contains a GST that is 32% identical to 
Bla g 5, developed immediate hypersensitivity reaction in the skin to cockroach GST (Bla g 
5), suggesting that some parasite-induced cross-reactivity may induce in vivo reactivity to the 
cross-reactive allergen in a common allergen source like house dust mite76.
Paramyosin is another allergen family from invertebrate muscle that are targeted in IgE 
responses against helminths77. A study among patients reporting symptoms of allergy and 
another group of Ascaris-infected subject in the Philippines showed evidence of cross-reactivity 
between paramyosin from mite (B. tropicalis) and paramyosin from A. lumbricoides78. This 
study observed that IgE to mite extract among allergic patients can be inhibited, up to 92%, 




infected subjects. Of note, IgE responses to the recombinant form of the paramyosin Blomia 
allergen (Blo t 11) were seen in 80% of allergic patients and 46% of Ascaris-infected subjects78. 
In general, IgE cross-reactivity between helminth antigens and allergens demonstrates 
a limited to diagnostic value of examining IgE responses to whole allergen extracts in 
helminth-endemic populations. Establishing the molecular basis of cross-reactivity between 
helminths and common allergen sources is essential to evaluate whether sensitization to the 
latter is true primary sensitization or cross-reactivity induced by helminths.
COMPONENT-RESOLVED DIAGNOSIS (CRD)  
IN ALLERGY DIAGNOSIS
For the past few decades, in vitro allergy diagnostics has been largely based on the detection 
of specific IgE to whole extracts comprised of allergenic and non-allergenic components. 
However, this approach has been problematic since the allergenic content of whole extracts 
is often difficult to standardize and also the specific allergic reaction inducing components in 
whole allergen extracts can be hard to identify. Such issues in in vitro allergy diagnostics led 
to the development of component-resolved diagnostics (CRD) in which purified natural or 
recombinant allergens are used to detect IgE sensitization to individual allergen molecules79,80.
The use of molecular techniques and recombinant DNA technology has allowed the 
sequencing, synthesizing and cloning of allergenic proteins leading to the production 
of recombinant allergens for CRD81. Recombinant allergens can be generated as defined 
molecules with consistent quality and without biological variation82.
The molecular biological techniques underlying CRD were initially employed for 
the determination of the primary structures and molecular identities of allergens83. The 
sequence analysis of allergens allowed the identification of structurally related allergens 
and also revealed how closely linked cross-reactive molecules may not be differentiated by 
the immune system83. CRD involves the use of specific marker allergens to identify primary 
sensitization towards a particular allergen source and to discriminate it from sensitization 
to CCD or to homologous allergens as a result of cross-reactivity84. CRD can therefore 
facilitate the differentiation between clinically important and less relevant specific IgEs85.
In terms of the application of CRD to research questions in helminth-endemic 
populations, the report by Amoah et al. on peanut allergy among Ghanaian school 
children found that in study subjects with elevated IgE to whole peanut allergen, responses 
to recombinant major peanut allergens (rAra h 1, rAra h 2 and rAra h 3) were generally 
undetectable or very low (<1 kUA/L)
65. In addition, among Brazilian children living in a 
helminth-endemic urban area, Carvalho et al. evaluated the use of IgE responses to B. 
tropicalis allergens (rBlo t 5 and rBlo t 21) in improving the specificity of determining mite 
allergy in this population86. The study showed that the assays using these recombinant 
marker allergens for primary B. tropicalis sensitization, exhibited no IgE cross-reactivity 
with A. lumbricoides antigens and therefore conferred higher specificity in detecting 




• Are the risk factors of atopic disorders different between children belonging to low 
or high socio-economic status living in the same urban area? 
• What are the risk factors for atopic disorders in children living in rural and semi 
urban areas where helminth infections are highly prevalent?
• What is the effect of long term anthelmintic treatment on atopic disorders?
• What is the profile of allergen specific IgE antibodies in children from helminth-
endemic areas?
SCOPE OF THE THESIS
In recent years, much research from the developed world has looked at risk as well 
as protective factors for childhood allergy. The sharp rise in atopic disorders in the 
developed world within a relatively short period of time indicates that environmental 
factors, in addition to the already known genetic pre-disposition, play an important role 
in development and control of these diseases. However, there are no conclusive answers 
on which are the most important environmental changes that underlie the increase in 
atopic disorders.  Interestingly, investigators are shifting their attention to the developing 
world for clues on how changes in the environment, influenced by socio-economic status 
(SES), affect the development of atopic disorders. One of these environmental factors is 
helminth infections. Indonesia is one of the low-to-middle income countries which is in 
epidemiological transition with increasing level of urbanization accompanied by changing 
disease patterns; where helminth infections are highly prevalent in rural areas but in 
urban centers there is a rise in atopic disorders. Therefore, this thesis set out to address the 
following four questions in Indonesia:
In Chapter 2 and Chapter 4, we show how environmental factors and socio-economic 
status effect atopic disorders in schoolchildren in different areas of a developing country. 
Chapter 3 provides an overview of the study population used in the following chapter 4, 5 
and 6. It has been published as a study protocol paper.
Chapter 5 provides the result of a household-based-cluster-randomized, double-blind 
placebo-controlled anthelminthic trial on allergy. 
In Chapter 6, we look at the characteristics of allergen specific IgE antibodies in order 
to better understand the molecular basis of IgE recognition of allergens in a helminth-
endemic area.
Chapter 7 summarizes our findings and provides directions for future research to understand 
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Background In urban centres of developing countries, there is great variation in socio-
economic status (SES) and lifestyle; however, little information is available on allergic 
disorders in groups with high- or low-SES within the same urban area.
Objective To determine the prevalence of allergic disorders and investigate risk factors 
related to them among high- and low-SES schoolchildren in Makassar, the capital city of 
South Sulawesi, Indonesia.
Method This cross-sectional study was performed in 623 children originating from high- 
(N = 349) and low-SES (N = 274) schools. Information on reported allergic symptoms and 
potential factors associated with allergic disorders was obtained by questionnaire. Specific IgE 
and skin prick test (SPT) reactivity were determined against aeroallergens [Dermatophagoides 
pteronyssinus [HDM] and cockroach]. Total IgE and helminth infections were also assessed.
Result The prevalence of SPT to any aeroallergens was significantly higher in high-SES 
than in low-SES school (25% vs. 8%, P < 0.001, respectively). However, specific IgE against 
cockroach and total IgE were significantly lower in high- than in low-SES children. Allergic 
symptoms were reported more often in low- compared to high-SES children. Specific IgE 
to aeroallergens significantly increased the risk of SPT positivity to the same aeroallergen 
in the high-, but not in the low-SES children. In the high- but not in low-SES, there was 
a significant positive association between SPT to HDM and wheeze. Similarly, cockroach 
skin reactivity and elevated BMI increased the risk of eczema in the high-SES children only.
Conclusion and Clinical Relevance Skin prick test positivity is more frequent in high-SES, 
whereas IgE and allergic symptoms are higher in low-SES children. Specific IgE is a risk 
factor for being SPT-positive, and SPT positivity is a risk factor for allergic symptoms but 
only in children of high- and not low-SES school. Therefore, the socio-economic status of a 
child might affect the diagnosis of allergic disease in a developing country.
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INTRODUCTION
It has long been known that allergic diseases cluster within families and this is likely to be 
due to genetic predisposition. However, environmental factors may modulate expression 
of allergic disorders. A higher prevalence of allergies in developed countries compared to 
developing ones1, and the great differences in prevalence between urban and rural populations 
particularly in developing2-6 but also in developed countries7-9 has clearly shown how 
important the influence of environmental factors is on the expression of allergic disorders.
The worldwide International Study of Asthma and Allergies in Childhood (ISAAC) has 
reported that Indonesia is one of the countries with low prevalence of allergy in the world1. 
However, this study reported data from only one center in Java. A study which was conducted in 
10 centers in India reported a large variation in the prevalence of asthma in the different centers 
(ranging from 3% to 17%), indicating that the information on allergic disorders in Indonesia 
reported by the published ISAAC study may not be representative of the whole country.
Several factors related to western lifestyle such as increase in exposure to outdoor pollutants10, 
increased indoor allergen load11, altered diet12,13 and changes in exposure to infection/microbial 
products14,15 have been hypothesized to explain the increase in allergic disorders. Socio-economic 
status (SES) also can affect allergic disorders, as studied in affluent countries16-18. However, there 
are not many studies addressing the pattern of allergic disorders within an urban center in a 
developing country where large differences in SES and life style are seen.
To investigate this, we initiated a study in two schools with different socio-economic 
backgrounds (high- and low-SES school) in an urban area of Makassar, South Sulawesi, to 
measure the prevalence of atopy and reported clinical allergy. Data on several factors such 
as parental education, parental occupation, the presence of smokers in house, pets in house, 
nutritional status and helminth infections were collected to determine how these factors 
influence the allergic phenotype.
METHODS
Study area and design 
The study was conducted in two elementary schools in Makassar, the capital city of South 
Sulawesi, Indonesia. Data were collected between October and December 2005. One school 
was attended by children from families with low-SES (SD Cambaya), and was located at the 
periphery of the city, near a port. The children from this school lived in the surrounding 
area and came from families with low education level who mostly worked as fishermen, 
menial laborers, or some that were skilled, but working in low ranking jobs. The high-SES 
school (SD Mangkura) was located in the city centre, about 7 km from the low-SES school. 
The houses of these children were spread in different parts of the city and had good sanitary 
facilities. The children went to school by private vehicles or by a school bus.
A month prior to the start of the study, the parents of children in both schools from 




sign a letter if they agreed for their child to participate in the study. Only children who 
returned the signed letters were included in the study. The study was approved by the ethical 
committees of Faculty of Medicine, Hasanuddin University, Makassar, Indonesia (ref:0147/
H4.8.4.5.31/PP36-KOMETIK/2005). In total 274 children from the low-SES and 349 from 
high-SES were included in the study (Figure S1).
Questionnaires 
Reported clinical symptoms of allergy were obtained by questionnaire. Clinical symptoms 
of asthma, allergic rhinitis and atopic dermatitis (eczema) in the previous 12 months 
were assessed using a modified ISAAC questionnaire (supplementary questionnaire 1-3), 
which had been translated into Bahasa Indonesia. Children were identified to have asthma 
symptoms (wheeze) if wheezing was reported in the past 12 months by parents or guardian. 
Rhinitis was defined by a positive response to the questions, ‘In the past 12 months, has your 
child had a problem with sneezing, or a runny or a blocked nose and has this nose problem 
been accompanied by itchy watery eyes?’. Eczema in the past 12 months was determined 
by a positive response to the questions, ‘Has your child had one or more skin problems 
accompanied by an itchy rash in the previous 12 months?’.
An additional questionnaire was applied to obtain data on parental education, parental 
occupation, the number of siblings and pet contact inside the house as well as smokers 
in the house. Parental occupation was classified into 2 groups of low- and high-skill jobs. 
Educational levels were categorized as: ‘low’ for illiterate, elementary school or high school 
and ‘high’ for academic/university and above. The questionnaire was administered to the 
parents or guardians of children.
Skin prick testing
Skin prick test (SPT) was performed if children were free from anti-histamine, anti-asthmatic 
or corticosteroid drugs for at least 7 days prior to the testing. SPT reactivity to aeroallergens 
was tested with extract of Dermatophagoides pteronyssinus (house dust mite (HDM); HAL 
Allergen BV, Leiden, The Netherlands) and Blattella germanica (cockroach; Lofarma, Milan, 
Italy). Histamin chloride (10 mg/ml) was used as the positive control and allergen diluents as 
the negative control. SPT was done on the volar side of the child’s lower arm, using separate 
skin prick test. The results for each child were measured after 15 minutes. Skin prick reactivity 
was determined to be positive if the longest diameter plus the diameter perpendicular of 
wheal size divided by two was at least 3 mm. Body height and weight were also measured.
Specific and total IgE
Serum level of mite- and cockroach-IgE was determined by radio allergosorbent test (RAST) 
as described previously19. Briefly, 50 µl serum was incubated overnight with 1.5 mg of 
Sepharose-coupled allergen in a final volume of 300 µl PBS, 3% BSA, 0.1% Tween-20. After 
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washing away non-bound serum components, radiolabelled sheep antibodies (Sanquin, 
Amsterdam, The Netherlands) directed to human IgE, were added. After overnight 
incubation and washing, bound radioactivity was measured. The outcomes were expressed 
as % binding. To convert these values into IU/ml, the result were plotted to non-linear 
regression curve of chimeric monoclonal IgE antibody dilution series against the major 
house dust mite allergen, Der p 2 and Sepharose-coupled mite extracts.
The levels of total IgE were measured by ELISA in The Netherlands as described 
previously20,21. The results were expressed as International Units (IU/ml).
Parasitological examination
The children were asked to fill a pot carefully using wooden spatula without water or urine 
contamination. The time of stool passed had to be recorded and the stool had to be stored 
in a cool area if it stayed overnight in the house before delivery to school. Only stools that 
arrived in the laboratory not more than 12 hours after passage were examined. The eggs 
from intestinal helminth such as Ascaris lumbricoides, Trichuris trichiura and hookworm 
were quantified using the Kato Katz methods22.
Statistical analysis
The collected data were analyzed using IBM Statistical Package for Social Sciences (IBM 
Corp., Armonk, New York, USA) version 20. We investigated potential factors for allergic 
disorders separately for each school. Age-standardized z-scores of body mass index (z-BMI) 
were calculated according to WHO references values23. Descriptive data were expressed as 
means (± standard deviations), frequency (percentage of collected data) and geometric means 
[95% confidence intervals (CI)]. Prevalence rates were calculated and compared for different 
schools using Pearson chi-square tests, while comparisons of continuous data were analyzed by 
using Student t-tests. Specific IgE (s-IgE) and total IgE were normalized by log-transformation 
to obtain normally distributed data. Logistic regression was used to analyze the associations 
between the potential factors and development of SPT and reported clinical symptoms of allergy 
in the past 12 months. Linear regression was used for analysis of continuous outcomes which 
provided estimated regression coefficients (β) and their corresponding 95% CI. In multivariate 
analysis, we included age and sex as a priori confounders, as well as other variables that were 
significant in univariate analyses. All statistical tests were considered significant at P < 0.05.
RESULTS
Characteristics of study participants
Among 917 children invited to the study, 71 (7.7%) refusals came from high-SES whereas 223 
(24.3%) were from low-SES (Figure S1). One of the reasons could have been illiteracy, but we 




the low-SES school were included in the study (Figure S1). Children were slightly younger 
in the high-SES compared to the low-SES school (mean age 9.05 vs. 9.92 years; P < 0.001), 
whereas sex distribution was similar in both schools (Table 1). This slight age difference 
did not affect the results, as repeating the analysis after matching the study population 
for age, revealed identical results for the outcomes reported in this study. Occupation and 
education of the parents were homogeneous within the schools but very different between 
schools: in the high-SES school, 98% and 65% of parents had a high-skill occupation and 
high education, respectively; whereas in the low-SES school, 84% (230/274) of parents had 
a low-skill occupation and almost all parents had low education (97%, 255/264) (Table 1).
Almost all children (90%) from low-SES school were infected with at least one species 
of helminth compared to 22% in high-SES school (Table 1). The most common helminth 
infections were T. trichiura (87% in low-SES and 19% in high-SES) and A. lumbricoides 
(low-SES: 77%, high-SES: 6%). The prevalence of hookworm infection was very low (9 of 
611, 1.5%); therefore, hookworm infection was excluded from further analysis.
Prevalence of reported symptoms, skin prick test and IgE
The prevalence of reported wheeze in the previous 12 months was lower in the high-SES 
(7.5%) compared to the low-SES school (12.9%) as were the prevalence of reported 
symptoms of eczema (9.9% in high-SES school and 18.2% in low-SES school) and allergic 
rhinitis (26.6% vs. 41.3%, P = 0.001, respectively) in the past 12 months (Table 1).
For analysis of skin reactivity to aeroallergens, we included only children with a positive 
skin test (≥ 3 mm) to histamine (Table 1). There were no differences in age and sex distribution 
between the histamine-negative population (N = 133 in high-SES and N = 77 in low-SES) 
and the histamine-positive population (high-SES: 216 children, high-SES: 197 children). The 
prevalence of positive SPT was higher in the high-SES school compared to low-SES school; any 
aeroallergen (25% vs. 8.1%, P < 0.001, respectively), HDM (15.7% vs 3%, P < 0.001, respectively) 
and cockroach (16.2% vs 6.1%, P = 0.001, respectively). In contrast, the levels of sIgE to cockroach 
as well as total IgE were significantly lower in the high-SES than in the low-SES. There were no 
differences in the levels of HDM sIgE between the two schools (Table 1).
Potential risk factors associated with reported clinical symptoms of allergy in the past 
12 months 
In the high-SES school, reported wheeze in the previous 12 months was significantly associated 
with SPT reactivity to HDM [odds ratio (OR), 3.18; 95% CI, 1.17–8.62; P = 0.023]. Skin 
reactivity to cockroach (OR, 3.40; 95% CI, 1.39–8.29; P = 0.007) and z-BMI (OR, 1.31; 95% 
CI, 1.02–1.69; P = 0.032) were positively associated with an increased risk for reported clinical 
symptoms of eczema in the past 12 months (Table 2a). However, we found no association 
between rhinitis and potential risk factors measured in the high-SES school (data not shown).
In the low-SES school, none of the exposures assessed were significantly associated with 
risk for reported clinical symptoms of allergy (Table 2b).
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Table 1. Characteristics of population and allergic disorders in high- and low-socio-economic status (SES) schools
High-SES Low-SES
P-valueN Result N Result
Age years (mean, SD) 349 9.05 ± 1.22 274 9.92 ± 1.62 <0.001
Sex (N, %)
Male 162 46.4 145 52.9 0.11
Female 187 53.6 129 47.1
Parental job (N, %)
Low skill 8 2.3 230 83.9 <0.001
High skill 341 97.7 44 16.1
Parental education (N, %)
Low 117 35.0 255 96.6 <0.001
High 217 65.0 9 3.4
Smoker inside the house (N, %)
No 162 48.4 76 28.8 <0.001
Yes 173 51.6 188 71.2
Pet inside house (N, %)
No 294 84.2 232 84.7 0.88
Yes 55 15.8 42 15.3
z-BMI (mean, SD) 349 -0.08 ± 1.39 274 -0.80 ± 1.24 <0.001
Number of siblings (N, %)
< 3 214 61.3 99 36.1 <0.001
3+ 135 38.7 175 63.9
Helminth infection (N, n%)
Any intestinal helminth 340 76 (22.4) 271 245 (90.4) <0.001
Ascaris lumbricoides 340 20 (5.9) 271 208 (76.8) <0.001
Trichuris trichiura 340 65 (19.1) 271 236 (87.1) <0.001
Clinical symptoms of allergy in the past 12 months (N, n%)
Wheeze 335 25 (7.5) 264 34 (12.9) 0.027
Rhinitis 335 89 (26.6) 264 109 (41.3) <0.001
Eczema 335 33 (9.9) 264 48 (18.2) 0.003
Skin prick test reactivity (N, n%)
Any skin prick test reactivity 216 54 (25.0) 197 16 (8.1) <0.001
Dermatophagoides pteronyssinus 216 34 (15.7) 197 6 (3.0) <0.001
Blattella germanica 216 35 (16.2) 197 12 (6.1) 0.001
Specific IgE  and Total IgE  (geometric mean, 95% CI)
House dust mite# (IU/ml) 272 0.27 (0.21-0.36) 243 0.24 (0.20-0.30) 0.55
B. germanica (IU/ml) 272 0.08 (0.07-0.10) 242 0.31 (0.27-0.36) <0.001
Total IgE  (IU/ml) 272 1267.6 (1024.8-1568.0) 240 12925.9 (10834.6-15420.9) <0.001
The number of positives (n) of the total population examined (N). The statistically significant results are given in 




Table 2. Association between potential risk factors and clinical symptoms of allergic diseases in (a) high- 
and (b) low-SES schools^
N
Wheeze Eczema
n (%) OR [95% CI] n (%) OR [95% CI]
(a)
Parental job
Low 8 0 0
High 327 25 (7.6) - 33 (10.1) -
Parental education
Low 117 5 (4.3) reference 10 (8.5) reference
High 217 20 (9.2) 2.27 [0.83-6.23] 23 (10.6) 1.27 [0.58-2.76]
Smoker inside the house
No 162 10 (6.2) reference 18 (11.1) reference
Yes 173 15 (8.7) 1.44 [0.63-3.31] 15 (8.7) 0.76 [0.37-1.56]
Pet inside house
Low 282 24 (8.5) reference 28 (9.9) reference
High 53 1 (1.9) 0.21 [0.03-1.56] 5 (9.4) 0.94 [0.35-2.57]
z-BMI∞ 335 -0.10 ± 1.37§ 0.86 [0.63-1.17] -0.10 ± 1.37§ 1.31 [1.02-1.69]*
Number of siblings
< 3 205 14 (6.8) reference 19 (9.3) reference
3+ 130 11 (8.5) 1.26 [0.55-2.87] 14 (10.8) 1.18 [0.57-2.45]
Any intestinal helminth
Negative 254 21 (8.3) reference 28 (11.0) reference
Positive 76 4 (5.3) 0.62 [0.20-1.85] 5 (6.6) 0.57 [0.21-1.53]
A. lumbricoides
Negative 310 24 (7.7) reference 31 (10.0) reference
Positive 20 1 (5.0) 0.63 [0.08-4.89] 2 (10.0) 1.00 [0.22-4.51]
T. trichiura
Negative 265 21 (7.9) reference 29 (10.9) reference
Positive 65 4 (6.2) 0.76 [0.25-2.30] 4 (6.2) 0.53 [0.18-1.58]
HDM SPT
Negative 301 19 (6.0) reference 29 (9.6) reference
Positive 34 6 (17.6) 3.18 [1.17-8.62]* 4 (11.8) 1.25 [0.41-3.80]
Cockroach SPT
Negative 301 22 (7.3) reference 25 (8.3) reference
Positive 34 3 (8.8) 1.23 [0.35-4.34] 8 (23.5) 3.40 [1.39-8.29]**
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n (%) OR [95% CI] n (%) OR [95% CI]
(b)
Parental job
Low 222 34 (15.3) 45 (20.3) reference
High 42 0 - 3 (7.1) 0.30 [0.09-1.02]
Parental education
Low 255 34 (13.3) 47 (18.4) reference
High 9 0 - 1 (11.1) 0.55 [0.07-4.53]
Smoker inside the house
No 76 10 (13.2) reference 14 (18.4) reference
Yes 188 24 (12.8) 0.97 [0.44-2.13] 34 (18.1) 0.98 [0.49-1.95]
Pet inside house
Low 223 28 (12.6) reference 41 (18.4) reference
High 41 6 (14.6) 1.19 [0.46-3.09] 7 (17.1) 0.91 [0.38-2.21]
z-BMI∞ 264 -0.79 ± 1.25§ 0.88 [0.66-1.17] -0.79 ± 1.25§ 1.17 [0.90-1.51]
Number of siblings
< 3 93 13 (14.0) reference 15 (16.1) reference
3+ 171 21 (12.3) 1.26 [0.55-2.87] 33 (19.3) 1.24 [0.64-2.43]
Any intestinal helminth
Negative 21 2 (9.5) reference 4 (19.0) reference
Positive 241 32 (13.3) 1.45 [0.32-6.54] 44 (18.3) 0.95 [0.30-2.96]
A. lumbricoides
Negative 58 4 (6.9) reference 10 (17.2) reference
Positive 204 30 (14.7) 2.33 [0.78-6.90] 38 (18.6) 1.10 [0.51-2.37]
T. trichiura
Negative 30 3 (10.0) reference 6 (20.0) reference
Positive 232 31 (13.4) 1.39 [0.40-4.85] 42 (18.1) 0.88 [0.34-2.30]
HDM SPT
Negative 258 32 (12.4) reference 47 (18.2) reference
Positive 6 2 (33.3) 3.53 [0.62-20.06] 1 (16.7) 0.90 [0.10-7.87]
Cockroach SPT
Negative 253 31 (12.3) reference 44 (17.4) reference
Positive 11 3 (27.3) 2.69 [0.68-10.66] 4 (36.4) 2.71 [0.76-9.67]
^association based on univariate logistic model. ∞Increase in risk of clinical symptoms of allergy for an 
increasing of each unitary in the tested variable. §Mean and standard deviation. The number of positives (n) 
of the total population examined (N).  OR: Odds ratio, CI: Confidence intervals. The statistically significant 




Potential risk factors associated with skin prick test reactivity
In high-SES school, skin reactivity to HDM was positively associated with high levels of 
sIgE to HDM (OR, 6.03; 95% CI, 3.34–10.88; P < 0.001), and skin reactivity to cockroach 
was positively associated with high levels of sIgE to cockroach (OR, 5.64; 95% CI, 2.18–
14.63; P < 0.001) (Table 3a).
In the low-SES school, higher z-BMI was associated with SPT reactivity to cockroach. 
However, no significant association was found between skin reactivity and sIgE (Table 3b).
Potential risk factors associated with total and allergen-specific IgE 
None of the measured potential risk factors were associated with total IgE or sIgE to 
aeroallergens in the high-SES school (Table S1a).
In the low-SES school, having parents with high-skill occupation (β = -0.31; P = 0.014) 
or high education (β = -0.63; P = 0.023) was associated with lower levels of sIgE to HDM. 
Levels of sIgE to cockroach as well as total IgE (β = 0.21; P = 0.012: β = 0.23; P = 0.021, 
respectively) were significantly higher in children with T. trichiura infections (Table S1b).
Multivariate analysis
In high-SES school, skin reactivity to HDM was an independent predictor of reported wheeze 
in the past 12 months (adjusted OR, 3.21; 95% CI, 1.17–8.78; P = 0.023) while eczema was 
independently associated with positive skin reactivity to cockroach as well as high z-BMI. 
Analysis of skin reactivity adjusted for confounding factors revealed that skin reactivity to 
HDM remained positively associated with sIgE to HDM (adjusted OR, 6.19; 95% CI, 3.40–
11.28; P < 0.001) while skin reactivity to cockroach remained positively associated with sIgE 
to cockroach (adjusted OR, 5.68; 95% CI, 2.13–15.18; P < 0.001) (Table 4).
In low-SES school, multivariate analysis revealed that high z-BMI was still associated 
with cockroach SPT reactivity (adjusted OR, 1.74; 95% CI, 1.02–2.96; P = 0.041; Table 4) 
and having parents with high-skill occupation was still associated with having low levels 
of sIgE to HDM (adjusted β = -0.28; P = 0.030). Following adjustment with age and sex, 
infection with T. trichiura remained positively associated with high levels of sIgE to 
cockroach (adjusted β = 0.22; P = 0.011) as well as total IgE (adjusted β = 0.23; P = 0.022).
DISCUSSION
This study has investigated allergic disorders in high-and low-SES school children living in 
the same urban centre of a developing country, namely Makassar, Indonesia. We observed 
the prevalence of skin prick test reactivity to aeroallergen was higher in high-SES compared 
to the low-SES school. Conversely, the prevalence of reported allergic symptoms, IgE to 
cockroach as well as total IgE were higher in low-SES compared to high-SES school children. 
In the high-SES school, high sIgE to aeroallergens increased the risk of skin reactivity to the 
30














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































same aeroallergens, and moreover, skin reactivity to HDM increased the risk of reported 
wheeze. In contrast to the findings among the high-SES children, in the low-SES school, sIgE 
did not significantly increase the risk of being SPT-positive and SPT was not a significant risk 
factor for clinical symptoms of allergy. Studies in children among 22 countries worldwide 
found large variation in the prevalence of allergic symptoms and atopic sensitization among 
populations and also reported that the association between atopic sensitization and clinical 
symptoms of asthma increased with economic development7. The latter would be in line 
with our observation that in high-SES sensitization is linked to clinical symptoms whereas 
in low-SES, this is not the case.
Most studies on the association between BMI and allergic disorders in children are in 
high-income countries24–26 while little is known on this association in children from low-
to-middle income countries. Among high-SES school children in this study, we also found 
that skin reactivity to cockroach and BMI were positively associated with the increased risk 
of eczema. There are to our knowledge, no published reports on the association between 
eczema and cockroach sensitization while a similar trend for association between eczema 
and BMI has been reported by Yao et al.27.
The fact that the prevalence of wheeze, allergic rhinitis and atopic eczema symptoms was 
lower in high-SES school children was opposite to the finding from a previous study conducted 
in children attending 30 schools in socio-economically diverse areas of Cape Town, South Africa, 
which reported that the prevalence of asthma, recent wheeze and allergic rhinitis increased from 
lowest to highest SES28,29. One of the possibilities to consider is that certain viral infections, 
Table 4. Multivariate models for association between potential risk factors and clinical symptoms of allergy 
or skin reactivity in (a) high- and (b) low-SES schools^
Clinical symptom of allergy  
in the past 12 months Skin prick test reactivity
HDM
adj. OR [95% CI]
Cockroach
adj. OR [95% CI] adj. OR [95% CI] adj. OR [95% CI]
(a)
z-BMI∞ 1.38 [1.06-1.78]*
SPT HDM  
[reference:negative]
3.21 [1.17-8.78]*
SPT cockroach  
[reference:negative]
3.81 [1.53-9.52]**
Specific IgE to HDM 6.19 [3.40-11.28]***
Specific IgE to cockroach 5.68 [2.13-15.18]***
(b)
z-BMI∞ 1.74 [1.02-2.96]*
^Multivariate model adjusted with age and sex. ∞Increase in risk of clinical symptoms of allergy or skin 
prick reactivity for an increasing of each unitary in the tested variable. OR: Odds ratio. CI: Confidence 
intervals. *P < 0.05, **P < 0.01, ***P < 0.001
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which might be associated with allergy-like symptoms and difficult to differentiate from real 
allergy by parents, were more prevalent in the low-SES children of the current study30,31.
High parental education and occupation, which are part of the indicators of high-SES, 
have been reported to be associated with atopy32,33. Here, we found no association between 
skin prick test reactivity or reported clinical symptoms of allergy and parental education 
nor with parental occupation, most likely due to homogeneity of these variables in each of 
high- and low-SES schools in our setting.
We could not find any association between allergic outcome measured and exposure to 
tobacco smoke or having pets at home which is similar to the findings is a study of rural 
and urban of Ecuador3. Although studies in Germany showed that being born and raised 
on a livestock farm protected against atopy and allergic symptoms34; however, significant 
heterogeneity effects have also been reported across Europe35.
Both helminth parasites and allergens are associated with Th2 immune responses 
characterized by the increased production of Th2 cytokines and with specific as well as 
polyclonal IgE36. In this study, total IgE levels were 10 times higher in the low-SES than 
in the high-SES school. In low-SES school, the levels of total IgE were significantly higher 
in children infected with T. trichiura where the prevalence of this infection was 87.1%. 
In the high-SES school where the prevalence of T. trichiura infection was much lower, 
infection with this parasite was not significantly associated with increased levels of total 
IgE, suggesting that levels of total IgE in low-SES school are likely to be the consequence of 
higher transmission of T. trichiura and other helminth such as A. lumbricoides which was 
also prevalent in low-SES school. In line with this, a study by Blackwell et al.37 showed that 
in rural Ecuador and Bolivia, total IgE increased with increasing helminth positivity and 
decreased in parallel with reduction of helminth infestation38.
Interestingly, the levels of sIgE to cockroach were higher in children infected with T. 
trichuria in the low-SES school. Additionally, in the same school, we found that having 
parents with high-skill occupation significantly reduced sIgE levels to HDM, which might 
be because high-skill occupation means less exposure to helminths. It is also possible that 
IgE antibodies generated to helminth antigens might cross-react with allergens39,40 as was 
shown by a recent study among Ghanaian children, which demonstrated that high levels of 
IgE to peanut were strongly associated with helminth infection41.
In multivariate analysis of data from the high-SES school, we found that the levels of sIgE 
to aeroallergens are strongly associated with the skin reactivity to the same aeroallergens. This 
is consistent with several studies which found a good agreement between SPT and sIgE in 
developed42–44 and in an urban area of developing country45. However, no significant association 
was observed in the low-SES which is in line with our previous study conducted in a rural area 
of Indonesia where a dissociation between sIgE levels to aeroallergens and skin prick test to the 
same allergens was found2. These data show that despite living in the same city, socio-economic 
differences might result in different association between sIgE and SPT reactivity.
The strength of this study is the relatively large number of children examined that lived 




to obtain information on clinical symptoms of allergic disease. The assessment of clinical 
symptoms of allergy by questionnaire could under or overestimate the real cases of allergic 
diseases. The other limitation of our current study was that the participant response rate 
particularly in low-SES was lower than in high-SES school, probably due to illiteracy but 
we have no data on this. In addition, in the low-SES school, the numbers of children with 
positive SPT were lower and therefore our studies of associations involving SPT might be 
underpowered. Confounding factors included in the study were limited; therefore, it is 
possible that we missed important potential confounding factors. The presence of helminth 
infection was determined by single Kato–Katz, which might miss light infections.
In conclusion, there are large differences between children from high- and low-SES 
schools in an urban area of Indonesia with respect to allergic disorders and factors that 
influence allergic outcomes. There is high IgE in low-SES but low SPT, while reported 
symptoms of allergy are higher in low-SES children. Our data also provide evidence that 
specific IgE is a risk factor for being SPT-positive and SPT positivity is a risk factor for 
allergic symptoms but only in children of high-SES and not low-SES school. Therefore, one 
needs to consider SES when testing for allergic disorders in cities in developing countries.
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The International Study of Asthma and Allergies in Childhood (ISAAC) core questionnaires
1. Core questionnaire for wheezing and asthma (all questions are about problems which occur when this 
child DOES NOT have cold or the flu)
No Question Answer
1 Have you ever had wheezing or whistling in the chest at any time 
in the past?
[  ] Yes
[  ] No
If no skip to Q6
2 Have you had wheezing or whistling in the chest in the last  
12 months?
[  ] Yes
[  ] No
If no skip to Q6
3 How many attacks of wheezing have you had in the last 12 months? [  ] None
[  ] 1-3
[  ] 4-12
[  ] > 12
4 In the last 12 months, how often, on average, has your sleep been 
disturbed due to wheezing?
[ ] Never woken with wheezing
[ ] Less than one night per week
[ ] One or more nights per week
5 In the last 12 months, has wheezing ever been severe enough to limit 
your speech to only one or two words at a time between breaths?
[  ] Yes
[  ] No
6 Have you ever had asthma? Diagnosed by a doctor [  ] Yes
[  ] No
7 In the last 12 months, has your chest sounded wheezy during  
or after exercise?
[  ] Yes
[  ] No
8 In the last 12 months, have you had a dry cough at night, apart 
from a cough associated with a cold or chest infection?
[  ] Yes
[  ] No
9 If yes for question number 6, what is the name of medicine that 
Doctor gave
10 Has any member of your family ever had asthma? [  ] Yes
[  ] No
[  ] No idea
11 If you answered “yes” to question 10, indicate relationship to you 
(tick all that apply)
[  ] Father
[  ] Mother
[  ] Brother or Sister
[  ] Mother’s family _____________
[  ] Father’s family______________
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2. Core questionnaire for allergic rhinitis (all questions are about problems which occur when this child 
DOES NOT have a cold or the flu)  
No Question Answer
1 Have you ever had a problem with sneezing or a runny or 
blocked nose (nose problem) without cold or the flu? 
[  ] Yes
[  ] No
If no skip to Q6
2 In the past 12 months, have you had a problem with 
sneezing, or a runny, or blocked nose when you DID NOT 
have a cold or the flu? 
[  ] Yes
[  ] No
If no skip to Q6
3 In the past 12 months, has this nose problem been 
accompanied by itchy-watery eyes? 
[  ] Yes
[  ] No
4 In which of the past 12 months did this nose problem 
occur? (Please tick any which apply) 
[  ] Jan    
[  ] Feb   
[  ] Mar   
[  ] Apr
[  ] Rainy season
[  ] Anytime    
[  ] Mei    
[  ] Jun     
[  ] Jul
[  ] Aug   
[  ] Dry season 
[  ] No idea
[  ] Sep
[  ] Oct
[  ] Nov 
[  ] Dec
5 In the past 12 months, how much did this nose problem 
interfere with your daily activities? 
[  ] Not at all    [  ] A Moderate 
[  ] A little   [  ] A lot 
6 Have you had a doctor diagnosed rhinitis allergy / hay fever? [  ] Yes
[  ] No
7 If yes for question number 6, what is the name of 
medicine that Doctor gave 
8 Has any member of your family ever had rhinitis allergy / 
hay fever? 
[  ] Yes
[  ] No 
9 If you answered “yes” to question 8, indicate relationship 
to you (tick all that apply) 
[  ] Father
[  ] Mother
[  ] Brother or Sister
[  ] Mother’s family _____________




3. Core questionnaire for eczema (show the pictures to the subject)
No Question Answer
1 Have you ever had an itchy rash which was coming and 
going for at least six months?
[  ] Yes, picture number_____
[  ] No
If no skip to Q6
2 Have you had this itchy rash at any time in the last 12 months? [  ] Yes
[  ] No
If no skip to Q6
3 Has this itchy rash at any time affected any of the following 
places: The folds of the elbows, behind the knees, in front of 
ankles, under the buttocks or around the neck, ears or eyes?
[  ] Yes
[  ] No
4 Has this rash cleared completely at any time during the 
past 12 months?
[  ] Yes
[  ] No
5 In the last 12 months, how often, on average, have you 
been kept awake by this itchy rash?
[  ] Never in the past 12 months
[  ] Less than one night per week
[  ] One or more nights per week
6 Have you had Doctor diagnosed dermatitis allergy/eczema? [  ] Yes
[  ] No
7 If yes for question number 6, what is the name of medicine 
that Doctor gave ------------------------------------------------
8 Has any member of your family ever had had allergy eczema? [  ] Yes
[  ] No
9 If you answered “yes” to question 8, indicate relationship to 
you (tick all that apply)
[  ] Father
[  ] Mother
[  ] Brother or Sister
[  ] Mother’s family _____________
[  ] Father’s family______________
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3.1 Modification in Indonesian version of ISSAC Questionnaire for eczema
 No Before Questions of eczema Answer 
1 Modify from Q1 Have you ever had skin problem that occur 
more than once in the same location? 
1. Yes 
2. No, You don’t need to continue 
2 Modify from Q6 Have your skin problem been diagnosed 
by doctor/nurse as dermatitis allergy? 
1. Yes 
2. No 
Additional SHOW ECZEMA PICTURE 
3 Modify from Q1 Have you ever had itchy skin problem 
that look like in the picture? 
1. Yes 
2. No 






Another area ……………… 
5 Q2 In the last 12 month have you ever had 
the symptoms? 
1. Yes 
2. No, You don’t need to continue. 
6 Q4 In the last 12 month, did your skin 
disorders completely disappear? 
1. Yes 
2. No 
7 Modify from Q5 In the last 12 month how many times 
you weak at night due to itchy of your 
skin disorders 
1. 1-3 x/ year 
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Background The prevalence of asthma and atopic disease has been reported to be low 
in low income countries, however helminth infections are likely to be high among these 
communities. The question of whether helminth infections play a role in allergic diseases 
can best be addressed by intervention studies. None of the studies so far have been based on 
a large scale placebo-controlled trial.
Method/Design This study was designed to assess how intestinal helminth infections can 
influence the immune response and atopic and allergic disorders in children in Indonesia. 
The relations between allergic outcomes and infection and lifestyle factors will be addressed. 
This study was set up among school-age children in semi urban and rural areas, located in 
Ende District of Flores Island, Indonesia. A randomized placebo-controlled anthelmintic 
treatment trial to elucidate the impact of helminth infections on the prevalence of skin prick 
test (SPT) reactivity and symptoms of allergic diseases will be performed. The children living 
in these semi-urban and rural areas will be assessed for SPT to allergens before and after 
1 and 2 years of treatment as the primary outcome of the study; the secondary outcome is 
symptoms (asthma and atopic dermatitis); while the tertiary outcome is immune responses 
(both antibody levels to allergens and cellular immune responses).
Discussion The study will provide information on the influence of helminth infections and 
anthelmintic treatment on immune response, atopy and allergic disorders.





Helminth infections are highly prevalent worldwide, with more than two billion people 
chronically infected by soil transmitted helminths such as Ascaris lumbricoides, Trichuris 
trichiura and/or hookworms (Necator americanus or Ancylostoma duodenale)1. These enteric 
infections affect populations living in subtropical and tropical regions of low-middle income 
countries, where access to hygiene, sanitation and source of clear water is limited2. The 
immune responses mounted to helminth infections is characterized by T-helper type 2 (Th2), 
which are thought to be protective3. However, there is also evidence that these parasites 
might enhance their own survival by modulating the immune responses of their host by 
inducing regulatory responses that dampen activity of effector cells4. Whether all different 
helminths are equally potent in inducing regulatory responses is not yet fully studied.
Allergens, like helminth antigens5,6 are potent inducers of Th2 responses7 and it is 
known that allergic diseases including asthma, eczema and rhinitis are associated with 
Th2 inflammation8. However, in contrast to helminth infections the Th2 associated 
allergic diseases, which are the most common cause of chronic disease of childhood in 
high income countries, appear to be less common in low income countries9. Thus, despite 
the close parallels between immune responses that characterize helminth infections and 
allergic diseases, namely increased levels of Immunoglobulin (Ig)-E, tissue eosinophilia 
and mastocytosis along with T cells that preferentially secrete Th2 cytokines interleukin 
(IL)-4, IL-5 and IL-138,10-12, the clinical outcome with respect to immediate hypersensitivity 
and inflammation is clearly not the same13. Indeed, often it has been reported that these 
diseases, appear to segregate geographically14 and several studies have reported a negative 
association between the presence of helminth infections and allergic disorders15-18. In 
experimental animal models, several parasitic helminths have been shown to prevent the 
development of eosinophilic airway inflammation and hyperresponsiveness19-21.
Mechanistically, a number of immune responses have been proposed to account for 
the negative association between helminths and allergies22. The observations that chronic 
helminth infections are associated with higher suppressive responses, such as IL-1023 and 
regulatory T cells24,25 have led to the proposal that a strong regulatory network induced 
by helminths might prevent the downstream effector phase of Th2 responses, preventing 
excess inflammation. Moreover, the possibility that in the presence of helminth infections, 
IgE antibodies generated are of lower affinity and therefore can not lead to mast cell 
degranulation has also been put forward22.
Given that a number of studies have on the other hand reported either no26,27 or a 
positive28,29 association between helminths and allergies, it is very likely that, apart from 
the source and chronicity of infection other factors such as exposure to non-helminth 
infections, and/or lifestyle play an important role in the development of allergies. The 
change from traditional to a more “modern” lifestyle which encompasses not only reduced 
exposure to micro-organisms and parasites but also an altered diet, in addition to changes 




disease patterns2. It is important to study and delineate the mechanisms that may protect 
from the development of allergic diseases. It is becoming clear that the prevalence of 
allergic diseases is increasing in low to middle income countries30 particularly in urban 
centers which often show higher prevalence of these diseases compared to rural areas14,31,32. 
It is therefore important to use this window of opportunity to identify risk and protective 
factors in cross sectional as well as longitudinal studies.
A study that would include both helminth infections and life style factors with respect to 
the development of allergies has been planned in Indonesia. The question of whether helminth 
infections play a role in allergic diseases can best be addressed by intervention studies. So far, 
one intervention study has suggested that anthelmintic treatment might increase the incidence 
of atopy reactivity33, which is in contrast to a large scale study where one year after treatment of 
intestinal helminths no changes were recorded in allergic disorders34. None of the studies have 
been based on a large scale placebo controlled trial. Although there clearly are ethical issues 
with such a design, the ethics committee of University of Indonesia, has granted permission 
for a placebo controlled trial providing that the community gets extensive medical care and 
excludes those with intense infections. In addition to helminth infections, the study of how 
other factors may contribute to the development of allergies is best achieved by longitudinal 
comparison of different areas along a rural-urban gradient. Numerous studies have analyzed 
the difference in the prevalence of allergic disorders in a rural to urban gradient35 but none so 
far has done so in a longitudinal manner with the exception of one study in Ghana31.
The ImmunoSPIN allergy project http://www.immunospin.org website36 has been 
initiated with this aim. This study is a randomized placebo-controlled anthelmintic 
treatment trial to elucidate the impact of helminth infections on the prevalence of atopy 
and allergic diseases. In this study the prevalence of IgE, skin prick test positivity and 
symptoms of allergic diseases such as asthma and atopic dermatitis in school-age children 
will be assessed in semi-urban and rural area in Flores, Indonesia. The ImmunoSPIN allergy 
project will establish the risk and protective factors and will include immune response 
measurements in order to understand the immunological mechanisms that are behind risk 
and protective factors in allergy development.
METHODS/DESIGN
The study area
For this study semi-urban (Nangapanda) and rural (Anaranda) sites located in Ende 
District of Flores Island, Indonesia were selected. Nangapanda is a sub-district situated in a 
coastal area with a population of approximately 22,000 (Figure 1c). Nangapanda is divided 
into 17 villages of which those located near the community health centre (Puskesmas), 
Ndeturea, Ndorurea 1, and Ndorurea together with a population of 465036, were included 
in the study. Local income in this area is based on fishing and farming while some engage 




Anaranda is a village in sub-district of Welamosa and is located 80 km north from 
Nangapanda with a population of approximately 1,600 (Figure 1d). The majority of income is 
generated by farming. The infrastructure is poor with no paved roads which makes the village 
isolated and with little access to amenities as were available in Nangapanda, such as electricity 
(which is provided 12 hours per day), fuel, natural water source (not processed water) and shops.
Preliminary surveys in 2005 and 2006 found these areas to be endemic for geohelminths 
(A. lumbricoides, hookworms and T. trichiuria).
A B
D C
Figure 1. The map of the study area in Flores, Indonesia. A. Indonesia map. B. Study areas in Flores island 
which star sign. C. Nangapanda (semi urban area) where each dot represents one household. D. Anaranda 
(rural area) where each dot represents one household.
Design
This study of schoolchildren is designed as a double-blind randomized trial with two arms. 
One arm is treatment with albendazole (single dose of 400 mg), while the other arm is 
treatment with matching placebo (both tablets from PT Indofarma Pharmaceutical, Bandung, 
Indonesia). The treatment will be provided every three months for a period of two years (total 
of 8 treatments). The resident population of the study area were randomized, by computer aided 




placebo or treatment. The treatment will be coded with random numbers and the code will 
be concealed from investigators and patients. Labels with the study subject ID will be printed 
from a computer database and attached to the appropriate strip of treatment by a separate team 
located in Jakarta without the involvement of the study investigators. Treatment codes will 
be unblinded by a monitoring committee after 1 year of treatment for interim analysis of any 
adverse effects that retention of anthelmintic treatment might have on the growth of children 
and on the incidence of allergy. If the trial continues, the final unblinding of the codes will take 
place after two years of treatment. At the end of the study the whole population will be treated.
From the total study population, schoolchildren aged 5-15 years will be included in the 
study of allergy parameters at pre, 1 and 2 years post treatment. The baseline demographic data 
as well as detailed questionnaires to delineate risk and protective factors for the development of 
allergies are planned at pretreatment stage. Skin prick testing (SPT) to allergens, International 
Study of Asthma and Allergy in Childhood (ISAAC) questionnaires, stool collection for 
helminth load, blood sampling for serology as well as whole blood culture is planned for time 
points pre, 1 and 2 years post treatment while exercise-induced bronchialconstriction (EIB) 
will be measured at pre and two years post treatment. Whereas SPT, ISAAC, parasitological 
examination as well as serology will be performed for all study subjects, where blood culture 
will be performed for children randomly selected based on households. The EIB will also be 
done in a subset of randomly selected children based on helminth as well as SPT status.
Sample size
Data available from a pilot study where 102 schoolchildren were skin prick tested as well 
as data available from studies on other areas of Indonesia38,39 were used for sample size 
calculations. Initial prevalence of SPT reactivity to a panel of allergens was found to be 
15%. In order to find a 50% increase or decrease in SPT in the population, and taking into 
account a loss to follow-up of 20%, 709 individuals were needed in each treatment arm 
(taking into account a power of 0.90 and an alpha of 0.05). The reported prevalence of SPT 
to aeroallergens in children rural versus urban areas in low and middle income countries 
is around 10% versus 20%31,40. Moreover, as treatment studies have often shown a doubling 
of SPT reactivity4,33, we have based our sample size calculation on a more modest increase 
as the prevalence of helminth infections is high in Anaranda and Nangapanda areas and 
therefore it might be difficult to eliminate these infections.
Information, recruitment, consent, specimen collection and storage
The local health authorities in Ende were informed and they gave their agreement and support 
for this study. Socialization took place over a two-year period, from 2006 to 2008. Staff members 
from the Puskesmas are being fully involved and 50 community workers are being trained for 
following study subjects, filling questionnaires and keeping the community well-informed and 
well-engaged. Through many organized sessions, the village heads are being involved in passing 




is explained and information sheets and consent forms (in Bahasa Indonesia) were distributed. 
Parents or guardians gave informed consent which was registered by signature or thumb print.
Peripheral blood will be drawn once a year at baseline, 1 and 2 years after treatment 
for immunological studies. Stool samples will be collected once a year for intestinal 
helminth examination. Whole blood cultures will be set up using samples from individuals 
identified in a subset of households randomly selected from the treatment and placebo 
arms (Figure 2). All blood samples (serum, cell pellet, plasma, and whole blood), blood 
culture supernatants, as well as stool samples for PCR, will be kept at -20°C and sent to 
Jakarta on dry ice to be kept at -20°C (plasma, cell plasma, blood culture supernatant) or 
-80°C (serum). At baseline, we mapped all houses using GPS system. All data that will be 
collected will be stored in an MS Access database (Microsoft, Redmond, WA, USA).
1. Questionnaires and additional measurements
Additional factors that could influence allergy or atopy will be obtained by questionnaires. The 
questionnaires include the core allergy symptoms questions of ISAAC and information on 
history of  disease  and  treatment  in the last 12 months, treatment for worm infections,  history 
of immunization, history of breast feeding and food consumption. The questionnaires will be 
administered to the parent or guardian of each child under supervision of an interviewer.
The same interviewer will dispense the ISAAC questionnaire during house to house visits. 
For core ISAAC questionnaires, we will show a video of asthma and rhinitis as well as pictures for 
dermatitis. Additional questionnaires will be held on socio-economic status, hygiene, ethnicity 
and environment factors. These questionnaires include information as material of the house, use 
of processed water, electricity, floor material, fuel, management of waste and exposure to pets and 
animals, and parent education level. Standing height and weight without shoes will be measured.
2. Skin prick test
Skin prick test (SPT) reactivity to common aeroallergens41 will be tested with extracts 
of Dermatophagoides pteronyssinus and farinae (HAL Allergy Laboratories, Leiden, The 
Netherlands) and Blattella germanica (Lofarma, Milan, Italy) and to four allergens with extracts 
of shrimp, soybean, peanut and fish (HAL Allergy). A histamine positive control and a saline 
negative control will be used to reduce false positives and negatives. SPT will be done on the 
volar side of the child’s lower arm using skin prick lancets (Stallergènes SA, Antony, France). The 
wheal size will be measured after 15 minutes. Skin prick reactivity is to be considered positive if 
the longest diameter of the wheal size plus the diameter perpendicular to it divided by two is at 
least 3 mm. All SPTs in the study will be performed by the same investigator.
3. Spirometric and exercise challenge test
One hundred and twenty children selected on the basis of being helminth positive or negative 


































































that fall into the four categories: helminth positive and SPT positive, helminth negative and 
SPT negative, helminth positive and SPT negative, helminth negative and SPT positive for 
spirometric test. This test will be performed before exercise, three minutes after exercise 
and at eight minutes after exercise. Each child will go through a vigorous six minutes free 
running exercise in the school playground and their heart rate will be recorded before and 
after exercise as a measurement of the level of exercise stress achieved. Spirometer calibrations 
will be done daily before use according to ambient atmospheric pressure and temperature. To 
determine whether EIB has occurred, we will compare the highest forced expiratory volume 
in one second FEV1 value from at least three acceptable trials before exercise with the lowest 
FEV1 from at least three acceptable trials after exercise. Spirometric tests will be performed 
using a portable spirometer (Jaeger, Germany) with the child sitting and with a nose clip. EIB 
will be defined as positive if FEV1 falls by 15% or more after exercise.
4. Parasitological examination
Stool examination by microscopy
The formol-ether acetate concentration method42 will be performed on the formalin 
preserved stool samples followed by microscopic examination for intestinal helminth 
infections, as well as protozoan infections. For the detection of hookworm larvae, an 
amount of fresh stool sample will be cultured using filter paper soaked by distilled water 
inside a sealed plastic bag according to the Harada Mori method and the presence of larvae 
will be determined by microscopic examination after seven days43.
Stool examination by real-time PCR
Stool examination by real time PCR will be done in the Netherlands as previously described36. 
Briefly, DNA will be extracted from unpreserved stool samples were stored at -20°C). A 
multiplex real-time PCR will be used for the specific amplification and detection of A. 
duodenale, N. americanus, A. lumbricoides, and S. stercoralis DNA44,45. Amplification reactions 
will be performed in white PCR plates in a volume of 25 μl with PCR buffer (Hotstar Taq 
master mix, QIAgen, Germany), 5 mM MgCl2, 2.5 μgram Bovine Serum Albumin (Roche 
Diagnostics Nederland B.V., Almere, the Netherlands), 5 pmol of each A. duodenale-specific 
primer, and of each N. americanus-specific primer, 2 pmol of each A. lumbricoides specific 
primer, 2.5 pmol of each S. stercoralis specific primer and 3.75 pmol of each PhHV-1-
specific primer, 1.25 pmol of each N. americanus specific XS-probe, A. lumbricoides specific 
XS-probe, S. stercoralis specific double-labelled probe, and PhHV-1-specific double-labelled 
probe, and 2.5 pmol of the A. duodenale specific XS-probe, and 5 μl of the DNA sample.
Amplification consists of 15 min at 95°C followed by 50 cycles of 15 s at 95°C, 30 s at 
60°C, and 30 s at 72°C. Amplification, detection, and analysis will be performed with the 
CFX real-time detection system (Bio-Rad laboratories). The PCR output from this system 
consists of a cycle-threshold (Ct) value, representing the amplification cycle in which the 




specific DNA load in the sample tested. Negative and positive control samples are included 
in each amplification run.
The amplification is considered to be hampered by faecal inhibitory factors if the expected 
cycle threshold (Ct) value of 33 in the PhHV-specific PCR is increased by more than 3.3 cycles.
5. Whole blood culture and cytokine measurements in supernatants
Whole blood culture will be undertaken in the field studies and cytokine measurements will 
be done in Jakarta, Indonesia as described previously36. Briefly, the heparinized blood will be 
diluted 1:4 with RPMI 1640 medium (Invitrogen, Breda, The Netherlands) and cultured in 96 
well round bottomed plates. Stimulations will be performed with medium/control, PHA (2 
μg/ml, Wellcome Diagnostics, Darford, UK), LPS (1 ng/ml Sigma-Aldrich, Zwijndrecht, The 
Netherlands), Pam3Cys (100 ng/ml, Cayla-InvivoGen Europe, Toulouse, France), PolyIC (50 
μg/ml, Cayla-InvivoGen Europe, Toulouse, France) and Ascaris antigen (20 μg/ml as prepared 
by van Riet E et al46. Supernatants will be collected on day 1 (unstimulated control, LPS, 
Pam3Cys) and day 3 (unstimulated control, PHA, Ascaris, PolyIC). TNF-α and IL-10 from 
day 1 supernatants as well as IL-2, IL-5, IL-10, IFN-γ, and TNF-α for day 3 supernatants will be 
analysed simultaneously using commercial Luminex cytokine kit (Biosource, Camarillo, CA, 
USA) and run on a Liquichip 200® Workstation (Qiagen, Venlo, The Netherlands) equipped 
with Liquichip analyzer software (Qiagen, Venlo, The Netherlands).
6. Antibody measurements
Antibody IgE measurement
Measurement of plasma specific IgE to A. lumbricoides antigen and to D. pteronyssinus (house 
dust mite), B. germanica, shrimp and peanut will be performed using an ImmunoCAP 
250 system (Phadia, Uppsala, Sweden) following the manufacturer’s instructions47. All 
measurement will take place in one laboratory in the Netherlands.
Total IgE
Total IgE will be measured in Jakarta, Indonesia as described previously36,48. Briefly, maxisorp 
plates (Thermo Fisher Scientific, Roskilde, Denmark) will be coated overnight with 1/1400 
diluted rabbit anti-human IgE (Dako, Glostrup, Denmark). Plates are blocked with phosphate 
buffered saline (PBS) containing 5% bovine serum albumin (BSA, Albumin Fraction V, 
Boehringer, Mannheim, Germany). Sera are diluted 1/200 in PBS containing 5% fetal calf serum 
(FCS, Greiner Bio-One, Alphen a/d Rijn, Netherlands). A positive standard serum containing 
human IgE (NIBSC, Potters Bar, UK) is incubated on each plate. Plates will be incubated for 1 
hour at room temperature. After a washing step, IgE biotinylated goat anti-human IgE antibody 
(1/1000 (Vector Laboratories, Burlingame, CA, USA)) and Streptavidin Alkaline Phosphatase 
conjugate (1/3000 (Boehringer, Mannheim, Germany)) will be incubated for 1 hour at room 




Outcomes and case definitions
The study aims to determine whether and how helminth infections may affect allergic disorders. 
The study will therefore determine the effect that anthelmintic treatment albendazole has 
versus placebo on SPT reactivity, symptoms of allergic diseases and immune responses. The 
primary outcome of the study is SPT; the secondary outcome is symptoms (asthma and atopic 
dermatitis); while the tertiary outcome is immune responses (both IgE levels to allergens and 
cellular immune responses that represent both innate and adaptive immune reactivities).
Helminth infections will be determined by the presence of parasites detected by 
microscopic examination of stool as well as by molecular (PCR-based) methods. Atopy will 
be defined as either positive in SPT (≥3 mm wheal size) to any of aeroallergens tested or the 
presence of allergen-specific IgE ≥ 0.35 kUA/L. Symptoms of asthma and atopic dermatitis 
will be assessed by modified ISAAC questionnaires41 that have been translated into Bahasa 
Indonesia and translated back to English and adapted for use in the study area. It has been 
tested in some areas in Sulawesi as well as in study areas during pilot studies. A positive answer 
to the questions (i) has your child ever had asthma? (ii) has this asthma been diagnosed by a 
doctor? and (ii) has your child ever or in the past 12 months had wheezing or whistling in the 
chest? will be interpreted as asthma, while a positive answer to the question (iv) has your child 
ever had doctor/paramedic diagnosed allergic eczema and (v) has your child ever had one or 
more skin problem accompanying an itchy rash? will be taken as atopic dermatitis.
In order to test the effect of helminths on bronchial hyper-responsiveness (BHR) we 
will test lung function following American Thoracic Society and European Respiratory 
Society (ATS/ERS) guidelines49 for lung function and BHR testing41,50,51. FEV1 will be 
measured before and after 6 minutes of exercise52 and a fall of 15% in FEV1 is considered 
to indicate EIB. In order to take into account confounding factors, data on family structure 
like number of siblings and birth order will be recorded, as well as details of birth and 
breastfeeding, hygiene, socio-economic status, annual health status, and food consumption.
Overview of plan of analyses
The baseline data will be analyzed to determine whether helminth infections are associated 
with allergen specific IgE, atopy and symptoms of asthma or eczema. Both presence of 
infection and intensity of infection will be used for logistic and linear regression analyses. 
Analysis will be adjusted for confounding factors such as socio-economic status, body mass 
index, age, sex and environmental exposure. Additional confounders that are identified 
during the study will also be used. In order to examine a general effect of parasite burden 
and rural and semi-urban differences in atopy and allergy will be compared. The effect of 
anthelmintic treatment on atopy and allergy will be assessed 1 and 2 years after treatment 
by analyzing prevalence as well as incidence. The analyses will be based on intention to treat 
approach. The groups in treatment and placebo arms will be compared as well as groups 
in whom helminth infection was reduced or remained unaltered irrespective of treatment 




presence of infection or newly gained infections over the follow up period. Individuals that 
are lost to follow up and individuals that are analyzed will be compared on the basis of their 
baseline characteristics, age, gender, village, socio-economic status and parasitic infections. 
A similar comparison will also be undertaken to compare the characteristics of individuals 
in the treatment and placebo groups at inclusion into the study. chi-square, t-tests and 
Mann-Whitney tests will be used to test for differences. For data-analyses we will use SPSS 
(SPSS Inc., Chicago, IL, USA) and ArcGis (ESRI; Redlands, CA, USA).
To summarize, the plan is to measure the prevalence of allergy in school-aged children 
in semi urban and rural areas, and to establish their association with helminth infections as 
well as various risk and protective factors. By studying cellular immunological parameters, 
it is also the aim to understand the immunological mechanisms that are behind risk and 
protective factors in allergy. 
The analysis will be divided into six principals study questions (Figure 3):
1. What is the association between helminth infections and atopy and allergy symptoms?
2. What is the association of helminth infections and immune responses?
3. What is the association between immune responses and atopy and allergy symptoms?
4. Does the immune response change after anthelmintic treatment?
5. Does the prevalence of atopy and allergy symptoms change after anthelmintic treatment?
6. What is the role of hygiene, geographic location and socio-economic status in helminth 
infection and allergy?
Ethical consideration and trial registration
The study was approved by the Ethical Committee of the Medical Faculty, University of 
Indonesia, Jakarta (ethical clearance ref: 194/PT02.FK/Etik/2006) and has been filed by 
ethics committee of the Leiden University Medical Center, The Netherlands. The trial was 




registered as clinical trial ref: ISRCTN83830814. Parental consent was obtained for children 
who participated in the study. The study is reported in accordance with the CONSORT 
guidelines for cluster-randomized studies.
DISCUSSION  
The prevalences of atopic disorders and asthma have been reported to be lower in low income 
than in high income countries, however these are becoming an increasingly important public 
health problem, particularly in urban centres of the developing world35,53. With the view to the 
increasing urbanization it is important to have data on factors and mechanisms underlying the 
development of allergic diseases in low to middle income countries. Indonesia is a prototype of 
a country in transition towards a well-developed economy with dynamic changes in lifestyle. 
The ImmunoSPIN project was designed to assess how helminth infections can influence the 
immune response and clinical outcome of allergic disease and this study will compare atopy and 
allergic symptoms in children living in a semi urban and rural setting in Indonesia. The relations 
between allergic outcomes and the numerous measured exposures will be addressed. 
In our study design we will use a longitudinal approach to assess the effect of anthelmintic 
treatment on prevalence, risk and protective factors in children living in semi urban and 
rural environments. The laboratory component will explore the relative importance of 
immunological mechanisms that are leading to increase in prevalence of allergic disorders. 
Statistical analysis will involve the use of strategies that link data from different levels (e.g. 
socio-economic, environmental, clinical and immunological factors) and will use advanced 
statistical techniques to deal with this complex mechanism.
The study has so far provided data that are shown in a flow chart given in Figure 2. A total 
of 1675 children were registered in 1058 households in study area, characteristics of the study 
population are given in table 1 with prevalence of helminth infection in both areas.
Distribution of sex and age groups are shown in (Figure 4) in the semi urban area which 
has three junior high schools and four elementary schools, as well as in the rural area which 
has only one elementary school. This results in a larger number of older children in semi 
urban area than in rural area. Some of the children from rural area leave the area to go to 
junior high school in surrounding larger villages but not necessarily to our semi urban 
study area (as the distance between our study areas is considerable). These children will be 
skin prick tested, and characterized via questionnaires. 
In addition, blood withdrawal will allow the determination of total and specific IgE in 
addition to cellular immunological measurements and in a sub sample the spirometric test will be 
performed. After completion of the study the whole population will be given adequate treatment 
for helminth infections. This study is also unique in that it will provide data on anthelmintic 
treatment efficacy and effectiveness in a defined large population in a developing country.
If helminth infections are proved to be associated with reduced allergic disorders, and the 
mechanisms behind such protective effect is elucidated, measures can be taken to ensure that 




with microbial products and allergens. If helminths are proved not to be associated but new 
factor(s) are identified along with the immunological mechanism(s) through which the 
development of allergies is affected, then appropriate preventive measures can also be planed.
In summary the ImmunoSPIN helminth-allergy study is the first and currently the only 
longitudinal study of helminth and allergy in Indonesia. The study has received enthusiastic 
support from the authorities in Ende and at the regional level. At the same time, the study 
facilitates the transfer of state of the art technologies in immunology, molecular biology, 
epidemiology and statistics to Indonesia.
Table 1. Characteristics of study population
Semi Urban Rural
Participants 1161 514
Age (mean, SD) 6.77 ± 3.31 5.85 ± 3.12
Sex, male/female (male%) 583/578 (50.2) 270/244 (52.5)
BMI (mean, SD) 15.4 ± 2.39 14.4 ± 1.83
Parasites (%)
Any helminths 53.2 40.8
Hookworms 11.8 18.5
Ascaris lumbricoides 38.7 21.8
Trichuris trichiura 25.3 11.8
Body Mass Index (BMI) = Weight (kg)/height(m) squared. Helminth infection was measured by 
microscopic examination
Figure 4. Distribution of sex and age in school children participating in the study. Distribution of children 
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Background The prevalence of allergic diseases has increased not only in high income but 
also in low-to-middle income countries. However, risk factors for their development are 
still not well established, particularly in the latter.
Objective To assess prevalence and identify risk factors for sensitization to two major 
inhalant allergens among children from semi-urban and rural areas in Indonesia.
Method A cross-sectional survey was performed among 1,674 school children aged 5–15 
years old. Information on potential risk factors and reported allergic symptoms were 
obtained by questionnaire. Helminth infections were assessed. Skin prick tests (SPT) 
were performed, total IgE as well as allergen-specific IgE for house dust mite (HDM) and 
cockroach were measured.
Result The prevalence of allergic skin sensitization to both aeroallergens was significantly higher 
in the semi-urban than in the rural area. However, serum IgE against HDM and cockroach as 
well as total IgE were significantly lower in semi-urban than in rural children. In the semi-urban 
area, there was a significant positive association between SPT to HDM and higher paternal 
education but a negative one with hookworm infection. The risk factors linked to cockroach 
sensitization were different: being of a farmer offspring and lacking access to piped water were 
associated with an increased risk for a positive SPT to cockroach. No significant associations 
between measured risk factors and having a positive SPT were found in the rural area.
Conclusion Sensitization to HDM and cockroach is common in Indonesia, more often 
translating into a positive SPT in the semi-urban than in the rural setting. Whereas high 
paternal education and low hookworm infection were associated with increased risk of 
a positive SPT to HDM, we were surprised to find that parameters of lower SES were 
identified as risk factor for a positive cockroach SPT.
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INTRODUCTION
The prevalence of allergic diseases has increased not only in high income but also in low-
to-middle income countries (LMIC)1. However, in the LMIC, whereas high prevalence of 
allergies is seen in urban centers, allergic disorders are usually rare in rural areas2,3.
It is well-established that the development of allergic disorders is the result of a complex 
interplay of genetic background and environmental factors4. Various exogenous factors 
including parental smoking, allergen exposure, and outdoor and indoor air pollution have 
been shown to be associated with an increase in the prevalence of allergic disease, while 
other factors such as exposure to infections in early childhood, a ‘traditional’ diet or lifestyle, 
and contact with animals were shown to reduce the risk of developing allergic disorders5.
With respect to infections, parasitic helminths have often been shown to be negatively 
associated with allergic outcomes6. Previous studies have shown that having Schistosoma7 
or filarial infection8 decrease the risk of skin prick test (SPT) positivity. Similarly, studies in 
Ecuadorian9 and Vietnamese10 children showed that having soil-transmitted helminth infections 
decrease the risk of atopy. In these studies, it was also clear that other factors such as overcrowding 
in household, poor sanitation as well as low socio-economic status can be associated with less 
atopy9,10. In general, helminth infections are associated with poor sanitation, low socio-economic 
status and rural setting in low income countries11, therefore dissecting the relative contribution of 
the different factors will be important in understanding the rise in allergies worldwide12.
Indonesia is one of the LMIC which is in epidemiological transition with increasing 
level of urbanization accompanied by changing disease patterns. Risk factors for the 
development of allergic disorders are still not well established in Indonesia. Therefore, we 
set up a study in a semi-urban and a rural area on Flores Island, in Indonesia, to estimate 
the prevalence of allergic sensitization to two major respiratory allergen sources (house 
dust mite and cockroach) and to identify associated risk factors.
METHODS
Study area and design 
This cross-sectional study was performed between January and June 2008 in Ende District of 
Flores Island, Indonesia, as part of a longitudinal study investigating the effect of anthelminthic 
treatment on malarial parasitemia and allergy, described in detail elsewhere13,14. In a 
preliminary study, we surveyed several areas in Ende district and found that both semi-urban, 
Nangapanda, and rural, Anaranda, were endemic for soil-transmitted helminth. A total of 
1674 (1161 and 513 from semi-urban and rural, respectively) school children aged 5 – 15 
years were included in this study. Allergic disorders were assessed by a questionnaire slightly 
modified from the validated questionnaire used by the International Study of Asthma and 
Allergy in Childhood (ISAAC) to accommodate local study requirements. Questionnaires 
were administered to obtain demographic data, socio-economic status and other potential 




and specific IgE (by ImmunoCAP) to house dust mite (HDM) and cockroach as well as total 
IgE (by ELISA) were measured. Stool was collected for determination of helminth infection. 
Written informed consent was obtained from parent or guardian of each child. The study was 
approved by the Ethical Committee of the Medical Faculty, University of Indonesia, Jakarta 
(ethical clearance ref: 194/PT02.FK/Etik/2006) and has been filed by ethics committee of the 
Leiden University Medical Center, The Netherlands.
Questionnaires 
Reported clinical symptoms of allergy were obtained by questionnaire. The interview 
was conducted with the parent or guardian of the children. History of asthma and atopic 
dermatitis (eczema) were assessed using a modified ISAAC questionnaire, which had been 
translated into Bahasa Indonesia. The prevalence of asthma symptoms were obtained from 
the following questions: (i) Has your child ever had wheeze? (ii) Has this asthma been 
diagnosed by a doctor? and (iii) Has your child ever or in the past 12 months had wheezing 
or whistling in the chest?; while eczema was obtained from the questions: (i) has your child 
ever had doctor diagnosed allergic eczema and (ii) has your child ever had one or more skin 
problems accompanied by an itchy rash?.
An additional questionnaire was administered to obtain data on demographic, parental 
education, parental occupation, water supply, living condition of families and other 
characteristics of the households. Educational levels were categorized as: low for illiterate or 
elementary school and high for secondary school or above. The majority reported parental 
occupation as ‘farmers’; therefore occupation was categorized into farmers and non-farmers.
Skin prick testing 
SPT reactivity to common aeroallergens was tested with extracts of HDM (Dermatophagoides 
pteronyssinus  and  D. farinae;  HAL Allergy Laboratories, Leiden, The Netherlands) and 
cockroach (Blattella germanica; Lofarma, Milan, Italy). Histamine and allergen diluents 
were used as positive and negative controls, respectively. SPT was done on the volar side 
of the lower arm. The wheal size was measured after 15 minutes. Skin prick reactivity 
was considered to be positive if the longest diameter of the wheal size plus the diameter 
perpendicular to it divided by two was at least 3 mm. Individuals with at least one positive 
reaction to either D. pteronyssinus or D. farinae were classified to be positive for SPT to HDM. 
The same investigator performed all the SPTs. Body weight and height were also measured.
Specific and Total IgE
The levels of specific IgE (sIgE) to  D. pteronyssinus  and  B. germanica  were measured in 
plasma using an ImmunoCAP 250 system, (Thermo Fisher Scientfic, Uppsala, Sweden) 
following the manufacturer’s instructions. All measurements were conducted in one 
laboratory in The Netherlands.
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The levels of total IgE were measured by ELISA in Jakarta as described previously13,14. 
The results were expressed in International Units (IU/ml).
Parasitological examination
The formol-ether acetate concentration method was performed on formalin-preserved stool 
samples followed by microscopic examination for detection of Trichuris trichiura. Aliquots of 
unpreserved stool samples were kept frozen at −20°C. DNA detection of the parasite in the 
stool samples was performed in the Netherlands. A multiplex real-time PCR was used for the 
specific DNA amplification and detection of hookworm (Ancylostoma duodenale and Necator 
americanus), Ascaris lumbricoides and Strongyloides stercoralis as has been described in detail 
previously13. PCR output was expressed as the cycle threshold (Ct) reflecting the load of 
parasite specific DNA in the sample tested. Parasite specific DNA loads of N. americanus and 
A. lumbricoides were categorized in low load (Ct≥30) and high load (Ct<30).
Statistical analysis
We investigated risk factors for allergic disorders separately for each area. Descriptive 
data were expressed as means (± standard deviations), geometric means [95% confidence 
intervals (CI)] and frequencies (percentage of collected data). Prevalence rates were 
calculated and compared for different areas using Pearson chi-Square tests. Age-standardized 
z-scores of body mass index (z-BMI) were calculated according to WHO references15. Log 
transformation of sIgE and total IgE was used to obtain normally distributed data. Student 
t-tests were used for comparison the differences between the outcomes studied in the two 
populations. The associations between the risk factors and development of positive SPT and 
reported clinical symptoms of allergy were tested by logistic regression. Linear regression was 
used for analysis of continuous outcomes which provided estimated regression coefficients 
(β) and their corresponding 95% CI. In multivariate analysis, we included age and sex as a 
priori confounders, as well as other variables that were previously significant in univariate 
analyses. We retained in the model those for which there was significant heterogeneity across 
categories, taking P < 0.05 as statistically significant. In the case of collinear variables of risk 
factors, we fitted each in the absence of the other and retained in the model the variable with 
the strongest effect. The collected data were analyzed using PASW Statistics for Windows, 
version 18.0 (SPSS Inc, Chicago, IL, USA) software. The risk factors of sensitization to HDM 
and cockroach were different; we have presented the results for each allergen separately.
RESULTS
Demographics and allergic disorders in the study population
Data were collected from 1161 and 513 school children in semi-urban and rural areas, 




to rural area (9.7 years) (P < 0.001). The percentage of children reported to have a history of 
wheeze was 4.1% (38 out of 927) and 1.1% (5 out of 453) in the semi-urban and rural areas, 
respectively. Only 16 out of 927 (2.3%) children in the semi-urban area and none in rural 
area reported doctor-diagnosed asthma. In the semi-urban area, eczema was reported in 
3.1% of the children (Table 1), while no case was reported in the rural area. 
In the semi-urban area the prevalence of a positive SPT was higher than in the rural 
area for both HDM (13.5% versus 8.5%; P = 0.007; respectively) and cockroach (23.8% vs 
18.3%; P = 0.021; respectively). In contrast, the levels of sIgE to HDM and cockroach as well 
as total IgE were lower in the semi-urban than in the rural area (Table 1).
Rural population were very homogeneous with regards to socio-economic conditions: 
parental education was low (89%), farming was the major occupation (95%), 92% (473/513) 
of houses were made up of bamboo, almost all children had helminth infection and a very 
high proportion of children (78%) had high load of hookworm infection. In contrast, the 
semi-urban area demonstrated more heterogeneity with 41% (314/760) of parents having 
high education, 62% (579/938) being farmers, 43% (143/332) of children having a high load 
of hookworm infection whereas 87% children had helminth infections.
Table 1. Characteristics of population and allergic disorders in semi-urban and rural areas
Semi Urban Rural
P-valueN Result N Result
Age years (mean, SD) 1161 10.6 ± 3.3 513 9.7 ± 3.1 <0.001$
Sex (N, %)
Male 583 50.2 272 53.0 0.29∞
Female 578 49.8 241 47.0  
Clinical symptoms of allergy (N, n%)
Asthma
History of wheeze 927 38 (4.1) 453 5 (1.1) 0.0026∞
Diagnosed-asthma by doctor 927 16 (2.3) 453 0
Wheeze in the last 12 months 927 15 (1.1) 453 3 (0.7) 0.14∞
Eczema 927 29 (3.1) 453 0  
Skin prick test reactivity (N, n%)
HDM 975 132 (13.5) 447 38 (8.5) 0.0066∞
Cockroach 975 232 (23.8) 447 82 (18.3) 0.021∞ 
Specific IgE and Total IgE (geometric mean, 95 CI)
HDM# (kUA/L) 592 0.66 (0.58-0.76) 292 1.13 (0.95-1.34) < 0.001$
Blattella germanica (kUA/L) 592 1.33 (1.15-1.54) 292 1.66 (1.38-2.00) 0.074
$
Total IgE  (IU/ml) 540 1896.9 (1696.8-2120.6) 340 4141.1 (3654.7-4692.3) < 0.001$ 
SD: standard deviation. The number of positives (n) of the total population examined (N). #IgE to 
Dermatophagoides pteronyssinus (HDM). The statistically significant results are given in bold. $P-value 
derived from Student t-test.  ∞P-value derived from Chi-Square test. 
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Risk factor associated with reported clinical symptoms of allergy
No association was found between measured risk factors and history of wheeze, wheeze in 
the last 12 months or eczema (data not shown).
Risk factors associated with skin prick test reactivity
In the semi-urban area, the skin reactivity to HDM was positively associated with high 
paternal education (OR, 1.68; 95% CI, 1.12–2.51) while a high load of N. americanus 
infection was associated with a reduced risk of HDM skin reactivity (OR, 0.47; 95% CI, 
0.23–0.95) (Table 2). The odds for positive skin reactivity to cockroach was significantly 
lower in children who had access to piped water (OR 0.73; 95% CI, 0.54–0.98) but was 
higher in children whose parents were farmers (OR 1.52; 95% CI, 1.07–2.17) (Table 2).
None of the measured socio-economic factors, z-BMI or helminth infection status was 
associated with skin reactivity in the rural area (Table S1).
Risk factors associated with total and allergen-specific IgE 
The risk factors for sIgE were very different from what was seen for SPT. There was no 
significant association between risk factors measured and the level of sIgE to HDM in 
the semi-urban area (Table 3). In the rural area, high load of N. americanus infection was 
associated with higher levels of sIgE to HDM (β, 0.25; P = 0.040) (Table S2).
The examination of cockroach sIgE revealed that in the semi-urban area, high parental 
education, high socio-economic status (SES) as represented by housing material, cooking 
fuel and type of floor as well as high z-BMI showed a significantly negative association 
with sIgE to cockroach. The high load of A. lumbricoides and having farmer parents were 
associated with high levels of sIgE to cockroach (Table 3). The levels of cockroach sIgE 
tended to be higher in children with high load of N. americanus infection in both semi-
urban and rural areas (Table 3 and Table S2).
With respect to the levels of total IgE, in the semi-urban but not in the rural area elevated 
levels of total IgE were associated with having farmer families as well as high load of N. 
americanus or A. lumbricoides infections (Table 3). High maternal education was associated 
with lower levels of total IgE in both semi-urban (β, -0.20; P < 0.001) and rural (β, -0.15; P = 
0.046) areas. The levels of total IgE were significantly lower in children with higher z-BMI 
(β, -0.06; P = 0.010) in the semi-urban area (Table 3). In rural area, using gas/kerosene as 
cooking fuel was associated with lower levels of total IgE (β, -0.32; P = 0.030) (Table S2).
Multivariate analysis
In the semi-urban area, multivariate analysis revealed that N. americanus infection tended to 
reduce the risk of skin reactivity to HDM (adjusted OR, 0.46; 95% CI, 0.21–1.00; P = 0.051) 
(Table 4). In this model, paternal education did not remain as a significant predictor of skin 








n (%) OR [95% CI] n (%) OR [95% CI]
z-BMI (mean, SD) 975 -1.27 ± 1.05b 0.95 [0.80-1.13] -1.27 ± 1.05b 0.93 [0.81-1.07]
Paternal education
Low 442 46 (10.4) reference 103 (23.3) reference
High 411 67 (16.3) 1.68 [1.12-2.51]* 89 (21.7) 0.91 [0.66-1.26]
Maternal education
Low 581 75 (12.9) reference 151 (26.0) reference
High 347 54 (15.6) 1.24 [0.85-1.82] 73 (21.0) 0.76 [0.55-1.04]
Parental job
Non farmer 300 43 (14.3) reference 55 (18.3) reference
Farmer 502 65 (12.9) 0.89 [0.59-1.35] 128 (25.5) 1.52 [1.07-2.17]*
House material
Bamboo / Wood 703 89 (12.7) reference 175 (24.9) reference
Stone 272 43 (15.8) 1.30 [0.87-1.92] 57 (21.0) 0.80 [0.57-1.12]
Water source
Non piped 445 68 (15.3) reference 120 (27.0) reference
Piped 530 64 (12.1) 0.76 [0.53-1.10] 112 (21.1) 0.73 [0.54-0.98]*
Toilet
No 88 10 (11.4) reference 27 (30.7) reference
Yes 887 122 (13.8) 1.24 [0.63-2.47] 205 (23.1) 0.68 [0.42-1.10]
Floor material
Mud 163 17 (10.4) reference 47 (28.8) reference
Cement / ceramic 812 115 (14.2) 1.42 [0.83-2.43] 185 (22.8) 0.73 [0.50-1.06]
Fuel
Wood 827 116 (14.0) reference 204 (24.7) reference
Gas / kerosene 148 16 (10.8) 0.74 [0.43-1.29] 28 (18.9) 0.71 [0.46-1.11]
Using sandals
No 608 79 (13.0) reference 146 (24.0) reference
Yes 313 45 (14.4) 1.12 [0.76-1.67] 75 (24.0) 1.00 [0.72-1.37]
N. americanus1
Low load 180 31 (17.2) reference 49 (27.2) reference
High load 135 12 (8.9) 0.47 [0.23-0.95]* 25 (18.5) 0.61 [0.35-1.05]
A. lumbricoides1
Low load 200 28 (14.0) reference 49 (24.5) reference
High load 115 15 (13.0) 0.92 [0.47-1.81] 25 (21.7) 0.86 [0.49-1.48]
T. trichiura2
Negative 288 32 (11.1) reference 67 (23.3) reference
Positive 190 32 (16.8) 1.62 [0.96-2.75] 51 (26.8) 1.21 [0.79-1.84]
aassociation based on univariate logistic model. bMean and standard deviation. 1diagnosed by PCR. 
2diagnosed by microscopy. The number of positives (n) of the total population examined (N).  OR: Odds 
ratio, CI: Confidence intervals. *P < 0.05
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(adjusted OR, 1.53; 95% CI, 1.07–2.20; P = 0.019), but the negative association with piped 
water was no longer significant (Table 4).
Children from farmer parents had higher levels of sIgE to cockroach (adjusted β, 0.24; 
P = 0.021) but high z-BMI and A. lumbricoides  load were no longer associated with sIgE 
(Table 4). Independently, the levels of total IgE were significantly increased with high 
load of N. americanus as well as high load of A. lumbricoides  infection (adjusted β, 0.33; 
P < 0.001: adjusted β, 0.22; P = 0.023, respectively) (Table 4).
Multivariate analysis in the rural area showed that high load of N. americanus infection was 
still associated with high levels of HDM sIgE (adjusted β, 0.27; P = 0.031) after adjusting with a 
priori confounders (Table S3). The levels of total IgE in analysis adjusted for age and sex were 
significantly lower if kerosene/gas was used as cooking fuel compared to wood (Table S3).
DISCUSSION
The present study showed higher prevalence of positive SPT in semi-urban compared to 
rural school children on Flores Island in Indonesia. This was accompanied by more reported 
allergy symptoms. Our finding on rural versus urban differences are in line with other studies 
showing higher allergies in urban than in rural areas3,16. Populations in rural areas often have 
helminth infections, traditional life style and lower socio-economic status. Here we assessed 
and determined the relative influence of these different factors. Our major finding in the 
semi-urban area was that although high paternal education was associated with increased 
risk of skin reactivity to HDM in univariate analysis, in multivariate it was found that only 
hookworm infection was an independent protective factor for HDM reactivity. This is 
consistent with a study in Vietnam10 which found that helminth infections were independent 
protective factor for HDM sensitization. The results were very different when cockroach 
skin reactivity was analyzed: factors associated with HDM SPT were not associated with 
cockroach SPT as has been reported before10. In our study, only having farmer parents 
increased the risk of being cockroach SPT positive. We found no association between skin 
sensitization to these two aeroallergens and any of the potential risk factors measured 
when we considered the rural area possibly due to low number of SPT positive subjects and 
homogeneity regarding high helminth load or socio-economic status (SES) factors, such as, 
low paternal education was almost universal and all children were of farmer families.
Sensitization in terms of serum IgE to HDM and cockroach as well as total IgE showed 
entirely different patterns. In contrast to SPT, sIgE as well as total IgE were higher in the rural 
than in the semi-urban area. Helminth infections were associated with higher levels of total 
IgE in the semi-urban area and tended to increase sIgE to aeroallergens in both rural and 
semi-urban areas. The finding of enhanced IgE is in line with several previous studies that 
have demonstrated that total IgE increased with the presence of helminth infections3,17,18.
Epidemiological studies have shown that high parental education, which is one of the 
indicators of high SES, is associated with atopy9,19. Our study also found that the prevalence 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4. Association between skin reactivity, specific IgE or total IgE and potential risk factors for atopy in 
the semi urban areaa
Skin prick test reactivity
IgE to B. germanica
adj. β (95% CI)
Total IgE
adj. β (95% CI)
HDM
adj. OR [95% CI]
Cockroach
adj. OR [95% CI]
General risk factors
z-BMI     -0.04 (-0.14-0.06) -0.01 (-0.10-0.07)
Paternal high education 
(reference: low)
1.82 [0.89-3.74]
Maternal high education  
(reference: low)
      -0.03 (-0.20-0.14)
Parental farmer  
(reference: non farmer)
  1.53 [1.07-2.20]* 0.24 (0.04-0.44)*  
Piped water  
(reference: non piped)
  0.84 [0.61-1.18]    
Specific parasite infection
N. americanus  
(reference: low load)
0.46 [0.21-1.00]¶     0.33 (0.16-0.50)***
A. lumbricoides  
(reference: low load)
    0.15 (-0.05-0.35) 0.22 (0.03-0.40)*
 aMultivariate model adjusted with age and sex. β (beta): estimate regression coefficients. CI: Confidence 
intervals. *P < 0.05,  ***P < 0.001, ¶P < 0.1
study paternal education disappeared as a significant predictive factor in multivariate 
analysis, while hookworm infection still remained as an independent protective factor on 
skin reactivity to HDM in the semi-urban area. Helminth infection has been shown in 
some studies to be inversely related with allergic skin sensitization6,10. As almost all of the 
population in rural area had intestinal helminth infection, this may explain the absence of 
an association between helminth infection and HDM reactivity in rural area. 
In our semi-urban population we found that the prevalence of skin reactivity to cockroach 
was lower in children using piped water and higher in children from farmer parents. Piped 
water is a marker of higher SES, therefore would be expected to be associated with increased 
SPT. Two possibilities might explain our finding; (i) bacterial contamination of the water 
which could affect the immune system and thereby atopic sensitization20, or (ii) piped water is 
associated with high SES and lower exposure to cockroach. However, in multivariate analysis 
only having farmer parents remained significantly associated with SPT reactivity to cockroach. 
The mechanism whereby being a child of farmer parents could increase risk of cockroach SPT 
positivity is not fully understood but might be related to increased exposure to this allergen. 
In addition to having different profile of risk factors for SPT and IgE, another issue of 
interest is the finding that in the face of high IgE in rural area low SPT is seen. The reason 
for this discrepancy could not be addressed in this study but it might be due to the fact 
that helminth infection can potentially induce the production of false-positive serum IgE 
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through cross-reactivity between helminth and aeroallergens as proposed earlier21: this is in 
line with the findings that sensitization to cockroach may not be driven by true cockroach 
exposure but by cross-reactive carbohydrate determinants (CCDs) as demonstrated in a 
study from Ghana (Akkerdaas J et al, manuscript in preparation).
The limitation of this study was the cross sectional design in an area with no data on 
allergen exposure and we could not examine the relation between risk/protective factors 
with allergic outcomes in the rural area because it was very homogenous with respect to 
factors such as helminth infection load and socio-economic status. In addition, we did not 
measure sensitization to Blomia tropicalis which is an important mite allergen source in 
the tropics. Another limitation is that the use of questionnaires to assess information on 
the presence of allergic disorders such as asthma and risk factors could make the study to 
information bias. Misclassification of exposure may also have occurred in the present study 
since we did not evaluate past helminth infection. However, we used a sensitive technique 
to measure hookworm and A. lumbricoides infection load.
In conclusion, the higher prevalence of SPT to HDM in the semi-urban area might be due to 
high level of education and low helminth burden compared to the rural area. However, we could 
not explain the lower prevalence of cockroach allergies in the semi-urban area as we found that 
having a farming family and proxies for lower socioe-conomic status, if anything, were associated 
with increased risk of allergies to cockroach. Further studies are needed to evaluate the possible 
risk and protective factors in more detail as well as to check possible cross-reactivity between 
allergens and helminths. So far, our data provide useful information on environmental as well 
as socio-economic factors which can be considered by clinicians and researchers working on 
prevention, diagnosis and treatment of allergic disorders in low-to-middle income countries.
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n (%) OR [95% CI] n (%) OR [95% CI]
z-BMI (mean, SD) 447 -1.68 ± 1.14b 1.11 [0.83-1.49] -1.68 ± 1.14b 0.86 [0.70-1.06]
Paternal education
Low 317 26 (8.2) reference 59 (18.6) reference
High 81 11 (13.6) 1.76 [0.83-3.73] 17 (21.0) 1.16 [0.63-2.13]
Maternal education
Low 364 32 (8.8) reference 62 (17.0) reference
High 74 6 (8.1) 0.92 [0.37-2.27] 18 (24.3) 1.57 [0.86-2.84]
Parental job
Non farmer 20 0 2 (10.0) reference
Farmer 367 37 (10.1) - 72 (19.6) 2.20 [0.50-9.68]
House material
Bamboo / Wood 410 36 (8.8) reference 76 (18.5) reference
Stone 37 2 (5.4) 0.59 [0.14-2.57] 6 (16.2) 0.85 [0.34-2.11]
Water source
Non piped 447 38 (8.5) 82 (18.3)
Piped 0 0 - 0 -
Toilet
No 199 19 (9.5) reference 36 (18.1) reference
Yes 248 19 (7.7) 0.79 [0.40-1.53] 46 (18.5) 1.03 [0.64-1.67]
Floor material
Mud 340 28 (8.2) reference 60 (17.6) reference
Cement / ceramic 107 10 (9.3) 1.15 [0.54-2.45] 22 (20.6) 1.21 [0.70-2.08]
Fuel
Wood 430 36 (8.4) reference 81 (18.8) reference
Gas / kerosene 17 2 (11.8) 1.46 [0.32-6.63] 1 (5.9) 0.27 [0.04-2.06]
Using sandals
No 425 37 (8.7) reference 76 (17.9) reference
Yes 22 1 (4.5) 0.50 [0.07-3.82] 6 (27.3) 1.72 [0.65-4.54]
N. americanus1
Low load 41 5 (12.2) reference 8 (19.5) reference
High load 149 13 (8.7) 0.69 [0.23-2.06] 31 (20.8) 1.08 [0.46-2.58]
A. lumbricoides1
Low load 161 16 (9.9) reference 35 (21.7) reference
High load 29 2 (6.9) 0.67 [0.15-3.09] 4 (13.8) 0.58 [0.19-1.77]
T. trichiura2
Negative 170 17 (10.0) reference 30 (17.6) reference
Positive 52 4 (7.7) 0.75 [0.24-2.34] 12 (23.1) 1.40 [0.66-2.98]
aassociation based on univariate logistic model. bMean and standard deviation. 1diagnosed by PCR. 
2diagnosed by microscopy. The number of positives (n) of the total population examined (N).  OR: Odds 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table S3. Association between specific IgE or total IgE and potential risk factors for atopy in the rural areaa
IgE to HDM#
adjusted β (95% CI)
Total IgE
adjusted β (95% CI)
General risk factors
Fuel kerosene/gas (reference: wood) -0.31 (-0.60- -0.30)*
Specific parasite infection    
N. americanus (reference: low load) 0.27 (0.03-0.51)*
 aMultivariate model adjusted with age and sex. #IgE to Dermatophagoides pteronyssinus (HDM). 
β (beta): estimate regression coefficients. CI: Confidence intervals. *P < 0.05.
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Background Helminth infections are proposed to have immunomodulatory activities affecting 
health outcomes either detrimentally or beneficially. We evaluated the effects of albendazole 
treatment, every three months for 21 months, on STH, malarial parasitemia and allergy. 
Methods A household-based cluster-randomized, double-blind, placebo-controlled trial 
was conducted in an area in Indonesia endemic for STH. Using computer-aided block 
randomization, 481 households (2022 subjects) and 473 households (1982 subjects) were 
assigned to receive placebo and albendazole, respectively, every three months. The treatment 
code was concealed from trial investigators and participants. Malarial parasitemia and 
malaria-like symptoms were assessed in participants older than four years of age while skin 
prick test (SPT) to allergens as well as reported symptoms of allergy in children aged 5–15 
years. The general impact of treatment on STH prevalence and body mass index (BMI) 
was evaluated. Primary outcomes were prevalence of malarial parasitemia and SPT to any 
allergen. Analysis was by intention to treat. 
Results At 9 and 21 months post-treatment 80.8% and 80.1% of the study subjects were 
retained, respectively. The intensive treatment regiment resulted in a reduction in the 
prevalence of STH by 48% in albendazole and 9% in placebo group. Albendazole treatment 
led to a transient increase in malarial parasitemia at 6 months post treatment (OR 4.16(1.35–
12.80)) and no statistically significant increase in SPT reactivity (OR 1.18 (0.74–1.86) at 
9 months or 1.37 (0.93–2.01) 21 months). No effect of anthelminthic treatment was found 
on BMI, reported malaria-like- and allergy symptoms. No adverse effects were reported.
Conclusions The study indicates that intensive community treatment of 3 monthly 
albendazole administration for 21 months over two years leads to a reduction in STH. This 
degree of reduction appears safe without any increased risk of malaria or allergies.
Trial Registration Controlled-Trials.com ISRCTN83830814
84
EFFECT OF ANTHELMINTIC TREATMENT ON MALARIA AND ALLERGY
5
INTRODUCTION
Soil transmitted helminths (STH) (hookworms, Ascaris lumbricoides and Trichuris trichiura) 
establish chronic infections in a large proportion of the world population1. Major intervention 
programs using mass drug administration (MDA) to control STH have been launched2. However, 
STH infections seem to persist in the targeted populations raising concern over the development 
of drug resistance3. It is therefore important to conduct well-designed studies that allow evidence-
based decisions to be made to maximize effective STH control toward elimination. 
While there is no doubt that STH are associated with morbidities in billions of people 
worldwide, there is also increasing awareness that helminth infections might, like bacterial 
commensals, play an important role in shaping human health4. Helminths may contribute to 
immunologic and physiologic homeostasis. The immune system is thought to have evolved 
to operate optimally in the face of helminth-induced immune regulation, and that any 
disturbance of this long evolutionary co-existence between humans and helminth parasites 
might be associated with the emergence of pathological conditions5 possibly involving 
outcomes of exposure to other pathogens or the development of inflammatory diseases.
In many parts of the world helminths and malarial parasites are co-endemic raising 
the question of what impact helminth infections may have on the plasmodial parasites that 
cause malaria. The results have been conflicting in this regard. In some studies a positive 
association has been reported between helminths and malarial parasitemia while in others, 
this has been refuted or in yet others a negative association has been shown between 
helminths and the severity of the clinical outcomes of malaria (reviewed by Nacher)6.
An increase in the prevalence of allergies has been reported worldwide, in particular in 
the urban areas of low- to middle-income countries7. Although majority of cross-sectional 
studies have reported inverse associations between helminth infections and allergies8,9, two 
randomized trials with albendazole, have shown conflicting results. One in Ecuador, based 
on school randomization, reported no change in either SPT reactivity to allergens or allergic 
symptoms after one year of albendazole treatment10 while another in Vietnam, in which 
the randomization unit was individual schoolchildren, showed increased SPT reactivity 
after one year of albendazole treatment, but consistent with the Ecuadorean study, clinical 
allergy did not change significantly11. It has been suggested that anthelminthic treatment of 
longer duration might be needed to reveal the modulatory effect of helminths12,13.
In the light of global deworming initiatives, it is important to assess the effectiveness of 
and to monitor the risks associated with anthelminthic treatment regiments. There is as yet 
no report of a household-based cluster-randomized double-blind placebo-controlled trial 
of repeated anthelminthic administration in a community that would be expected to more 
effectively reduce transmission of STH by decreasing household cross-contamination.
In an area where STH and malaria are co-endemic on Flores Island, Indonesia, we conducted 
a household cluster-randomized trial of three-monthly albendazole treatment over a two year 
study period in a whole community to assess benefits and risks associated with this anthelmintic 





Study population and design 
This trial was conducted in two villages in the Ende District of Flores Island, Indonesia (Appendix 
S1, p2) as described in detail elsewhere14,15. The treatment was based on household and given 
to all household members except those less than two years old or pregnant (the Indonesian 
national program guideline). Directly observed treatment was given three monthly during 
the trial period (June 2008 to July 2010, with treatment starting in Sept 2008). The primary 
outcomes were prevalence of malarial parasitemia and SPT reactivity to allergens. Additional 
outcomes were treatment effect on STH and BMI as well as malaria-like and allergy symptoms. 
We measured malaria outcomes in Nangapanda only. Malaria was not endemic 
in Anaranda. Artemisinin-combination therapy (ACT) treatment and treated bed net 
distribution were not implemented during our study period16,17.
Allergy outcomes were measured, in both villages, in school-age children (5–15 years 
old) as this group is particularly at risk of developing allergy and asthma18 and is the target 
population of global deworming programs.
The study was approved by the Ethical Committee of the Medical Faculty, University 
of Indonesia (ethical clearance ref: 194/PT02.FK/Etik/2006) and filed by the Committee 
of Medical Ethics of the Leiden University Medical Center. The trial was registered as 
clinical trial (Ref: ISRCTN83830814). Prior to the study, written informed consent was 
obtained from participants or from parents/guardians of children. The study is reported in 
accordance with the CONSORT guidelines for cluster-randomized studies. 
Randomization and masking
The population was randomized by Iwan Ariawan (IA) using computer aided block 
randomization at household level utilising Random Allocation software to receive 
albendazole (single dose of 400 mg) or a matching placebo (both tablets from PT 
Indofarma Pharmaceutical, Bandung, Indonesia). The treatment code was concealed from 
trial investigators and participants. The un-blinding of treatment codes occurred after all 
laboratory results had been entered into the database (August 2011).
Procedures
Trained community workers measured fever, administered monthly malaria-like symptoms 
questionnaire which was based on WHO definitions19 and took finger-prick blood for the 
three-monthly malarial parasitemia survey. Subjects with fever (≥37.5°C) or additional 
malaria-like symptoms (headache, fatigue and nausea) at the time of visits were referred 
to the local primary health centre (puskesmas). Thick and thin Giemsa-stained blood 
smears were read at University of Indonesia. At baseline, 9 months and 21 months after the 
first round of treatment blood was collected for PCR-based detection of Plasmodium spp. 
(supplementary methods), a method that is more sensitive than microscopy20.
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Regarding allergy outcomes, skin prick tests (SPT) with allergens were performed on school-
age children in Nangapanda and Anaranda and clinical symptoms of allergy were recorded. 
House dust mite (Dermatophagoides pteronyssinus and D. farinae; kindly provided by Paul 
van Rijn from HAL Allergy Laboratories, Leiden, The Netherlands) and cockroach (Blattella 
germanica; Lofarma, Milan, Italy) were used for SPT which was considered positive with 3 mm 
cut off14. The SPT was performed by one investigator. IgE with specificity for aeroallergens (D. 
pteronyssinus and B. germanica) was measured in plasma using an ImmunoCAP 250 system 
(Phadia, Uppsala, Sweden) following the manufacturer’s instructions. All measurements were 
conducted in one laboratory in the Netherlands. Symptoms of asthma and atopic dermatitis 
were recorded using a modified visually-assisted version of the International Study of Asthma 
and Allergy in Childhood (ISAAC) questionnaire as reported before14.
Yearly stool samples were collected on a voluntary basis. Trichuris was detected by 
microscopy and a multiplex real-time PCR was used for detection of hookworms (Ancylostoma 
duodenale, Necator americanus), Ascaris lumbricoides, and Strongyloides stercoralis DNA as 
detailed before15 (supplementary methods). Very few subjects were infected with S. stercoralis 
and therefore this infection was not included in analyses.
Body weight and height were measured using the National Heart Lung and Blood Institute 
practical guidelines (scale and microtoise from SECA GmBH & Co, Hamburg, Germany).
Power calculation
Sample size estimation was based on the expected change in primary outcomes taking into 
account a power of 90% and a significance level of <0.05 with a loss to follow-up of 20%. 
Based on previous observations we expected to find a decrease in malarial parasitemia 
prevalence and an increase in SPT reactivity after anthelminthic treatment. Based on a 
prevalence of about 10% and a risk ratio (RR) of 0.60 we aimed to include 2412 people in 
the malaria assessments. In a pilot study we found SPT to D. pteronyssinus to be around 
15%, and expected that due to treatment the prevalence would increase. In order to find a 
RR of 1.5 we aimed to include at least 1418 children.
Statistical analyses
For children ≤19 years, BMI age-standardized z-scores were calculated according to WHO 
references21. The IgE data were log-transformed to obtain normally distributed variable. To 
assess treatment effects generalized linear mixed models were used which provide a flexible 
and powerful tool to derive valid inference while capturing the data correlations induced by 
clustering within households and repeated evaluations in time of the same subject. Parameter 
estimates for treatment effects at 9 and 21 months and 95% confidence intervals are reported. 
The reported P-values were obtained using likelihood ratio tests by comparing the model with 
and without the treatment effect. Unless stated otherwise, all outcomes were adjusted for area 
(the two study villages in Ende District: Nangapanda or Anaranda) as covariate in the model. 




namely to model clustering within households, a random household specific intercept was used 
and to model correlation within subjects a random subject specific intercept and slope were used. 
For the binary outcomes a logistic model was used with random household effects and random 
subject effects. All models were fitted using the lme4 package (supplementary appendix, p6-7)23. 
For each fever and additional malaria-like symptoms, total number of events and person months 
are computed for each treatment arm. Hazard ratios for effect of treatment were calculated with 
Cox regression with robust SE to allow for within-household clustering (STATA 11). 
RESULTS
At baseline, 954 households with 4004 subjects were registered. Randomization of 
households resulted in 1982 people assigned to albendazole treatment and 2022 people to 



















































Figure 1. Trial Profile. HH: Household. Lost to follow up implies that the participants have no data from this 
time point onward. Temporarily absent implies that the participants have no data at this time point but have 
data available at other time point
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Table 1. Baseline characteristic study population
N Placebo N Albendazole
Age (mean in years, SD) 2022 25.7 (18.7) 1982 25.8 (18.7)
Sex (female, n, %) 2022 1090 (53.9) 1982 1042 (52.6)
Area (rural,  n, %) 2022 260 (12.9) 1982 253  (12.8)
BMI  > 19 years old (mean, SD) 575 22.3 (4.0) 582 21.8 (3.6)
Z score of BMI ≤ 19 years old (mean, SD) 427 -1.20 (1.2) 386 -1.37 (1.3)
Parasite infection (n, %)
Helminth (any spp) 655 571 (87.2) 609 533 (87.5)
Hookworm1 683 509 (74.5) 629 486 (77.3)
N. americanus1 683 503 (73.7) 629 481 (76.5)
A. duodenale1 683 44 (6.4) 629 41 (6.5)
A. lumbricoides1 683 238 (34.9) 629 209 (33.2)
S. stercoralis1 683 7 (1.0) 629 18 (2.9)
T. trichiura2 953 258 (27.1) 852 237 (27.8)
Malarial parasitemia (any spp)2 1225 60 (4.9) 1187 52 (4.4)
P. falciparum 1225 32 (2.6) 1187 28 (2.4)
P. vivax 1225 26 (2.1) 1187 18 (1.5)
P. malariae 1225 2 (0.2) 1187 7 (0.6)
Malarial parasitemia (any spp)1 772 195 (25.3) 739 200 (27.1)
P. falciparum 772 106 (13.7) 739 112 (15.2)
P. vivax 772 102 (13.2) 739 93 (12.6)
P. malariae 772 10 (1.3) 739 18 (2.4)
Skin prick reactivity (n, %)
Any allergen 711 190 (26.7) 653 163 (25.0)
House dust mite 711 88 (12.4) 653 75 (11.5)
Cockroach 711 163 (22.9) 653 140 (21.4)
Specific IgE, kUA/L (median, IQR)
House dust mite 452 0.8 (0.3-2.6) 431 0.8 (0.2-2.4)
Cockroach 452 1.5 (0.4-5.7) 431 1.9 (0.5-5.0)
1diagnosed by PCR; 2diagnosed by microscopy. The number of positives (n) of the total population examined (N)
At baseline 87·3% of the individuals were infected with one or more helminth species. 
The baseline characteristics were similar between the treatment arms (Table 1). The overall 
trial profile is shown in Figure 1, and Figure S1A, S1B, S1C in supplementary figures 
separately for malaria, allergy and helminth outcomes. The analysis was intention-to-treat 
and involved all participants as assigned randomly at the start of the trial. During the study, 
in the albendazole arm 61 people moved to a house that was assigned to placebo while 




subjects who died during the trial, included 4 people below the age of 20, 3 between 20 and 
40 and the rest above 40 years of age, and were equally distributed between the treatment 
arms. At 9 months post-treatment full compliance was 77.8% for albendazole treatment and 
78.0% for placebo. This was 63.1% and 62.5% respectively at 21 months. 
This intensive treatment with albendazole resulted in a reduction but not elimination of 
STH. There was a decrease both after 9 (OR (95% CI) = 0.07 (0.04–0.11) and 21 months (0.05 
(0.03–0.08)) of treatment (P < 0.0001). Albendazole had the largest effect on hookworm 
followed by  Ascaris  while the effect on Trichuris was less pronounced (Figure 2A  and 
Table S1 in supplementary tables). Treatment also led to statistically significant reduction 
in the intensity of hookworm and Ascaris infection as determined by PCR (Figure 2B). 
The fact that the stool sampling was on a voluntary basis could have created a selection 
bias. Analyzing baseline characteristics of subjects providing stool samples and those who 
did not at 9 months follow up, showed no differences in helminth prevalence, age and sex. 


































Figure 2. Effect of treatment on helminth prevalence and intensity. A) Percentage of helminth infected subjects 
in placebo and albendazole treatment arms. The presence of hookworms (by PCR), Ascaris lumbricoides (by PCR) 
and Trichuris trichiura (by microscopy) or any of these helminth infections in subjects who provided stool samples 
at baseline, 9 and 21 months post treatment (numbers are given in Table S1A). B) Effect of albendazole treatment 
on reduction in the intensity as well as percentage of subjects positive for hookworm and Ascaris infection as 
determined by PCR. Negative is when no helminth specific DNA was found. Positive Ct- values were grouped into 
three categories: Ct<30.0, 30.0≤Ct<35.0 and ≥35.0 representing a high, moderate and low DNA load, respectively.
A. Percentage of helminth infected subjects in placebo and albendazole treatment arms
B. Effect of albendazole treatment on reduction in the intensity as well as percentage of subjects positive 
for hookworm and Ascaris infection as determined by PCR
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Malarial parasitemia by microscopy
0 month 32/1225 (2.6) 28/1187 (2.4) 26/1225 (2.1) 18/1187 (1.5) 2/1225 (0.2) 7/1187 (0.6)
3 months 41/897 (4.6) 46/910 (5.1) 17/897 (1.9) 22/910 (2.4) 1/897 (0.1) 6/910 (0.7)
6 months 8/815 (1.0) 20/794 (2.5) 4/815 (0.5) 9/794 (1.1) 0 0
9 months 14/947 (1.5) 7/950 (0.7) 4/947 (0.4) 5/950 (0.5) 1/947 (0.1) 1/950 (0.1)
12 months 9/834 (1.1) 9/813 (1.1) 4/834 (0.5) 2/813 (0.2) 0 0
15 months 14/773 (1.8) 13/772 (1.7) 3/773 (0.4) 4/772 (0.5) 1/773 (0.1) 3/772 (0.4)
18 months 3/815 (0.4) 10/803 (1.2) 1/815 (0.1) 1/803 (0.1) 1/815 (0.1) 1/803 (0.1)
21 months 6/824 (0.7) 11/824 (1.3) 6/824 (0.7) 0 3/824 (0.4) 1/824 (0.1)
Malarial parasitemia by PCR
0 month 106/772 (13.7) 112/739 (15.2) 102/772 (13.2) 93/739 (12.6) 10/772 (1.3) 18/739 (2.4)
9 months 35/656 (5.3) 56/627 (8.9) 56/656 (8.5) 50/627 (8.0) 7/656 (1.1) 9/627 (1.4)
21 months 21/584 (3.6) 31/553 (5.6) 24/584 (4.1) 27/553 (4.9) 10/584 (1.7) 5/553 (0.9)
The number of positives (n) of the total population examined (N).
Although at 21 months post treatment, sex and helminth prevalence were not different, age 
was slightly but significantly higher in subjects who provided stool samples, with a mean 
age in years (SD) = 29.9 (20.4) vs 24.3 (17.5), P = 0.006).
The overall percentage of subjects with malarial parasitemia, irrespective of treatment 
arm, decreased over the trial period (Table 2). However, when the data were modelled to 
assess the effect of albendazole treatment over time, there was a significant (P = 0.0064) 
increase, which might result from the transient four-fold increased risk of malarial 
parasitemia (OR 4.16 (1.35–12.80)) (Table 3) at 6 months after initiation of treatment (after 
2 doses of albendazole). 
The effect of anthelminthic treatment was assessed in those younger than 15 years of age 
who would be the prime target of the global deworming programs. The transient increase in 
parasitemia was only seen in the older (>15 years) age group (Figure 3). 
Malarial parasites were also assessed by PCR, at 9 and 21 months after initiation of 
treatment and revealed that albendazole had no effect when all Plasmodium species were 
considered together, but when analyzed separately there was a significant increase in the 
percentage of subjects positive for P. falciparum at 9 months post-treatment (Table 4). There 
was no difference in the incidence of fever and additional malaria-like symptoms between 








n/N (%) OR (95%CI)
Malarial parasitemia (any spp)
3 months 59/897 (6.6) 72/910 (7.9) 1.54 (0.75-3.16)
6 months 12/815 (1.5) 29/794 (3.7) 4.16 (1.35-12.80)
9 months 19/947 (2.0) 13/950 (1.4) 0.57 (0.16-2.04)
12 months 13/834 (1.6) 10/813 (1.2) 0.62 (0.12-3.15)
15 months 18/773 (2.3) 20/772 (2.6) 1.17 (0.18-7.65)
18 months 5/815 (0.6) 12/803 (1.5) 1.84 (0.12-29.03)
21 months 15/824 (1.8) 12/824 (1.5) 0.26 (0.01-6.59)
The number of positives (n) of the total population examined (N). Odds ratio and 95% confidence interval 
are based on mixed effects logistic regression models. OR’s and 95% CI are shown for the separate time 
points on malarial parasitemia. The P-value is generated from the modeled data for the combined effect 
of albendazole treatment over time, which is significant (P = 0.0064) and might result from the effect of 6 
months post treatment time point
Figure 3. Effect of albendazole treatment on malarial parasitemia based on two age categories. Malarial 
parasitemia A) ≤15 and B) >15 years of age. The risk of malarial parasitemia after albendazole treatment 
compared to placebo is shown as odds ratio with 95% CI. The reference line is set at 1, indicating that symbols at 
the right of this line represent an increased risk, while symbols at the left of the line would predict decreased risk 
of malarial parasitemia. Note: at 9 month time point in those >15 years of age, the OR is ∞
A. 15 years of age B. 15 years of age













The proportion of subjects with SPT reactivity was 353/1364 (25.9%) at baseline. 
Albendazole treatment had no statistically significant effect on SPT to any allergen 
(Table 5), but it was noted that there was an incremental increase in the risk of being SPT 
positive to any allergen at 9 months and 21 months post initiation of treatment. Moreover, 
additional analysis on allergens separately, showed a significantly higher SPT to cockroach 
at 21 months after treatment (OR 1.63 (1.07–2.50)) (Table 6). The levels of IgE to allergens 
showed that albendazole treatment had no effect on sensitization (Table 6). No effect of 
treatment was seen on symptoms of asthma or atopic dermatitis (Table S3).
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n/N (%) OR (95% CI) 
Malaria (any spp)
9 months 95/656 (14.5) 103/627 (16.4) 1.13 (0.77-1.64)
21 months 53/584 (9.1) 59/553 (10.7) 1.09 (0.68-1.76)
P. falciparum
9 months 35/656 (5.3) 56/627 (8.9) 2.82 (1.29-6.15)
21 months 21/584 (3.6) 31/553 (5.6) 1.63 (0.63-4.22)
P. vivax
9 months 56/656 (8.5) 50/627 (8.0) 0.84 (0.41-1.71)
21 months 24/584 (4.1) 27/553 (4.9) 1.40 (0.56-3.52)
P. malariae
9 months 7/656 (1.1) 9/627 (1.4) 0.34 (0.04-2.79)
21 months 10/584 (1.7) 5/553 (0.9) 0.04 (0.00-0.39)
The number of positives (n) of the total population examined (N). Odds ratio and 95% confidence interval 
based on logistic mixed models. The statistically significant results are given in bold. The P-values are 
generated from the modeled data for the combined effect of albendazole treatment over time for each of the 
species separately, which were significant for P. falciparum (P = 0.029) and P. malariae (P = 0.016).





n/N (%) OR (95%CI)
SPT to any allergen
9 months 80/462 (17.3) 82/454 (18.1) 1.18 (0.74-1.86)
21 months 145/455 (31.9) 161/439 (36.7) 1.37 (0.93-2.01)
The number of positives (n) of the total population examined (N). *Odds ratio and 95% confidence interval 
are based on mixed effects logistic regression models. OR’s and 95% CI are shown for the separate time 
points on SPT to any allergen. The P-value is generated from the modeled data for the effect of albendazole 
treatment overtime and no significant effects were found (P > 0.05).
No significant change in BMI was observed in children or in adults (Table S4). Moreover, 
there was no adverse effect of treatment reported.
DISCUSSION
This household-based clustered-randomized, double-blind, placebo-controlled trial shows 
that administering a total of seven single doses of albendazole, at three-monthly intervals, 
to a population living in an area of Indonesia where STH are highly prevalent, leads to 











n/N (%) OR (95% CI)
House dust mite
9 months 36/462 (7.8) 35/454 (7.7) 1.31 (0.52-3.27)
21 months 77/455 (16.9) 76/439 (17.3) 1.37 (0.62-3.02)
Cockroach
9 months 60/462 (13.0) 65/454 (14.3) 1.27 (0.75-2.15)
21 months 112/455 (24.6) 139/439 (31.7) 1.63 (1.07-2.50)
Specific IgE** N (Median, IQR) N (Median, IQR) β (95% CI)
House dust mite
9 months 391 (0.46, 0.16-2.35) 381 (0.46, 0.14-1.98) 1.01 (0.91-1.12)
21 months 339 (0.82, 0.27-3.29) 334 (0.65, 0.20-2.69) 0.93 (0.81-1.06)
Cockroach
9 months 391 (1.47, 0.30-5.01) 381 (1.55, 0.44-4.40) 1.04 (0.93-1.16)
21 months 339 (1.83, 0.47-5.44) 334 (1.64, 0.42-4.82) 0.98 (0.85-1.14)
The number of positives (n) of the total population examined (N). *Odds ratio and 95% confidence interval based 
on logistic mixed models; **β (beta) and 95% confidence interval based on generalized linear mixed models from 
the log-transformed IgE. The values shown are back-transformed. The P-values are generated from the modeled 
data for the effect of albendazole treatment overtime and no significant effects were found (P > 0.05).
be taken as an incomplete reduction. The results show a transient increase in malarial 
parasitemia in the albendazole- compared with the placebo-treated arm in the first six 
months after initiation of treatment. Albendazole treatment had no statistically significant 
effect on the designated co-primary outcome, skin prick test reactivity to allergens.
The clinical data collected of fever and additional malaria-like symptoms, were not 
affected by the deworming. Clinical signs of asthma and atopic dermatitis were also not 
affected by albendazole treatment.
The prevalence of infection was high (>60%), which reflects the situation in many areas 
that are being targeted by the global deworming programs. Using a three-monthly treatment 
regimen which represents an extreme scenario for helminth control strategy, percentage of 
subjects positive for STH was reduced by 39% compared to placebo. It should be noted that in 
our study the sensitive PCR method has been used. The reduction in the proportion of subjects 
infected with hookworm and  Ascaris  was more pronounced than for  Trichuris  infections, 
confirming the findings using a single dose of albendazole24. Subjects who provided stool 
samples at 21 months were slightly but significantly older than those who did not. Given 
that hookworm infection is more prevalent in older subjects, this may have contributed to 
the poor deworming achieved by albendazole. The reduction achieved in worm loads, did 
not have any beneficial effect on BMI. Observational studies have reported that helminth 
infections affect growth; however randomized trials have not been consistent25,26.  In this 
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regard, our study would support the outcome of a recent Cochrane review of no beneficial 
effect of deworming programs on nutritional indicators27 even though it can be argued that 
in our study the suboptimal reduction in the STH would not allow any beneficial effect of 
anthelmintic in terms of BMI to be seen in the community. Importantly, the fact that the 
effect of such an intensive deworming strategy in a community is incomplete, needs to be 
considered in the agenda for the control and elimination of helminth diseases of humans28.
Most studies on the effect of helminth infections on malarial parasitemia and clinical 
malaria episodes have used cross-sectional designs and have been inconclusive6. Longitudinal 
studies of anthelmintic treatment have also reported conflicting results29,30. A small study 
conducted in Madagascar has reported an increase in malarial parasitemia in levimasole 
treated subjects, older than 5 years of age29, while in Nigeria, albendazole treatment of pre 
school children was associated with lower P. falciparum infection and anemia, however, the 
lost to follow up in this study was very high30. The question whether albendazole treatment 
during pregnancy could affect health outcomes in the offspring, was addressed in a recent 
report from Uganda31. It was found that the incidence of malaria up to one year of age was 
not different in the offspring of mothers born to those treated with albendazole or placebo. 
Our study reports the results of a community wide randomized-controlled trial that used 
three-monthly malarial parasitemia data obtained by microscopy. A significantly higher 
percentage of subjects positive for malarial parasites in the albendazole compared to the 
placebo arm was seen but this seemed to be a transient effect and restricted to individuals 
older than 15 years of age, an age group that is not the main target of the current deworming 
programs. The question arises as to why this effect was only seen in those >15 years of age. 
This could be due to the fact that Ascaris infection is lower in older age and therefore more 
easily cleared. It has been suggested that Ascaris is the species of helminth that has the most 
effect on malarial parasitemia and diseases6. Therefore by removing Ascaris in older age, we 
might be seeing a more profound effect on malarial parasitemia.  
Using PCR, which enables detection of sub-microscopic infections at species level, it was 
also concluded that albendazole did not affect overall malarial parasitemia. When malaria 
species were analyzed separately, the percentage of subjects infected with P. falciparum 
but not with P. vivax increased significantly in the first 9 months post-treatment in the 
albendazole-treated arm, which is contrary to our hypothesis that anthelminthic treatment 
would reduce prevalence of malarial parasitemia32. It was expected that by decreasing 
STH, the immune hyporesposiveness would be reversed and this would be associated with 
stronger immune effector responses to malaria parasites. One of the possible explanations 
for the enhanced malarial parasitemia would be that with a reduction in STH, there is 
increased nutrient availability for other co infections and their growth. 
It has been suggested that there are different malaria outcomes with different species of 
helminths; Ascaris being associated with protection regarding parasitemia and severity of malaria 
while hookworm with higher incidence of malaria6. Our study was not powered to conduct a 
stratified analysis, and with the overall gradual decrease in malaria in the study area during our 




The findings concerning allergy outcomes, although not significant, are in line with 
our hypothesis that anthelminthic treatment would increase SPT reactivity. The risk 
of SPT reactivity increased incrementally with longer treatment and raises the question 
whether even longer deworming periods are needed for more pronounced effects on 
allergic outcomes. In support of this, a recent study reported that 15-17 years of ivermectin 
treatment for onchocerciasis control in Ecuador led to a significant increase in SPT reactivity 
to allergens12. In the same country, one year of anthelmintic treatment in schoolchildren did 
not lead to any change in SPT10. The question whether different species of helminths might 
affect allergic outcomes to a different degree, remains unanswered. It is interesting that 
one year anthelmintic treatment in Vietnam where hookworm infection was the prominent 
species, as in our study, resulted in a significant increase in SPT positivity in schoolchildren. 
This is in contrast to what was seen in Ecuador where A. lumbricoides was the most prevalent 
species. One common feature of the anthelmintic trials seems to be that clinical symptoms 
of allergy do not change with deworming. However, an important trial in pregnant women 
in Uganda has shown an increased risk of infantile eczema in infants of mothers treated 
with anthelminthics compared to those that received placebo33. This could indicate that 
exposure to worms in early life, might affect allergic outcomes more profoundly than when 
helminths are removed later in life34. 
One of the limitations of this trial is the overall decrease in malarial parasitemia during 
the two-year study period, most probably caused by actively referring subjects with malaria-
like symptoms to puskesmas. Therefore further studies in areas highly endemic for malaria 
are needed. Treatment in the trial did result in a significant reduction in percentage of 
subjects infected with STH, but this reduction was incomplete. It is therefore possible that 
the community was insufficiently dewormed. However, our primary aim was to measure the 
possible effect of deworming programmes on malaria or allergy. We conclude that despite 
transient increase in malarial parasitemia as a result of albendazole treatment, there were 
no clinically relevant changes to outcome measures 21 months after treatment was initiated. 
In conclusion, an extremely intensive anthelminthic treatment in a community where 
STH are highly endemic, does not lead to elimination but reduces both prevalence and 
intensity of helminths. Such MDA regiment appears safe and does not lead to any significant 
change with respect to malaria infections or allergies. However, it is worrying that such 
vigorous community treatment does not have a more pronounced effect on STH burden. 
Better integrated control strategies would be needed to deworm and subsequently assess 
whether the risk for malaria infections or allergies change.
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Additional information on the study area and procedures
Ende district, an area highly endemic for STH, is situated near the equator (8o45’S, 
121o40’E) and it is characterized by a uniform high temperature, in the range of 23-33.5 °C, 
with humidity of 86-95%. Average yearly rain fall is 1.822 mm with about 82 rainy days, 
especially from November to April, with the peak in December until March. The semi-
urban village of Nangapanda, endemic for malaria, had a population of 3583 and is located 
in the coastal area with most villagers being farmers and fishermen with some government 
officers or private sector employees. The rural village Anaranda had 1631 inhabitants and is 
located 80 km further inland of Nangapanda. There was poor infrastructure and inhabitants 
generated income mainly from farming.  
Regarding the availability of the anthelminthics in the community, there was no 
deworming campaign in this area during the study period. Pyrantel pamoat (Combantrin®) 
and dehydropiperazine (Bintang 7 puyer 17®) were the only available anthelminthics in the 
market. The local primary health centre (Puskesmas) did not provide the current trial study 
participants by any anthelminthic treatment but referred them to the trial team. 
Malaria control, such as by artemisinin-combination therapy (ACT) treatment and 
insecticide-treated nets (ITN) or long-lasting insecticide-treated nets (LLIN) although 
planned, were not implemented yet during our study period. This was due to several 
difficulties faced in some parts of Indonesia, such as instable drug supply, lack of training on 
definitive diagnosis of malaria by the laboratory staff, as well as insufficient bednet supply 
and poor compliance17. Malaria drugs such as chloroquine and quinine were available in the 
shops, however, little information is available on proper self medication. Therefore, before 
and during the study period, regular training of field workers was undertaken on how to 
prevent malaria (use of repellent and bednet, irrigation of breeding places) and how to 
treat malaria (not to self medicate but to visit puskesmas for diagnosis and treatment). 
Indoor residual spraying was done by the local health authority for dengue control against 
an outbreak at the beginning of 2008.
The treatment of suspected malaria cases at the puskesmas was chloroquine and 
primaquine for P. vivax, while for P. falciparum sulfadoxine/pyrimethamine was commonly 
used. Subjects in our study with fever and/or any one of the malaria-like symptoms (see 
below for detailed description) were referred to the puskesmas for assessment and treatment 
according to local health center policy.
The anthelmintic treatment and placebo were coded and the code was concealed from 
trial investigators and participants. The tablets were distributed by trained health workers 
and the intake was directly observed. Labels with the study subject ID were printed from 
a computer database and attached to the appropriate strip of treatment by a separate team 
located in Jakarta without the involvement of the study investigators. In order to assess 
whether anthelminthic treatment had any adverse effect on the growth of children or 




monitoring committee. After completion of the study the whole population was treated 
with albendazole (a single dose of 400mg for three consecutive days).
The malaria slides were read by microscopy at the Department of Parasitology in Jakarta. The 
quality control for microscopic reading took place in the pilot phase of the project. In cooperation 
with NAMRU-2 (US Naval Medical Research Unit-2) two microscopists from our team were 
trained, inter-observer differences were assessed and following satisfactory training they were 
certified. At the pilot phase, and throughout the study, PCR was used to monitor the microscopy 
data with a high degree of agreement between microscopy and PCR. In a random sub-sample at 
9 months and 21 months post-treatment we measured malarial parasitemia by PCR.
Primers and the P. falciparum, P. vivax, P. ovale, and P. malariae-specific probes were used 
with some modifications in the fluorophore- and quencher-chemistry. Amplification reactions 
of each DNA sample are performed in white PCR plates, in a volume of 25 μl with PCR buffer 
(HotstarTaq master mix), 5 mmol/l MgCl2, 12.5 pmol of each Plasmodium-specific primer and 
15 pmol of each PhHV-1-specific primer, 1.5 pmol of each P. falciparum, P. vivax, P. malariae-
specific XS- probes, and PhHV-1-specific Cy5 double-labelled detection probe, and 2.5 pmol of 
each P. ovale-specific XS-probes (Biolegio), and 5 μl of the DNA sample were used. Amplification 
consists of 15 min at 95ºC followed by 50 cycles of 15 s at 95ºC, 30 s at 60ºC, and 30 s at 72ºC. 
Amplification, detection, and analysis are performed with the CFX96 real-time detection 
system (Bio-Rad laboratories). The PCR output from this system consists of a cycle-threshold 
(Ct) value, representing the amplification cycle in which the level of fluorescent signal exceeds 
the background fluorescence, and reflecting the parasite-specific DNA load in the sample tested. 
Negative and positive control samples are included in each amplification run.
Stool samples were collected and preserved in 4% formaldehyde for microscopy 
examination or frozen (-20°C) unpreserved for PCR detection. The formol-ether acetate 
concentration method was performed on the formalin preserved stool samples followed 
by microscopic examination for Trichuris trichiura infections. As described in detail 
before15, DNA was isolated from approximately 100 mg unpreserved feces and examined 
for the presence of Ancylostoma duodenale, Necator americanus, Ascaris lumbricoides and 
Strongyloides stercoralis DNA by the multiplex qPCR. The qPCR output from this system 
consisted of a Ct value; negative and positive control samples were included in each run 
of the amplification. Positive Ct- values were grouped into three categories: Ct<30.0, 
30.0≤Ct<35.0 and ≥35.0 representing a high, moderate and low DNA load, respectively. 
Data collection on clinical symptoms
A year before the study enrolment, community workers were recruited and trained in taking 
finger-prick blood for the three-monthly malarial parasitemia survey in Nangapanda, 
observing drug intake, recording adverse treatment effects, as well as measuring fever and 
administering monthly malaria-like symptoms questionnaire. These questionnaires were 
based on WHO definitions19 and were assessed in all individuals that were present at the time 
of the survey. Subjects with fever (≥37.5oC) or additional malaria-like symptoms (headache, 
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fatigue and nausea) at the time of visits were referred to the puskesmas for treatment 
according to local standard protocols. The monthly data on fever (≥37.50C, using digital 
thermometer) and additional malaria-like symptoms were collected at baseline September 
2008 and in the months Oct 08, Nov 08, Dec 08, Jan 09, Feb 90, March 09, Apr 09, May 09, 
June 09, Aug 09, Sept 09, Oct 09, Nov 09, Dec 09, Jan 10, Feb 10, March 10 and Apr 10. At 
baseline, 1396 individuals were assessed in placebo and 1381 in the albendazole arm and at 
the last timepoint, 1165 and 1181 subjects were followed up in the two groups, respectively. 
Questionnaire data were available for all timepoints from 45.8% and 47.2% of placebo and 
albendazole group whereas data for 80% of the timepoints were available from 83.8% and 
87.6% of the two groups, respectively. The number of events was recorded in total of 15259 
and 15307 person months at risk for placebo and albendazole groups, respectively.
The modified video-assisted (for asthma symptoms) and illustration-assisted (for atopic 
dermatitis) ISAAC questionnaire, translated to Bahasa Indonesia and back translated for use 
in our studies within the EU funded project GLOFAL (www.glofal.org), were administered 
at baseline and at 21 month timepoints. Data were available from 629 in placebo and 635 
in albendazole arm at baseline, while these numbers were 460 and 445, respectively, at the 
21 month timepoint. These questionnaires were administered to the parents/guardians of 
subjects who were skin prick tested with allergens: the trial profile is given in supplementary 
Figure 1B. The prevalence of asthma symptoms were obtained from the following questions: 
(i) has your child ever had asthma? (ii) has your child ever been diagnosed for asthma by 
a doctor? and (iii) has your child in the past 12 months had wheezing or whistling in the 
chest?; while the prevalence of atopic dermatitis was obtained from the questions: (i) has 
your child ever had doctor/paramedic diagnosed allergic eczema and (ii) has your child 
ever had one or more skin problems accompanied by an itchy rash?  
If the answer to one or more of these questions was positive, the subjects were considered 
to have either asthma or atopic dermatitis symptoms.
Detailed description of the statistical models used 
Descriptives were computed for each variable (mean and standard deviation or median 
and interquartile range for continuous outcomes, numbers and percentages for categorical 
variables). For children ≤ 19 years, BMI age-standardized z-scores were calculated according 
to WHO references21.
Two sources of correlation among observations should be accounted for when modeling 
these data, namely observations at various timepoints for a subject are correlated due to subject 
specific effects and observations within households are correlated due to environmental 
effects shared within households. To model these correlations we used random effects. For 
subject effects a random intercept and a random slope were used, i.e. each subject has its own 
intercept and slope, where the latter models the change of the outcome variable over time. 
Observations within a household also have a shared random intercept. Thus the intercept for 




subject specific effect plus the household effect. By doing so correlation among observations 
of the same household was modeled since these observations share the same household 
effect. To assess treatment effects generalized linear mixed models22 were used where the 
term “mixed” corresponds to the used random effects. Unless stated otherwise all models 
included area as covariate in the model to take into account the differences between the two 
villages. Generalized linear mixed models provide a flexible and powerful tool to derive valid 
inference while capturing the data correlations induced by clustering within households and 
repeated evaluations in time of the same subject.
For continuous outcome variables which were measured at 0, 9 and 21 months, treatment 
effects were modeled at timepoint 9 and 21 months, because treatment started at 0 months and 
the design is a randomized trial no treatment effect should be present at time 0. We allowed for 
different treatment effects at 9 and 21 months. Beta’s and 95% confidence intervals are provided 
for 9 and 21 months. The betas represent the mean difference between the placebo and treatment 
group. An overall test for treatment effect over time was performed by using a likelihood ratio 
test which compares the model with and without the treatment effect (2 df test).
For binary outcome variables measured at 9 and 21 months, the logit link was used 
(mixed effect logistic regression). In these models only the two random intercepts were 
included and the random subject specific slope was omitted. Odds ratios and 95% confidence 
intervals are reported. Analogously to continuous outcome variables two degrees of freedom 
likelihood ratio tests were performed to assess treatment effects over time. Note that the 
model based odds ratios are different from crude odds ratios directly computed from the 
sample due to missing observations and due to the presence of random effects and the 
covariate area in the model. Malarial parasitemia by microscopy was measured at a three 
monthly basis. To model these data, similar models were used. Specifically at each of the 
seven timepoints (excluding time zero) a treatment effect was included. The likelihood ratio 
test for treatment effect over time has therefore 7 degrees of freedom. All generalized linear 
mixed models were fitted using the lme4 package (Douglas Bates, Martin Maechler and Ben 
(2011). lme4: Linear mixed-effects models using S4 classes. R package version 0.999375-42. 
http://CRAN.R-project.org/package=lme4)  in R23.
For each malaria-like symptom (fever, headache, fatigue, and nausea), total number of 
events and person months were computed for each treatment group. We calculated incidence 
rates for all events. Symptom episodes within three months of an initial presentation with 
the same symptom were regarded as part of the same episode. Hazard ratios for effect of 
treatment were calculated with Cox regression with robust SE to allow for within-subject 
and within household clustering (STATA 12).
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n/N (%) OR (95% CI)
Helminth infection (any spp)
9 months 395/477 (82.8) 247/480 (51.4) 0·07 (0·04-0·11)
21 months 353/448 (78.8) 172/411 (41.9) 0·05 (0·03-0·08)
Hookworm1
9 months 359/524 (68.5) 161/508 (31.7) 0·02 (0·01-0·04)
21 months 305/466 (65.5) 99/423 (23.4) 0·01 (0·01-0·03)
A. lumbricoides1
9 months 174/524 (33.2) 65/508 (12.8) 0·24 (0·16-0·36)
21 months 140/466 (30.0) 41/423 (9.7) 0·18 (0·11-0·29)
T. trichiura2
9 months 219/726 (30.2) 160/673 (23.8) 0·58 (0·42-0·80)
21 months 177/633 (28.0) 101/571 (17.7) 0·40 (0·28-0·58)
The number of positives (n) of the total population examined (N).1diagnosed by PCR. 2diagnosed by 
microscopy. Odds ratio and 95% confidence interval based on logistic mixed models. The P-values are 
generated from the modeled data for the combined effect of albendazole treatment over time, which were 
significant (P < 0.001) for any helminth and for each of the species separately.








per PM Events (PM)
Incidence 
per PM
Fever 414 (18494) 0.02 429 (18636) 0.02 1.03 1.03
Headache 333 (19067) 0.02 340  (19563) 0.02 1 1
Fatigue 49 (22362) 0.002 69  (22535) 0.003 1.39 1.41
Nausea 76 (21749) 0.003 55 (22211) 0.002 0.71 0.71
Any symptom 661 (15259) 0.04 690 (15307) 0.05 1.04 1.04
IRR: incidence rate ratio. PM: Person months. Adjusted with age and sex. The P-values are generated from 
Cox regression of albendazole treatment over time with robust SEs to allow for within-subject and within 








n/N (%) OR (95% CI) 
Asthma
21 months 8/461 (1.7) 11/445 (2.5) 1.11 (0.07-17.26)
Atopic dermatitis
21 months 13/461 (2.8) 9/445 (2.0) 0.57 (0.16-2.02)
The number of positives (n) of the total population examined (N). The P-values are generated from the 
modeled data for the effect of albendazole treatment after 21 months and no significant effects were found 
(P > 0.05). At baseline 8/692 (1.2%) and 18/692 (2.6%) in the placebo group reported symptoms of asthma 
and atopic dermatitis, respectively, while in Albendazole this was 10/635 (1.6%) and 11/635 (1.7%). 





N (Median, IQR) β (95% CI)
BMI
9 months 498 (22.42, 19.91 - 25.54) 499 (22.07, 19.96 - 24.56) -0·10 (-0·29-0·09)
21 months 430 (22.42, 19.68 - 25.56) 425 (21.56, 19.44 - 24.12) -0·15 (-0·39-0·10)
z-BMI
9 months 346 (-0.81, -1.44 - -0.13) 334 (-0.96, -1.56 - -0.30) -0·04 (-0·17-0·09)
21 months 272 (-1.29, -2.21 - -0.56) 269  (-1.57, -2.32 - -0.74) -0·07 (-0·23-0·10)
The total population examined (N). IQR = Interquartile range. β (beta) and 95% confidence interval based 
on generalized linear mixed models. The P-values are generated from the modeled data for the combined 
effect of albendazole treatment over time and no significant effects were found (P > 0.05).  Baseline data are 
shown in Table 1 of the manuscript.
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Figure S1B. Profile of trial with skin prick test (SPT) reactivity as outcome in children 5-15 years of age in 
both Nangapanda and Anaranda




































Background Helminth infections induce Th2 immunity with strong IgE responses, against 
parasite antigens and common allergens. Yet chronic helminth infections have been 
reported to be inversely associated with skin reactivity and clinical allergy.
Aim Molecular characterization of IgE responses against common allergen sources in a 
helminth-endemic area.
Methods A selection of 150 sera of school children from Flores Island, Indonesia, previously 
tested by ImmunoCAP and skin prick test (SPT) for IgE against house dust mite (HDM), 
cockroach, grass pollen (no SPT), peanut and shrimp were tested for IgE against 112 
purified natural allergens by ImmunoCAP-ISAC microarray. ImmunoCAP inhibition was 
used to assess the role of cross-reactive carbohydrate determinants (CCD).
Results Of the 150 sera, 65% to 90% were positive by ImmunoCAP for the common inhalant 
and food allergen sources. At the molecular level, IgE against established major allergens 
was <10% for HDM and cockroach and absent for peanut and shrimp. Only for grass pollen 
(and tree pollen and walnut), IgE was detected in approximately half of the children, but 
selectively against natural glycoproteins. ImmunoCAP inhibition showed that CCD is at 
the basis of these IgE responses, most likely induced by helminths. Only venom allergens 
were frequently recognized without carrying CCD.
Conclusions ImmunoCAP-ISAC has revealed that in helminth-endemic areas, CCD 
contributes significantly to high sensitization levels to common allergen sources. Purified 
natural plant glycoproteins consequently have a negative impact on the specificity of such 
microarrays. These cross-reactive IgE responses are most likely part of the explanation of 
the inverse association between helminth infections and clinical allergy.
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INTRODUCTION
The prevalence of asthma and allergic diseases has increased in affluent countries over 
recent decades, and the same development has now begun in many non-affluent countries1. 
At the same time however, helminth infections remain one of the major health problems in 
these countries, especially in tropical regions, where such infections are linked to poverty 
and rural living2. Both helminths and allergens are potent inducers of T helper 2 (Th2) 
responses that lead to high levels of immunoglobulin (Ig) E, mast cells, tissue eosinophilia 
and the secretion of Th2 cytokines such as interleukin (IL)-4, IL-5, IL-9 and IL-133.
Despite the similar immunological profiles of helminth infections and allergy, several 
cross-sectional studies have suggested a protective effect of helminth infection on atopic 
disorders4,5, with a number of intervention studies supporting this notion6-9. It has been 
reported that high intensity helminth infection protects subjects from skin test reactivity to 
allergens10,11. Although not all studies confirm this, it has been proposed that the negative 
association between helminth infections and allergies might be the result of the strong 
immune-regulatory cell networks induced by chronic helminth infections that prevent pro-
inflammatory Th2 responses from triggering disease in target organs12,13. However, there is also 
evidence for a parallel mechanism: the possibility that helminth infections are accompanied by 
IgE responses that are cross-reactive between helminth antigens and common environmental 
and/or food allergens, but of low biological activity and therefore associated with low or 
negligible skin prick test (SPT) reactivity to such cross-reactive allergens14-16.
Laboratory diagnostics and skin test reagents to support the diagnosis of allergy have until 
recently always been based on allergen extracts. The increasing knowledge on the serological 
and clinical role of individual allergenic molecules in these extracts and their availability as 
purified natural or recombinant reagents has opened new diagnostic avenues. The introduction 
of so-called component-resolved diagnosis (CRD) based on individual allergen molecules has 
been instrumental in improving the clinical prognostic relevance of diagnostic tests and in 
identifying the origin of sensitization. Some individual allergen molecules have proven to be 
better predictors of clinical allergy17 than whole extracts and have been shown to be risk factors 
for severe clinical phenotypes18. In addition, we now know that some allergens are biomarkers 
for primary sensitization to particular types of allergen sources, like group 5 allergen (e.g. Phl 
p 5) for grass pollen, group 1 and 2 allergens (e.g. Der p 1 and Der p 2) for house dust mite, 
and Ara h 2 for peanut sensitization19. On the other hand, cross-reactive structures have been 
identified that are present in many inhalant and food allergens sources, leading to positive IgE 
outcomes for many extract-based tests, without really revealing whether recognition is based 
on primary sensitization and/or cross-reactivity. The most relevant broadly cross-reactive 
structures are the pathogenesis-related (PR)-10 proteins (i.e. Bet v 1 and homologues in 
fruits and tree nuts)20, profilins21, tropomyosins22 and lipid transfer proteins23. A special cross-
reactive structure is not of protein but of carbohydrate nature, i.e. cross-reactive carbohydrate 
determinants (CCD)14,24. IgE against CCD has a very broad spectrum of cross-reactivity across 




and parasites. Sensitization to CCD has first been shown to find its origin in pollen, bee and 
wasp venom allergies. In hay fever patients with strong pollen sensitization, IgE against CCD 
is most common and often accompanied by sensitization to profilin. It has been demonstrated 
convincingly that CCD-specific IgE is of poor biological activity and consequently of no 
clinical relevance25. Later it was suggested that helminth infections in humans and in cattle 
can play an important role in sensitization to CCD16,26.
Many biomarkers for primary sensitization as well as cross-reactive allergens are now 
available as single diagnostic reagents on e.g. ImmunoCAP, but more recently, protein 
microarray technology has entered the field of molecular allergology, i.e. the ImmunoCAP-
ISAC microarray with 112 individual purified natural and recombinant inhalant and food 
allergens27,28. This technology allows testing for individual IgE recognition profiles with a 
limited volume of serum, providing comprehensive information about likely sources of 
primary sensitization and cross-reactivity. For epidemiological research such technology 
has proven to provide an enormous resource of data29 that can help elucidate the process of 
sensitizations and identify risk and protective factors for clinical phenotypes30,31.
To the best of our knowledge, the present study is the first to characterize IgE profiles to 
allergen components using the ImmunoCAP-ISAC technology in a developing country in an 
area where helminths are endemic. Our aim was to elucidate the molecular basis of the extremely 
high prevalence of sensitization to common allergen sources (65% - 85%) but low SPT reactivity 
and virtually absent clinical allergy, observed amongst Indonesian school children.
METHODS
Study population 
This study was part of a longitudinal study investigating the effect of anthelminthic treatment 
on malarial parasitemia and allergy, described in detail elsewhere32,33. In short, the study was 
conducted between 2008 and 2010 in a semi-urban (Nangapanda) and a rural (Anaranda) site, 
both located on Flores Island, where the infrastructure, access to electricity, shops and health 
care were low in the latter. A total of 1674 schoolchildren aged 5-15 years old were included 
in the study of allergic outcomes. Children were asked to undergo skin prick testing, provide 
blood for serum IgE testing, and a stool sample for diagnosis of soil-transmitted helminth 
infections. In addition, parents or guardians were asked to fill out a questionnaire to record self-
reported allergic symptoms. Written informed consent was obtained from a parent or guardian 
of each child. This investigation was carried out within the ImmunoSPIN programme (www.
immunospin.org) and approved by the Ethical Committee of the Medical Faculty, University of 
Indonesia, Jakarta and has been filed by the ethics committee of the Leiden University Medical 
Center, the Netherlands. The study was registered as clinical trial (ISRCTN83830814).
Due to budgetary restrictions, 150 serum samples could be analyzed in the current study. 
These were selected, based on plasma availability and complete information regarding skin 
prick test (SPT) reactivity, clinical symptoms of allergy as well as ImmunoCAP IgE data.
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Questionnaires
Symptoms of asthma and atopic dermatitis in the past 12 months were recorded using a 
modified version of the International Study of Asthma and Allergy in Childhood (ISAAC) 
questionnaire as reported before33. 
Skin prick test
House dust mite (Dermatophagoides pteronyssinus and D. farinae), peanut, shrimp (kindly 
provided by Paul van Rijn from HAL Allergy Laboratories, Leiden, The Netherlands) and 
cockroach (Blattella germanica; Lofarma, Milan, Italy) were used for SPT. The SPT was 
considered positive when a wheal size was more 3 mm as described33.
IgE antibody measurement
ImmunoCAP (ThermoFisher Scientific, Uppsala, Sweden) was used to measure IgE 
against house dust mite (D. pteronyssinus), cockroach (B. germanica), grass pollen (Phleum 
pretense), bromelain (Ananas comosus), peanut and shrimp, following to the manufacturer’s 
instructions. Levels of ≥ 0.35 kUA/L were considered positive.
For multiplex analysis, the ImmunoCAP-ISAC 112 with 112 allergen molecules 
(ThermoFisher Scientific) was used following manufacturer’s instructions. Briefly, arrays 
were incubated with 30 μL of plasma for 2 hours. After washing and drying, arrays were 
incubated for 30 minutes with fluorescently labeled anti-human IgE. After further washing, 
arrays were read with a laser scanner. Results were expressed as ISAC standardized units 
(ISU)/L. Levels of >0.3 ISU/L were considered as positive.  
Total IgE was measured by ELISA as described previously32,33. The results were expressed 
in International Units (IU/ml).
IgE inhibition assay
For ImmunoCAP inhibition assays, 4 separate pools of plasma were prepared, a HDM-, a 
cockroach-, a grass pollen- and a peanut-positive pool which each contained equal volumes 
(n=16, n=11, n=3, and n=18, respectively) of plasma samples that were positive (IgE levels 
≥5 kUA/L) for the respective allergen sources. Inhibitors used were bromelain (marker 
for CCD), SEA (soluble egg antigen of Schistosoma haematobium, a source of helminth 
CCD)16 and Ascaris lumbricoides antigen (locally endemic parasite). Each 75 μL of pooled 
plasma was mixed with an equal volume of inhibitor dilutions (titrated inhibition) and pre-
incubated at room temperature for 1 hour. Subsequently, samples were analyzed for HDM-, 
cockroach-, grass pollen- and peanut-specific IgE, following the normal ImmunoCAP 





Trichuris trichiura was detected by microscopy and a multiplex real-time PCR was used for 
detection of hookworms (Ancylostoma duodenale, Necator americanus), A. lumbricoides, 
and Strongyloides stercoralis DNA as detailed previously32,33.
Statistical analyses
Statistical analyses were performed using IBM Statistical Package for Social Sciences (IBM Corp., 
Armonk, New York, USA) version 20. Descriptive data were expressed as means (± standard 
deviations), frequency (percentage of measured data) and geometric means [95% confidence 
intervals (CI)]. The correlation of IgE levels between natural or recombinant allergens or whole 
allergen extracts and CCD was examined with Spearman rank correlation coefficients. Logistic 
regression was used to examine the association between helminth infection and IgE reactivity 
to allergen component measured on ImmunoCAP-ISAC as well as the association between 
helminth infection and IgE reactivity to whole allergen extract tested on ImmunoCAP with 
adjustment for age, sex, and area. A P-value < 0.05 was considered statistically significant.
RESULTS
Sensitization by extract ImmunoCAP and SPT
Of the 150 sera selected for ImmunoCAP-ISAC, sensitization to cockroach, as assessed 
by extract ImmunoCAP, was highest (86.7%), followed by shrimp (79.3), HDM (74%) 
and peanut (64.7%). However, skin prick reactivity was much lower and highest for HDM 
(26.7%), followed by cockroach (24%), peanut (5.5%) and shrimp (4.7%). Total IgE was 
high with a geometric mean of 2816.4 IU/ml (95% CI, 2256.5-3515.2) (Table 1). 
In this group, wheeze or eczema in the past 12 months was reported for only 5 children. 
None of the study subjects reported any symptoms of food allergy. With such small numbers 
it was not possible to use these data in further statistical analyses.
In this group of 150 subjects, 74 had stool samples and the prevalence of helminth infections 
was 93.2% (69/74). Analyzing characteristics of subjects providing stool samples and those who 
did not, showed no differences in atopic sensitization (SPT and IgE), age and sex.
Sensitization by ImmunoCAP-ISAC microarray
A total of 112 (74.7%) children recognized at least one allergen component. Of 112 allergens 
tested by ISAC, 46 allergens were recognized (Figure 1 and Table S1). The prevalence of 
recognition of purified natural glycosylated allergens was highest for those from grass 
pollen (nPhl p 4; 53.3%; nCyn d 1: 50.7%), followed by those from walnut (nJug r 2: 32.0%), 
and tree pollen (plane nPla a 2: 30.7%; cypress nCup a 1: 21.3%; Japanese cedar nCry j 
1: 18,7%). IgE to MUXF3 representing the CCD glycan structures commonly found on 
these glycoproteins was detected in 21.3%. Recombinant allergens and non-glycosylated 
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natural allergens (walnut nsLTP, cockroach and shrimp tropomyosin) not substituted with 
CCD-type glycans (n=28) was found in < 3.4% with the exception of one recombinant tree 
pollen allergen (rPla a 1: 12.7%) and three recombinant venom allergens (honey bee rApi g 
1: 18.7%; paper wasp rPol d 5: 36.7%; common wasp: 34.0%).
Mono sensitization was found in 12 children (8%), with 3 subjects positive for 
recombinant plane tree (rPla a 1), 3 subjects positive for paper wasp (rPol d 5), 2 subjects 
positive for nCyn d 1 and the other 4 subjects recognized different type of allergens (nPhl p 
4, saltwort weed pollen [nSal k 1], dog [rCan f 2] and latex [rHev b 5]).
Correlation between IgE to natural allergens and CCD
The correlation of IgE (ImmunoCAP-ISAC) to natural glycosylated allergens nJug r 2, nCyn 
d 1, nPhl p 4, nCup a 1, and nPla a 2 and to CCD (MUXF3) was high: r = 0.77, 0.66, 0.72, 
0.60, and 0.74, respectively; P < 0.001 (Figure S1). IgE levels to both extracts of grass pollen 
and peanut detected by ImmunoCAP were highly correlated with those against bromelain 
IgE (r=0.87 and 0.84, respectively; P < 0.001, Figure S2a-b). We found a weak correlation 
Table 1. Characteristic of the study population
  N n (%)
Age (mean in years, SD#) 150 10.6 (2.9)
Sex (female) 150 83 (55.3)
Skin prick test
House dust mite 150 40 (26.7)
Blattella germanica (cockroach) 150 36 (24.0)
Peanut 150 8 (5.3)
Shrimp 150 7 (4.7)
Specific IgE (cut off ≥ 0.35 kUA/L)
Dermatophagoides pteronyssinus 150 111 (74.0)
B. germanica 150 130 (86.7)
Peanut 150 97 (64.7)
Shrimp 150 119 (79.3)
Phleum pretense (grass pollen) 30 27 (90)
Ananas comosus (bromelain) 30 26 (86.7)
Total IgE (geometric mean, 95% CI) 133 2816.4 (2256.5-3515.2)
Helminth infection (n, %) 
Any helminths 74 69 (93.2)
Hookworms1 76 58 (76.3)
Ascaris lumbricoides1 76 32 (42.1)
Trichuris trichiura2 104 30 (28.8)




Figure 1. The levels of IgE to purified  natural and recombinant allergens recognised on ImmunoCAP-
ISAC (N=150). Solid circles represent natural (n) component allergens, open circles represent recombinant (r) 
component allergens. Cross reacting allergen to: *tropomyosin, #non-specific lipid transfer protein (nsLTP), $the 
pathogenesis-related (PR)-10 protein, +Cross reactive carbohydrate determinants (CCDs). Each circle represents 
a single positive subject and the dotted line indicates the cut-off value for the ISAC assay (0.3 ISU/L). ISU, ISAC 
Standardized Unit. The allergen abbreviations are given in Table S1
between bromelain IgE and IgE levels to cockroach (r= 0.53; P = 0.002) and a trend for 
HDM (r=0.32; P = 0.085) (Figure S2c-d).
IgE inhibition assay 
Titrated CAP inhibition assays demonstrated that binding of IgE from peanut- and 
grass pollen-pooled samples was inhibited by bromelain (76.1% and 57.5% inhibition, 
respectively) and SEA (76.3% for peanut-pooled IgE and 45% for grass pollen-pooled IgE) 
whereas this was much less when the endemic helminth A. lumbricoides antigen was used for 
inhibition (25% for peanut-pooled IgE and 17% for grass pollen-pooled IgE) (Figure 2a-b). 
In HDM- and cockroach-pooled plasma; bromelain, SEA and Ascaris antigens could only 
inhibit up to 25% binding of IgE (Figure 2a-c).
Comparison of aero- and food-allergens measured on ImmunoCAP and ImmunoCAP-ISAC
Using ImmunoCAP, IgE sensitization to whole extract of HDM was detected in 74% of 
the study subjects. When the same samples were tested against HDM components on 
ImmunoCAP-ISAC, we found only up to 5% of the subjects showed IgE reactivity specific 
to natural or recombinant component of house dust mite (Figure 3a).
Of 113 subjects positive for IgE against cockroach extract on ImmunoCAP, only 2% 
of the children were reactive to cockroach allergen components; either nBla g 7 (1.3%) or 
rBla g 1 (0.7%) on ImmunoCAP-ISAC (Figure 3b). Peanut reactivity on CAP was observed 
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in 97 subjects but none of them showed any reactivity to 6 peanut components present on 
ImmunoCAP-ISAC. Of 27 subjects positive to whole extract of timothy grass pollen in CAP 
assay, 21 (77.7%) recognized nPhl p 4 on ImmunoCAP-ISAC. However, no reactivity was 
observed to the other 7 recombinant allergens of grass pollen (Figure 3d).
Association between helminth infection and IgE to allergen components and whole 
allergen extracts 
Given the high prevalence of any helminth infection (93.2%) in our study subjects, it is not 
possible to determine the association of any helminth with allergen reactivity. However, 
the analysis of the association with specific helminths such as hookworm (76.3%), A. 
lumbricoides (42.1%) and T. trichiura (28.8%) was possible.  We found that having A. 
lumbriodes was positively associated with IgE reactivity to rVes v 5 on ImmunoCAP-ISAC 
(OR, 3.42; 95% CI 1.22-9.59; p=0.019). No other associations were observed. No association 
between specific helminths and IgE in ImmunoCAP was seen.
DISCUSSION
To our knowledge, this is the first study to investigate IgE reactivity using an IgE microarray 
assay involving school children in an area in a developing country where helminth infections 
are highly endemic. We found strong IgE reactivity to natural component allergens from the 
pollen group, walnut and CCDs. Similarly, we found high reactivity to recombinant venom 
allergens (paper wasp, common wasp and honey bee). The reason for high reactivity to the 
pollen group and peanut appeared to be due to cross reactivity with the well-known CCD 
structures the α(1,3)-linked fucose and β(1,2)-linked xylose34,35 which are carbohydrate 
components of plant and insect glycoproteins but also in helminths36. Little IgE reactivity was 
found to recombinant allergens of pollens. Importantly, for HDM and cockroach, the high 
reactivity, again was not directed to recombinant versions of well-established major allergens 
Figure 2. IgE inhibition assay. IgE cross-reactivity of house dust mite, cockroach, peanut and grass pollen extract tested 
by using an IgE ImmunoCAP inhibition assay. Bromelain, soluble egg antigens (SEA) of Schistosoma haematobium 




associated with primary sensitization. In this case IgE responses showed weaker associations 
to the typical CCD sources (MUXF3/bromelain), and more limited cross-reactivity in IgE 
inhibition. This leaves the question as to whether slightly different carbohydrate structures 
are responsible for sensitization and cross-reactivity or that other protein moieties thus far 
not present on the ISAC chip are involved. Since common allergens known to be associated 
with primary sensitization to house dust mite and cockroach were rarely recognized, 
sensitization to such “missing” allergens would most likely also be caused by other primary 
sources such as helminths. Some candidates have identified such as tropomyosin22, but in 
our cohort this pan-allergen seems to be of limited importance (≤ 2% recognition). Other 
candidates not on the chip may be gluthation-S-transferases and paramyosins. As there is 
far less SPT or symptoms than IgE reactivity in this group studied, the data support the 






















































house dust mite components
(c) (d)
cockroach components

































CAP (kU/L) ISAC (ISU)
Figure 3. The levels of IgE to; (a) house dust mite, (b) cockroach, (c) peanut, and (d) grass pollen measured 
by ImmunoCAP and ImmunoCAP-ISAC. The single allergens in ISAC are related to the whole allergen extracts 
tested in CAP. Solid circles represent natural (n) component allergens, open circles represent recombinant (r) 
component allergens.
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cross reactivity between helminth derived or environmental carbohydrate structures and 
that these antibodies have poor functional properties.
Our results are in line with studies among subjects with and without allergic rhinitis in 
Philippines that showed an almost exclusive IgE reactivity to natural grass pollen allergens 
whereas non-glycosylated recombinant grass pollen allergens were hardly recognized37. 
Several studies in affluent countries have shown the existence of IgE antibodies directed 
to CCDs with negligible if any clinical relevance. Serum IgE from European pollen allergic 
patients cross-reacted with extracts from various allergenic foods which seemed to be 
tolerated24. Treating the extracts with periodate, which destroys the carbohydrate structures, 
abolished the reactions, indicating the involvement of carbohydrates in this cross reactivity24. 
Another study showed that elevated levels of IgE against peanut extract among grass pollen-
sensitized European patients did not seem to translate to peanut SPT reactivity or clinical 
symptoms of peanut allergy38. In some of these patients, almost complete inhibition of IgE 
to peanut was possible with CCDs38. This was supported by another study, where about 
42% of European pollen-allergic patients were found to have specific IgE to CCD marker 
bromelain without skin reactivity to this molecule30. The most convincing piece of evidence 
highlighting the lack of clinical relevance of CCD was provided by oral challenge with a 
purified glycoprotein polyvalently substituted with CCD25.
In our study, we found that IgE against peanut as well as IgE to grass pollen were inhibited 
by bromelain (CCDs) which demonstrates that at least for pollen,  anti-CCD IgE results in 
false-positive in vitro allergy test responses. Parasitic helminths carry carbohydrate structures 
which react with IgE. However, although bromelain could inhibit the ImmunoCAP of grass 
pollen and peanut, the extract of A. lumbricoides, which is endemic in our study area, was 
less potent. This indicates that either hookworm or Trichuris which are the other helminth 
species present in the study area might be the source of CCD. To support involvement of 
parasite-derived CCD, we used SEA from a non-endemic parasite that had been shown to be 
highly cross-reactive with peanut in a group of Ghanaian school children16. In the Ghanaian 
study, A. lumbricoides was also a poor inhibitor, as in our study. Using SEA, we found a 
strong inhibition of IgE to peanut and grass pollen. The characterization of the glycome of 
the endemic intestinal helminths should help us answer the question whether other cross 
reactive carbohydrate structures can explain the high IgE to peanut and grass pollen. The 
possibility that sources other than helminths in the rural area are responsible for the high 
cross reactive IgE seen in the area should also be studied further.
Although none of the study subjects showed IgE reactivity to natural bee venom allergen 
nApi m 4, we observed high IgE reactivity to recombinant venoms (rApi m 1, rPol d 5 or 
rVes v 5). However, why we find such high reactivity to venom allergens in children is not 
clear yet.  Although it is possible that there is a true sensitization to venom allergens, it is 
also possible that the majority of positivity to honey bee/wasps represents sensitization to 
a peptide cross-reactive epitopes present on other insect proteins or helminths. We found 
that having A. lumbricoides increased the risk of IgE reactivity to rVes v 5, however, not to 




in helminth endemic areas is not fully understood, it might be a cross-reactive response 
as a result of increased exposure to helminths which carry venom like proteins such as 
antigen 5. Although the clinical relevance of the high IgE to venoms needs to be formally 
investigated, there were no reports of clinical allergy to these allergens.
The strengths of this study include the microarray biochip which has allowed us to 
perform a comprehensive analysis of IgE reactivities to 112 component allergens from 51 
source allergens, requiring only a small serum volume, which would have been impossible 
with traditional diagnostic tests. The ISAC chip is thus well suited where only small volumes 
of serum are available. However, a limitation of our study is that it was performed using a 
cross-sectional design in an area with no data on allergen exposure. 
In conclusion, we provide evidence that there is cross-reactivity between IgE to allergens 
and CCD markers in a helminth-endemic area of Indonesia. Further epidemiological and 
clinical studies are needed to enable differentiation between IgE directed against protein 
structures that may be biologically active and IgE directed against carbohydrate moieties on 
glycosylated allergens that might be clinically irrelevant.
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Table S1. The prevalence of sensitization on ImmunoCAP-ISAC
Component allergens N (%) Component allergens N (%) 
Food components Cockroach
Shrimp (nPen m 2) 2 (1.3) Cockroach (rBla g 1) 1 (0.7)
Shrimp (nPen m 4) 3 (2.0) Venom
Walnut (nJug r 2) 48 (32.0) Honey bee (rApi m 1) 28 (18.7)
Soybean (nGly m 5) 2 (1.3) Paper wasp (rPol d 5) 55 (36.7)
Soybean (nGly m 6) 1 (0.7) Common wasp (rVes v 5) 51 (34.0)
Wheat (rTri a 19.0101) 1 (0.7) Latex  
Grass pollen Latex (rHev b 5) 2 (1.3)
Bermuda grass (nCyn d 1) 76 (50.7) Cross-reactive 
Timothy grass (rPhl p 1) 1 (0.7) Tropomyosin
Timothy grass (nPhl p 4) 80 (53.3) Anisakis (rAni s 3) 1 (0.7)
Tree pollen Cockroach (nBla g 7) 2 (1.3)
Japanese cedar (nCry j 1) 28 (18.7) D. pteronyssinus (rDer p 10) 3 (2.0)
Cypress (nCup a 1) 32 (21.3) Shrimp (nPen m 1) 2 (1.3)
Olive pollen (nOle e 1) 13 (8.7) nsLTP  
Olive pollen (rOle e 9) 1 (0.7) Walnut (nJug r 3) 2 (1.3)
Plane tree (rPla a 1) 19 (12.7) Peach (rPru p 3) 2 (1.3)
Plane tree (nPla a 2) 46 (30.7) Plane tree (rPla a 3) 1 (0.7)
Weed pollen PR-10 protein  
Plantain (rPla l 1) 1 (0.7) Hazel pollen (rCor a 1.0101) 3 (2.0)
Saltwort (nSal k 1) 1 (0.7) Hazelnut (rCor a 1.0401) 4 (2.7)
Animal Apple (rMal d 1) 4 (2.7)
Dog (rCanf2) 1 (0.7) Peach (rPru p 1) 5 (3.3)
Mold Kiwi (rAct d 8) 2 (1.3)
Alternaria (rAlt a 6) 2 (1.3) CCD
Aspergillus (rAsp f 1) 1 (0.7) nMUXF3 32 (21.3)
Aspergillus (rAsp f 3) 3 (2.0)
Cladosporium (rCla h 8) 1 (0.7)
Mite
Blomia tropicalis (rBlo t 5) 3 (2.0)
Dermatophagoides farinae (nDer f 1) 7 (4.7)
D. farinae  (rDer f 2) 2 (1.3)
D. pteronyssinus (nDer p 1) 6 (4.0)
D. pteronyssinus  (rDer p 2) 1 (0.7)
Lepidoglyphus destructor (rLep d 2) 2 (1.3)
Natural (n) and recombinant (r) allergen components. The number positive (N) of 150 subjects examined.
120
MOLECULAR DIAGNOSTICS IN A HELMINTH-ENDEMIC AREA
6
Figure S1. Correlation between IgE to CCD and natural allergens on ImmunoCAP-ISAC; (a) walnut, (b) 
bermuda, (c) timothy, (d) cypress, and (e) plane tree. nMUXF3 is a marker glycoprotein for CCD reactivity on 
ISAC assay. r = correlation coefficient. ISU, ISAC Standardized Unit.
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Figure S2. Correlation between IgE levels to bromelain and allergens on ImmunoCAP; (a) timothy, (b) peanut, (c) 
cockroach, and (d) house dust mite. Bromelain is a marker glycoprotein for CCD reactivity. r = correlation coefficient.
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WHAT WAS ALREADY KNOWN ABOUT THE RELATIONSHIP 
BETWEEN HELMINTH INFECTIONS, SOCIO-ECONOMIC  
STATUS AND ALLERGIC DISORDERS?
It has been reported in several epidemiological studies that the prevalence of atopic disorders is 
higher in developed countries than in developing countries1,2. In contrast, intestinal helminth 
infections such as Ascaris lumbricoides, Trichuris trichiura and/or hookworms (Necator 
americanus or Ancylostoma duodenale) are still highly prevalent in developing countries3. 
Interestingly, both helminth infection and allergens are potent inducers of Th2 responses that 
lead to high levels of IgE, tissue eosinophilia, as well as the secretion of Th2 cytokines such 
as IL-4, IL-5, IL-9 and IL-134,5. Despite the similar immunological profiles associated with 
both helminth and allergies, the relation between helminth infections and atopic diseases is 
still unclear. Several studies have reported an inverse relation between helminth infections 
and atopic diseases6-8 while other studies have shown that helminth infections might increase 
the risk of asthma or be associated with higher prevalence of atopy9 (reviewed in Chapter 
1). Interventional studies have also not been consistent; one large study in Ecuador found 
no changes in allergic disorders after one year treatment of intestinal helminths using 
albendazole10, which is in contrast to an intervention study in Vietnamese children that 
suggested repeated anthelmintic treatment might increase the incidence of atopy11.
Several studies have shown conflicting results with regards to the role of socio-economic 
status (SES) in the development of atopic disorders12. However, a recent systematic review 
has suggested that lower socio-economic levels are associated with higher prevalence of 
asthma, whereas the prevalence of other allergies such as food allergy and atopic dermatitis 
is associated with higher SES12. This systematic review might coffer from emphasis 
on data from Europe and the Americas, as well as data from high- and middle-income 
countries. Moreover, skin prick test (SPT) reactivity to any allergens has been reported to 
be more common in high-SES groups compared to low-SES groups within urban centers of 
developing countries13,1.
In both developed and developing countries, a strong correlation is observed between 
allergen-specific IgE and symptoms of allergy among urban populations of high SES. 
However, in rural populations or urban population of developing countries with low SES, 
helminth-induced IgE cross-reactivity and regulatory networks may prevent the translation 
of allergen-specific IgE into skin reactivity or allergic symptoms as discussed in Chapter 1.
In addition, the isolation and characterization of allergen components, as well as their 
production by recombinant techniques, has led to significant progress in allergy diagnosis15. 
Component-resolved diagnostics (CRD) allows the detection of specific IgE against 
individual allergen molecules instead of against allergen extracts comprised of mixtures of 
allergen molecules that are commonly used in SPT and conventional specific IgE testing. The 
advantage of CRD is that distinction can be made between IgE antibodies against allergenic 
structures with different degrees of clinical relevance, ranging from irrelevant such as cross-




SUMMARY OF WHAT WAS ALREADY KNOWN
• There is an inverse geographical relationship between allergy and helminth infections.
• The prevalence of atopy and allergic diseases is increasing in both developed and 
developing countries.
• Low socio-economic status is associated with asthma symptoms and negatively with 
skin prick test (SPT) reactivity to any allergens.
• Anthelmintic treatment increases SPT in Vietnam but not in Ecuador.
• High levels of total IgE and allergen-specific IgE do translate into skin reactivity 
or clinical symptoms of allergy in most affluent countries.
• Component-resolved diagnosis of the specific IgE responses improves the specificity, 
sensitivity and clinical performance of laboratory assays used in the diagnosis of 
atopic disorders in developed countries.
method has been widely used in developed countries15, but has still not been widely used in 
less affluent areas where helminth infections are highly prevalent.
HOW DID OUR STUDIES ADVANCE THE FIELD?
In order to move the field further, we designed a population study on Flores Island in 
Indonesia, detailed in Chapter 3.
Risk factors for atopic disorders and interactions with socio-economic status
In Chapter 2 and 4, evidence was provided that socio-economic status is an important factor 
in atopic disorders in Indonesia. We found that high parental education, which is one of 
the indicators of high-SES, was associated with skin reactivity to house dust mite (HDM) 
(Chapter 4). In addition, we also found that the prevalence of skin prick test reactivity to any 
allergens was higher in high-SES compared to low-SES schoolchildren (Chapter 2) or higher 
in a semi urban compared to a rural area (Chapter 4). This result is in line with other studies 
conducted in Ghanaian children, which found that the prevalence of SPT to any allergens 
was higher in urban rich compared to urban poor children13,14. We also observed that there 
was a strong association between specific IgE and SPT reactivity to the same aeroallergen 
in the children from a high-SES school (Chapter 2), a result that is consistent with what 
is found in developed countries18,19. However, no such association was seen in the low-SES 
group (Chapter 2) living in the same urban area. Similar dissociation between specific IgE 
(sIgE) to aeroallergens and skin prick test reactivity to the same allergen has been reported 
by us in a rural area of Indonesia (Chapter 4). The prevalence of allergic symptoms was 
higher in low-SES children than in high-SES children which is in contrast to what is often 




due to respiratory infections rather than allergy. Indeed, we observed that SPT positivity is a 
risk factor for reported symptoms of allergy in high-SES but not in low-SES children (Chapter 
2). This result implies that SPT can be used as a good predictor for allergy symptoms in 
high-SES children, comparable to the situation in developed countries, but not for children 
of low-SES. Altogether, the high-SES life-style which is associated with western diet and less 
physical activity may contribute towards atopy compared to low-SES environments.
Environmental factors are closely related to socio-economic status. One of the important 
environmental factors is thought to be helminth infection. In Chapter 2 and 4 we provide 
evidence that helminth infections are more prevalent among low SES groups compared to high 
SES groups. Important contextual determinants for helminth infection are poverty, lack of 
sanitation and poor hygiene practices in low-SES population22. With regard to the association 
between helminth infections and atopic disorders, in a meta-analyses, Feary et al. have shown 
that hookworm infections determined by microscopy are significantly associated with lower SPT 
reactivity to HDM23. In chapter 4, we used a highly sensitive and specific method (polymerase 
chain reaction, PCR) for detection of soil transmitted helminth infections and were able to 
demonstrate that high load of hookworm infection decreased the risk of being prick test positive 
to HDM in the semi-urban area only (Chapter 4). However, the situation was different when 
SPT to cockroach was examined. In the same semi-urban area, children with access to piped 
water coming from non-farming families had reduced risk of SPT to cockroach (Chapter 4). 
The precise cause of this association for skin reactivity to cockroach is unknown but it is thought 
to be related to higher exposure to this aeroallergen in low-SES houses, which might defy the 
mechanisms that are responsible for the lower prevalence of SPT to HDM. However, it is also 
possible that different mechanisms govern HDM versus cockroach SPT reactivity.
In summary, within the same urban centres of a developing country; our study found 
that depending on the level of SES of a child, the prevalence of different allergy outcomes 
or risk factors for atopic disorders may be very different. Our study also indicates that the 
lower prevalence of skin reactivity to HDM in a rural area of Indonesia might be due to 
a lower level of education (as part of the SES indicators) and a greater degree of helminth 
infections compared with the semi urban area. Moreover, the risk factors for sensitization to 
HDM are distinct from those for sensitization to cockroach. Together, these results highlight 
that environmental as well as socio-economic factors should be considered by clinicians and 
researchers working on prevention, diagnosis and treatment of atopic disorders in low-to-
middle income countries. In addition, many factors in the environment contribute to the 
development of allergies (e.g. diet, immunisation, pets, tobacco smoke, and air pollution), 
therefore, more research is needed to evaluate the possible risk and protective factors in more 
detail as well as to pinpoint elements of SES that matter in the development of atopic disorders.
Effect of anthelmintic treatment on atopic disorders
Considering that cross sectional studies can only show relationships and do not demonstrate 




used to remove helminths or intentional infection with helminths are needed. With respect to 
anthelmintic treatment, a study of soil transmitted helminth infected subjects demonstrated 
that regular anthelmintic treatment resulted in significant increase in skin test reactivity as 
well as IgE in serum to aeroallergens24. In line with this, anthelmintic treatment of Gabonese 
children chronically infected with Schistosoma haematobium and soil transmitted helminths 
resulted in increased SPT reactivity7. Two large interventional studies previously mentioned 
conducted in Ecuador and Vietnam showed different results. In Ecuador, treatment with 
albendazole every two months for one year, did not affect SPT nor clinical symptoms of 
allergy10, but in Vietnam, three monthly treatment with albendazole resulted in a significant 
increase in SPT positivity but not in allergy symptoms11. In Chapter 5, our randomised placebo 
controlled trial showed that intensive community treatment of 3 monthly albendazole for 21 
months was not associated with increased risk of SPT to any allergen but post hoc analysis 
showed that SPT to cockroach allergen was increased in the albendazole arm compared to 
placebo. However, in agreement with the studies in Ecuador and Vietnam, there was no 
effect on reported clinical symptoms of allergy (Chapter 5). It has to be noted that one study 
in Venezuela showed that anthelmintic treatment resulted in improvement in all clinical 
indicators of asthma25. It is important to mention that in our study, helminth infections were 
not completely cleared; therefore the effect to anthelmintic treatment on allergy outcome 
could not be fully seen. A study in Ecuador, looking at communities receiving anthelmintic 
treatment with ivermectin for 15-17 years compared to non-treated communities showed 
an increase in the prevalence of allergen skin test reactivity in treated communities26. This 
suggests that longer anthelmintic treatment in our study may have been needed to see the 
effect of treatment on atopic disorders. When considering anthelmintic treatment given 
during pregnancy, a large randomized, double-blind, placebo-controlled trial carried out in 
Uganda found that treatment of pregnant women with albendazole (compared with placebo) 
was strongly linked to an increased risk of doctor-diagnosed infantile eczema in their infants27.
Taken together, most studies, but not all, show that helminth infections are associated 
with decreased SPT but there does not seem to be a strong effect on clinical symptoms with 
the possible exception of a beneficial effect on infantile eczema. For anthelmintic treatment 
studies, it is possible that different helminths with their varying life cycles and locations in 
tissues, would lead to different effects on allergic outcomes.  Moreover, it should be noted that 
chronicity of infection as well as worm burden might be important parameters to take into 
account when studying the association between helminths and allergies. Chronic infections 
as well as higher worm burdens might have stronger regulatory effect on allergies than 
acute or light infections28. Another mechanism that might explain the inverse association 
between helminth infections and atopy may involve helminth-induced IgE cross-reactivity. 
Current helminth infections are associated with increased levels of allergen-specific IgE 
that do not translate into skin reactivity or clinical symptoms. This helminth-induced IgE 
may be of low affinity; this might explain why it does not lead to SPT reactivity. Finally, 
attention should be paid to the methods used to assess clinical symptoms of allergy as these 




Microarray and Helminth-induced IgE
In recent years, microarray biochips have been developed to allow the simultaneous 
measurement of specific IgE to multiple recombinant and natural allergen components 
using a small amount of serum. These microarray biochips are increasingly used in 
developed countries to provide additional information on IgE profiles of poly-sensitized 
allergic patients to improve the management of their conditions15,29,30.
In a group of children (described in chapter 4), high levels of IgE to house dust mite 
were found, but these did not translate into skin prick test reactivity. In this study, helminth-
induced IgE cross-reactivity was implicated as a possible explanation for the elevated 
levels of clinically irrelevant allergen-specific IgE. In a subset of these children, the specific 
IgE to Dermatophagoides pteronyssinus (Der p) determined by the ImmunoCAP method 
(sensitization cut-off ≥ 0.35 kUA/L) was compared to semi-quantitative IgE analysis using a 
commercially available microarray chip (ImmunoCAP-ISAC). We found that the prevalence 
of IgE sensitization to whole house dust mite extract (Der p) was 74% while sensitization 
to purified recombinant and natural house dust mite allergens such as Der p 1 and Der p 
2 as assessed by the microarray biochip was generally weak and only up to 5% (Chapter 
6). This investigation also demonstrated that among these same children, there was IgE 
reactivity to purified natural (glycosylated) allergens of Bermuda and Timothy grass pollen 
but not to (non-glycosylated) recombinant grass pollen allergens on the chip (Chapter 6). 
As shown in Figure 1, the microarray technique used on a serum sample from a helminth-
infected individual compared to a European allergic patient can differentiate between IgE 
directed against protein structures that may be biologically active and IgE directed against 
carbohydrate moieties on glycosylated allergens (such as natural glycosylated pollen allergens) 
that have been shown to be  clinically irrelevant. Essentially, helminth-infected Indonesian 
children recognize purified natural pollen allergens because of having carbohydrate-specific 
IgE antibodies but do not recognize non-glycosylated recombinant pollen (and house dust 
mite) allergens. Helminth-induced cross-reactivity is most likely at the basis of these IgE 
responses. European children on the other hand clearly react with the latter category of 
allergens supporting true sensitization. Also, the high prevalence of positive IgE to peanut 
in the Indonesian children was shown to be caused by IgE against CCD, as demonstrated 
by inhibition with bromelain (a commonly used marker glycoprotein for CCD reactivity) 
and SEA (soluble egg antigen of S. haematobium, a source of helminth-derived CCD). The 
commonly recognized major peanut allergens (Ara h 1, 2, 3 and 6) were not recognized.
As described in Chapter 6, we also found high reactivity to recombinant venom allergens 
among school children in Indonesia. This cannot be explained by CCD. The source of 
sensitization to these venom allergens in children who do not appear to have clinical venom 
allergy is yet not clear. This unexpected IgE detection can be explained in two possible ways; 
there is a true sensitization to some kind of venom allergens (not necessarily the common 
wasps or bees represented by the recombinant allergens on the chip), or the majority of 
cases of double positivity to honey bee/wasp allergens may be due to sensitization to cross-
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Figure 1. Determination of allergic sensitization by microarray. An illustration of typical component-resolved 
diagnosis results generated using the ImmunoCAP ISAC™ microarray. The microarray shown contains natural and 
recombinant grass pollen as well as natural and recombinant peanut allergens. For an allergic European, the IgE 
recognizes and binds to the protein structures on both the natural and recombinant allergens for both grass pollen and 
peanut. This IgE is biologically active and also clinically relevant. In the serum of a helminth infected subject, elevated 
levels of IgE are observed that recognize and bind to carbohydrate moieties on the natural allergen components. This IgE 
does not bind to the protein structures of these components, is clinically irrelevant, and shows poor biological activity.
In summary, the study presented on the profile of IgE antibodies using a biochip array and 
plasma from a helminth-endemic area has provided evidence that there is a strong IgE reactivity 
to some of the natural allergen components from pollen which carry CCDs. This reactivity is 
probably helminth-induced. Our study also found unexpectedly high reactivity to recombinant 
venom allergens in children from a helminth-endemic area, but the origin of this sensitization 
still needs to be elucidated. We provide evidence of cross-reactivity between IgE to allergens and 
CCD markers, suggesting that using natural and recombinant allergens on microarray might 
help to better differentiate between real allergic sensitization and cross-reactivity for diagnosis 
of atopic disorders in low-to-middle income countries where helminth infections are prevalent. 
Further research into helminths and IgE should focus on refining and preparing new diagnostic 
methods for the developing world where allergies are increasing but the diagnosis is hampered by 
the lack of knowledge on locally important allergen sources and the complexity of the specificities 
and characteristics of IgE antibodies. Furthermore, a better understanding of how IgE cross-




SUMMARY OF THE FINDINGS
In this thesis, we investigated the risk factors for atopic sensitization and allergic 
disease in some areas of Indonesia where the socio-economic status and life style are 
very different from affluent countries. We studied the effect of anthelmintic treatment 
on atopic disorders. Furthermore, we characterized the IgE antibody profiles among 
children who are living in a helminth-endemic area. The main findings are:
• Specific IgE was a risk factor for being SPT positive and SPT positivity was a major 
risk factor for reported clinical symptoms of allergy in high-SES children from an 
urban area but not in low-SES (Chapter 2).
• High load of hookworm (Necator americanus) infection based on PCR method was 
an independent protective factor for HDM skin reactivity (Chapter 4)
• Cockroach skin reactivity was increased in children from farmer families, which are 
presumed to have higher exposure to cockroach (Chapter 4)
• Repeated three-monthly treatment with single dose albendazole over 21 months 
reduced but did not eliminate helminth infection (Chapter 5)
• Two years anthelminthic treatment increased skin reactivity especially to cockroach 
(Chapter 5).
• In an helminth-endemic area, carbohydrate-bearing allergens were more recognized 
than recombinant allergen components (Chapter 6)
• High reactivity to recombinant venom allergen was observed in children from a 
helminth-endemic area (Chapter 6)
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There has been a global increase in prevalence of allergic diseases. This is particularly so in 
developed and in urban centres of developing countries.  An inverse geographical pattern is seen 
when one considers helminth infections. Exposure to helminth infections has been minimal 
in developed countries and is being controlled in urban centres of developing countries due to 
improvement in sanitation and education as well as improved medical care. At the same time, in 
rural areas of developing countries helminth infections are still highly prevalent.  
Interestingly, both helminth infection and allergens are potent inducers of Th2 responses 
that lead to high levels of IgE, eosinophils, as well as the secretion of Th2 cytokines such as IL-4, 
IL-5, IL-9 and IL-13. Despite the similar immunological profiles associated with both helminth 
and allergies, several epidemiological studies have failed to show a consistent relationship 
between helminth infections and allergies. The role of socio-economic status (SES) which can 
be intertwined with presence or absence of helminth infections, has been examined in relation 
to development of allergic disorders in several studies. The results are gain conflicting. 
In both developed and developing countries, a strong correlation is observed between 
allergen-specific IgE and symptoms of allergy among urban populations of high SES. 
However, in developing countries, in rural populations or urban populations with low SES, 
helminth-induced IgE cross-reactivity and regulatory networks may prevent the translation 
of allergen-specific IgE into skin reactivity or allergic symptoms.
In addition, the isolation and characterization of allergen components, as well as their 
production by recombinant techniques, has led to significant progress in allergy diagnosis. 
Component-resolved diagnostics (CRD) allow the detection of specific IgE against 
individual allergen molecules instead of against allergen extracts comprised of mixtures of 
allergen molecules, which are commonly used in SPT and conventional specific IgE testing. 
The CRD method has been widely used in developed countries, but less used in non-affluent 
areas where helminth infections are highly prevalent.
The studies presented in this thesis shed light on the relationship between helminth 
infection, SES and atopic disorders in a developing country (Indonesia) where large 
differences in life-style, environmental exposure and SES are seen.
Chapter 1
This chapter presents the associations found between helminth infections and atopic 
disorders from previous studies. It also discusses how helminth infection can lead to IgE 
cross-reactivity with allergens and how this IgE has poor biological activity. In addition, it 
describes important information regarding the use of new diagnostic methods using CRD 




Chapters 2 and 4
Recent studies indicate that helminth infection is one of the environmental factors that, 
together with socio-economic status (SES), contribute to the development of allergies. In 
Chapters 2 and 4 we examined differences in prevalence of allergic outcomes in rural and 
semi-urban areas of Indonesia on Flores Island and in children of high and low SES families 
from an urban centre. Higher prevalence of skin reactivity to house dust mite (HDM) was 
found in the semi-urban area that seemed to be due to higher level of education (as part of 
the SES indicators) and a lower degree of helminth infections compared to the rural area. 
When considering children from the same urban centre but belonging to families with 
different socio-economic status, we found that whereas specific IgE to HDM increased the 
risk of being skin prick test positive and that a positive SPT to HDM was then associated 
with increased risk of wheezing in children of high SES, this was not the case in children 
of low SES families. Taken together, these results highlight that environmental as well as 
socio-economic factors should be considered by clinicians and researchers working on 
prevention, diagnosis and treatment of atopic disorders in low-to-middle income countries. 
More research is needed to evaluate the possible risk and protective factors in more detail 
as well as to pinpoint elements of SES that matter in the development of atopic disorders. 
Chapter 3
Here we provide a study protocol of a household randomized placebo-controlled trial in Flores 
Island to answer the question whether helminth infections play a role in the development of 
atopic disorders.  This chapter describes in detail the overview of the study population in a 
semi-urban and a rural area of Flores Island, Indonesia, which is used in chapters 4, 5 and 6.
Chapter 5
This chapter reports the malarial parasitemia and allergy outcomes of a 2-years duration 
randomized trial. Our two-year placebo controlled deworming trial shows a trend that 
deworming increases skin reactivity to any allergen. We found a significant increase in 
SPT reactivity to cockroach after 21 months of anthelmintic treatment. In addition, we 
also found that repeated three-monthly treatment with albendazole reduces but does not 
eliminate helminth infection. These findings suggest that longer intensive anthelmintic 
treatment, possibly a combination of drugs, or drugs and environmental control, is needed 
for future studies to achieve helminth elimination.
Chapter 6
The study presented here, regarding the profile of IgE antibodies using a biochip array and 
plasma from a helminth-endemic area, provides evidence that there is strong IgE reactivity to 
some of the natural allergen components from pollen which carry cross-reactive carbohydrate 




unexpectedly high reactivity to recombinant venom allergens (bee, common wasp and paper 
wasp) in children from a helminth-endemic area, but the origin of this sensitization still 
needs to be elucidated. We provide evidence of cross-reactivity between IgE to allergens and 
CCD markers, suggesting that using natural and recombinant allergens on the microarray 
might help to better differentiate between primary sensitization that is biologically relevant 
and cross-reactivity for diagnosis of atopic disorders in helminth-endemic low-to-middle 
income countries. Further research into helminths and IgE should focus on refining and 
preparing new diagnostic methods for the developing world where allergies are increasing 
but the diagnosis is hampered by the lack of knowledge on locally important allergen sources 
and the complexity of the specificities and characteristics of IgE antibodies.
Chapter 7
This chapter summarizes and discusses the main findings of the thesis. Taken together, we have 
demonstrated the association between atopic disorders and helminth infection and SES, as well 
as provided evidence that two years of deworming has a minimal impact on allergy outcomes. 
We characterized IgE antibody profiles in a helminth-endemic area and we showed that high 






De prevalentie van allergische aandoeningen neemt wereldwijd toe, zowel in de Westerse 
wereld als in stedelijke gebieden in ontwikkelingslanden. De geografische verspreiding van 
helminth-infecties laat een omgekeerd patroon zien: blootstelling aan wormen is minimaal 
in Westerse landen en wordt in de steden van ontwikkelingslanden verminderd door 
maatregelen op het gebied van hygiëne, voorlichting en medische voorzieningen. Op het 
platteland van ontwikkelingslanden is de prevalentie van helminth-infecties echter nog hoog. 
Interessant genoeg induceren zowel worminfecties als allergenen een sterke Th2-
immuunreactie, die bestaat uit hoge IgE-concentraties, eosinofilie en de uitscheiding van 
Th2-cytokines zoals IL-4, IL-5, IL-9 en IL-13. Ondanks het vergelijkbare immunologische 
profiel van helminth-infecties en allergieën, komt uit epidemiologische onderzoeken en 
interventiestudies geen eenduidige relatie tussen beide naar voren. Het hebben van een 
helminth-infectie is gedeeltelijk vervlochten met sociaal-economische status (SES). Uit 
verschillende onderzoeken naar de rol die SES speelt bij het ontwikkelen van allergieën 
komen wisselende resultaten naar voren. 
In zowel ontwikkelde als ontwikkelingslanden wordt er een sterke correlatie gevonden 
tussen allergeen-specifiek IgE en allergische symptomen in stadspopulaties met een hoge 
SES. Deze correlatie gaat in ontwikkelingslanden echter niet op voor plattelandsbewoners 
en stedelingen met lage SES, hetgeen mogelijk verklaard wordt door worm-geassocieerde 
IgE-kruisreactiviteit en immunoregulatoire netwerken die de progressie van allergeen-
specifiek IgE naar huidreacties of allergische symptomen voorkomen.
De isolatie, karakterisatie en productie van allergeencomponenten met behulp van 
recombinante technieken heeft geleid tot belangrijke verbeteringen binnen de diagnostiek van 
allergieën. ‘Component-resolved diagnostics’ (CRD) maakt het mogelijk om specifiek IgE te 
detecteren dat gericht is tegen  individuele allergenen, in plaats van tegen een mix van allergeen-
extracten zoals gebruikt wordt bij huidpriktesten (skin prick test, SPT) en conventionele 
methoden om specifiek IgE te detecteren. De CRD-methode wordt veel gebruikt in de Westerse 
wereld, maar minder in ontwikkelingslanden, waar worminfecties veelvuldig voorkomen.
De onderzoeken in dit proefschrift bekijken de relatie tussen worminfecties, SES en 
atopische aandoeningen in een ontwikkelingsland (Indonesië), waar grote verschillen 
bestaan in levensstijl, blootstelling aan omgevingsfactoren en SES.
Hoofdstuk 1
Dit hoofdstuk vat gegevens uit voorgaande studies samen over de associatie tussen 
worminfecties en atopische aandoeningen. Tevens wordt hierin besproken hoe 
worminfecties kunnen leiden tot IgE-kruisreactiviteit met allergenen en het feit dat dit IgE 
slechts matige biologische activiteit heeft. Verder wordt belangrijke informatie beschreven 
betreffende het gebruik van CRD beschreven als nieuwe diagnostische methode voor 




Hoofdstukken 2 en 4
Recent onderzoek heeft uitgewezen dat helminth-infectie één van de omgevingsfactoren 
is die samen met SES bijdraagt aan het ontstaan van allergieën. In hoofdstukken 2 en 4 
belichten we de verschillen in prevalentie van allergieën, zowel tussen het platteland en 
semi-stedelijke gebied op het eiland Flores (Indonesië) als tussen stedelijke kinderen 
met lage en hoge SES. Ten opzichte van het platteland bleek in semi-stedelijk gebied 
een hogere prevalentie van huidreacties tegen huisstofmijt, waarschijnlijk veroorzaakt 
door een hoger opleidingsniveau (onderdeel van de SES) en minder helminth-infecties. 
Wanneer we kinderen van verschillende SES binnen dezelfde stad vergeleken, bleek dat 
alleen in kinderen met een hoge SES de kans op een piepende ademhaling voorspeld 
werd door een positieve huidtest tegen huisstofmijt, hetgeen op zichzelf geassocieerd 
was met het hebben van specifiek IgE tegen huisstofmijt. Beide verbanden gingen niet 
op voor kinderen met een lage SES. Samenvattend geven deze resultaten aan dat zowel 
omgevings- als socioeconomische factoren in acht moeten worden genomen door artsen 
en onderzoekers die werken op het gebied van preventie, diagnostiek en behandeling van 
atopische aandoeningen in laag- en midden-inkomenslanden. Er is meer onderzoek nodig 
om de mogelijke risico- en beschermende factoren die betrokken zijn bij het ontstaan van 
atopische aandoeningen in meer detail uit te zoeken en om te achterhalen welke onderdelen 
van de SES hierin de belangrijkste rol spelen. 
Hoofdstuk 3
Hier wordt het studieprotocol weergegeven van een placebo-gecontroleerde trial 
gerandomiseerd op huishouden op het eiland Flores, om de vraag te beantwoorden of 
worminfecties een rol spelen bij de ontwikkeling van atopische aandoeningen. Dit hoofdstuk 
beschrijft gedetailleerd de onderzoekspopulaties in een semi-stedelijk en een plattelandsgebied 
op het eiland Flores (Indonesië), die gebruikt zijn in de hoofdstukken 4, 5 en 6.
Hoofdstuk 5
Dit hoofdstuk beschrijft de resultaten ten aanzien van malaria-parasitemie en allergie-
prevalentie van het twee jaar durende veldonderzoek. Onze trial van twee jaar placebo-
gecontroleerd ontwormen laat zien dat het behandelen van wormen de allergische 
huidreactiviteit licht verhoogd. Er was een  significante toename van huidreactiviteit 
tegen kakkerlak-componenten na 21 maanden ontwormen in vergelijking met placebo. 
Verder bleek dat herhaalde behandeling met albendazol elke drie maanden de hoeveelheid 
worminfecties vermindert maar niet geheel elimineert. Dit suggereert dat langere en 
intensievere wormbehandeling, mogelijk met een combinatie van middelen, nodig is bij 





Het onderzoek in hoofdstuk 6, waarin het profiel van IgE-antilichamen werd bepaald met 
een biochip-array in plasmamonsters uit een gebied endemisch voor wormen, levert bewijs 
dat er sterke IgE-reactiviteit is tegen sommige componenten van pollen die kruisreagerende 
koolhydraatdeterminanten (cross-reactive carbohydrate determinants, CCDs) bij zich 
dragen. Deze reactiviteit wordt waarschijnlijk veroorzaakt door worminfecties. Onze studie 
heeft ook onverwacht hoge reactiviteit gevonden tegen recombinante toxines van bijen en 
wespen in kinderen uit een wormrijk gebied, maar de oorsprong van deze reactiviteit moet 
nog verder worden onderzocht. We laten zien dat er kruisreactiviteit bestaat tussen IgE tegen 
allergenen en koolhydraatdeterminanten. Dit suggereert dat het gebruik van natuurlijke en 
recombinante allergenen op de microarray in helminth-endemische ontwikkelingslanden 
zou kunnen leiden tot een beter onderscheid tussen kruisreactiviteit en primaire sensitisatie 
die werkelijk biologisch relevant is. Verder onderzoek naar wormen en IgE zou zich moeten 
richten op nieuwe en meer verfijnde diagnostische methoden voor ontwikkelingslanden. 
Dit is van belang omdat allergieën steeds meer voorkomen in ontwikkelingslanden maar de 
diagnostiek wordt gehinderd door gebrek aan kennis over lokaal voorkomende allergenen 
en de complexe eigenschappen van IgE-antilichamen.
Hoofdstuk 7
In dit hoofdstuk worden de belangrijkste bevindingen van dit proefschrift samengevat en 
bediscussieerd. We hebben aangetoond hoe worminfecties en SES een rol spelen bij het 
ontstaan en de ontwikkeling van atopische aandoeningen en we hebben bewijs geleverd dat 
twee jaar ontwormen een minimale impact heeft op allergie. We hebben IgE-antilichamen 
verder gekarakteriseerd in een wormrijk gebied en we hebben laten zien dat hoge IgE-
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